Compound_CID,Name,Synonyms,Molecular_Weight,Molecular_Formula,Polar_Area,Complexity,XLogP,Heavy_Atom_Count,H-Bond_Donor_Count,H-Bond_Acceptor_Count,Rotatable_Bond_Count,InChI,SMILES,InChIKey,IUPAC_Name,Exact_Mass,Monoisotopic_Mass,Charge,Covalent_Unit_Count,Isotopic_Atom_Count,Total_Atom_Stereo_Count,Defined_Atom_Stereo_Count,Undefined_Atom_Stereo_Count,Total_Bond_Stereo_Count,Defined_Bond_Stereo_Count,Undefined_Bond_Stereo_Count,Linked_PubChem_Literature_Count,Linked_PubChem_Patent_Count,Linked_PubChem_Patent_Family_Count,MeSH_Headings,Annotation_Content,Annotation_Type_Count,Linked_BioAssays,Create_Date,Data_Source,Data_Source_Category,Tagged_by_PubChem,Mechanism_of_Action,Main_Medical_Use,drug_class
3016,Diazepam,"diazepam|Valium|439-14-5|Ansiolisina|Diazemuls|Apaurin|Faustan|Relanium|Seduxen|Sibazon|Stesolid|Alboral|Bialzepam|Ceregulart|Neurolytril|Serenamin|Valrelease|Ansiolin|Apozepam|Atensine|Calmpose|Cercine|Lembrol|Morosan|Setonil|Sonacon|Stesolin|Tranimul|Atilen|Duxen|Eridan|Levium|Paxate|Paxel|Vivol|Noan|Methyldiazepinone|Calmocitene|Condition|Diacepan|Diazepan|Diazetard|Dipezona|Domalium|Kiatrium|Liberetas|Paranten|Quetinil|Quiatril|Quievita|Relaminal|Renborin|Seduksen|Serenack|Serenzin|Tensopam|Tranqdyn|Tranquase|Tranquirit|Unisedil|Valitran|Aliseum|Amiprol|Assival|Diapam|Diastat|Dienpax|Duksen|Evacalm|Freudal|Frustan|Gihitan|Horizon|Plidan|Saromet|Sedipam|Umbrium|Vatran|Velium|Solis|Valeo|Vival|Zipan|Usempax ap|LA III|Methyl diazepinone|Centrazepam|Q-pam|Dialar|Dizac|La-Iii|An-Ding|e-Pam|Servizepam|Diazepam Intensol|Ro 5-2807|NSC-77518|Diacepin|Nervium|7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Diazepam-Lipuro|WY-3467|7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one|Diazepamum|Tensium|7-Chloro-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Diastat Acudial|Diazepam civ|LIBERVANT|2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-1-methyl-5-phenyl-|7-Chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2(1H)-one|DTXSID4020406|Methyldiazepinone (pharmaceutical)|Q3JTX2Q7TU|NRL-1|7-Chloro-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepine|7-Chloro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|NSC-169897|VALTOCO|RO-5-2807|1-Methyl-5-phenyl-7-chloro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Ro-52807|DTXCID20406|CHEBI:49575|7-chloro-1-methyl-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|NSC77518|NSC169897|Scriptopam|Valclair|Dialar fte|Diazepam Oral|Gabavale-5|Alupram 2|Alupram 5|Alupram 10|RefChem:6418|DIAZEPAM, CHOLINE|Diazepam Oral Solution (Concentrate)|7-Chloro-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on|207-122-5|NSC46083|Bensedin|Ruhsitus|Armonil|Dialag|Eurosan|Lamra|Kabivitrum|Gewacalm|Novazam|Valaxona|Valiquid|Diapax|Dipam|Paceum|Jinpanfan|Antenex|Arzepam|Drenian|Ducene|Kratium|Nellium|Nerozen|Zepaxid|Doval|Paxum|Sipam|Vazen|Placidox 5|D-Pam|Faustan,|Wy 3467|CHEMBL12|DZP|Alupram|Methyldiazepinone, pharmaceutical|Reliver|Sedapam|Apo-diazepam|LA 111|7-Chloro-1-methyl-5-3H-1,4-benzodiazepin-2(1H)-one|NCGC00178168-02|Calmociteno|Ansilive|Anxicalm|Anxionil|Benzopin|Betapam|Britazepam|Calmaven|Chuansuan|Desconet|Desloneg|Diaceplex|Diapine|Diaquel|Diatran|Diazepin|Disopam|Faustal|Gradual|Iazepam|Medipam|Mentalium|Metamidol|Nivalen|Nixtensyn|Notense|Novodipam|Ortopsique|Paralium|Prozepam|Psychopax|Radizepam|Trankinon|Trazepam|Valuzepam|Vanconin|Baogin|Calmod|Caudel|Diazem|Lovium|Mandro|Parzam|Dipaz|Dupin|Gubex|Lizan|Pomin|Winii|Diazepam Nordic|Diazepan leo|Diazepam Elmu|Diazepam Fabra|Diazepam Stada|Metil Gobanal|Diazepam Dak|Tranquo-tablinen|Diazepam Desitin|Euphorin P|Mandro-Zep|Sico Relax|Diazepam Rectubes|S.a. r.l.|Elcion CR|Placidox 2|Kratium 2|Diazepam-ratiopharm|Placidox 10|Diazepamu [Polish]|Diazepam-Eurogenerics|Diazepam (1mg/mL in Methanol)|Diazepamu|Mandrozep|Plumiaz|Tranquo-puren|Diazepamum [INN-Latin]|7-chloro-1-methyl-5-phenyl-1,3-dihydro-benzo[e][1,4]diazepin-2-one|WLN: T67 GNV JN IHJ CG G1 KR|CAS-439-14-5|SMR000058398|CCRIS 6009|Best [Pharaceutical]|HSDB 3057|2H-1, 7-chloro-1,3-dihydro-1-methyl-5-phenyl-|EINECS 207-122-5|UNII-Q3JTX2Q7TU|LA-111|1-Methyl-5-phenyl-7-chloro-1,4-benzodiazepin-2-one|7-Chloro-1-methyl-5-phenyl-1,4-benzodiazepin-2-one|NSC 169897|BRN 0754371|Anlin|DEA No. 2765|Pro pam|Diastat (TN)|Valium (TN)|Diazepam [USAN:USP:INN:BAN:JAN]|DIAZEPAM [HSDB]|DIAZEPAM [IARC]|DIAZEPAM [USAN]|DIAZEPAM [INN]|DIAZEPAM [JAN]|DIAZEPAM [MI]|DIAZEPAM [VANDF]|Spectrum3_001780|Spectrum4_000576|Spectrum5_001890|DIAZEPAM [MART.]|DIAZEPAM [WHO-DD]|BIDD:PXR0158|Oprea1_126223|SCHEMBL21442|BSPBio_003279|KBioGR_001012|5-24-04-00300 (Beilstein Handbook Reference)|MLS000759402|MLS001424086|BIDD:GT0105|DIAZEPAM [GREEN BOOK]|DivK1c_000967|Diazepam (JP18/USP/INN)|Diazepam, 1mg/ml in Methanol|DIAZEPAM [ORANGE BOOK]|DIAZEPAM CIV [USP-RS]|GTPL3364|S.A.R.L.|DIAZEPAM [EP MONOGRAPH]|DIAZEPAM [USP MONOGRAPH]|SCHEMBL29362687|HMS503A15|KBio1_000967|KBio3_002780|Diazepam 0.1 mg/ml in Methanol|Diazepam 1.0 mg/ml in Methanol|CHEBI:194180|NINDS_000967|HMS2051N04|HMS3393N04|Tox21_113071|Tox21_202458|7-Chloro-1-methyl-5-phenyl-1H-benzo[e][1,4]diazepin-2(3H)-one|BDBM50000766|STK735517|AKOS003367969|Diazepam 1000 microg/mL in Methanol|Tox21_113071_1|AB02310|BNZ - Human Serum, Benzodiazepine mix|CCG-100997|CS-0653|DB00829|NC00247|Ro 5-2805|IDI1_000967|NCGC00178168-01|NCGC00178168-03|NCGC00178168-04|NCGC00260007-01|AC-10561|HY-17027|DB-051179|NS00008403|NS00114260|C06948|D-1450|D00293|A826456|Q210402|BRD-K16508793-001-01-8|BRD-K16508793-001-05-9|Diazepam, European Pharmacopoeia (EP) Reference Standard|7-chloranyl-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one|7-chloro-1-methyl-5-phenyl-1H-1,4-benzodiazepine-2(3H)on|Diazepam, United States Pharmacopeia (USP) Reference Standard|7-chloro-1-methyl-5-phenyl-1,3-dihydro-[1,4]benzodiazepin-2-one|7-Chloro-1-methyl-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one|7 -chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H -1,4-benzodiazepin-2-one|7-chloro-1-methyl-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|7-Chloro-1-methyl-5-phenyl-2-oxo-2,3-dihydro-1H-benzo[f]-1,4-diazepine|7-chloro-1,3-dihydro-1-(methyl-d3)-5-(phenyl-d5)-2H-1,4-benzodiazepin-2-one|7-chloro-1-((2)H3)methyl-5-((2)H5)phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Diazepam for system suitability, European Pharmacopoeia (EP) Reference Standard|11100-37-1|7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one; 1-Methyl-5-phenyl-7-chloro-1,3-dihydro-2H-1,4-benzodiazepin-2-one ;  Alboral|7-chloro-5-(2,3,4,5,6-pentadeuteriophenyl)-1-(trideuteriomethyl)-3H-1,4-benzodiazepin-2-one|InChI=1/C16H13ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h2-9H,10H2,1H",284.74,C16H13ClN2O,32.7,403.0,3.0,20,0,2,1,"InChI=1S/C16H13ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3",CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,AAOVKJBEBIDNHE-UHFFFAOYSA-N,"7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one",284.0716407,284.0716407,0,1,0,0,0,0,0,0,0,53846,132264,36629,Diazepam,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Associated Disorders and Diseases|Spectral Information|Taxonomy|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,19,192|248|256|485|631|731|781|782|880|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1032|1040|1048|1049|1051|1066|1085|1135|1136|1189|1194|1195|1199|1203|1205|1208|1209|1214|1216|1217|1220|1222|1229|1236|1251|1274|1304|1321|1325|1359|1362|1415|1416|1423|1424|1434|1439|1440|1441|1443|1445|1446|1448|1454|1456|1460|1461|1463|1466|1467|1468|1469|1477|1479|1481|1486|1490|1496|1509|1510|1515|1527|1529|1530|1531|1533|1556|1565|1566|1578|1580|1581|1582|1583|1584|1585|1586|1587|1588|1589|1590|1593|1594|1595|1596|1597|1598|1599|1600|1601|1602|1603|1604|1605|1606|1607|1608|1609|1610|1612|1613|1614|1616|1619|1625|1626|1628|1631|1634|1654|1656|1665|1700|1706|1721|1722|1766|1768|1775|1776|1777|1778|1779|1789|1800|1817|1822|1825|1845|1861|1863|1865|1868|1903|1961|1984|1986|2006|2012|2013|2014|2058|2071|2073|2100|2101|2107|2112|2147|2240|2241|2242|2275|2288|2289|2313|2314|2315|2322|2330|2451|2472|2517|2528|2546|2549|2551|2662|2675|2676|2685|2732|3491|4134|4535|4551|7783|8002|13304|13305|13306|13307|13308|15120|16092|18847|19006|19262|19424|19427|21849|21851|21852|21853|21856|21858|22293|23479|26304|26380|27580|28233|28235|28236|28392|28399|28956|28957|29360|29421|29423|29811|29844|29925|32979|33556|35392|39905|39916|39918|39930|39931|39938|39939|40070|40228|40230|40231|40236|40239|40241|40361|40373|40381|40503|40513|40519|40520|40521|40522|40525|40661|40664|40666|40670|40671|40817|40822|40823|40826|40830|40831|40832|40835|40965|40966|40967|40968|40969|40970|40974|40987|40995|40997|40998|41000|41742|41852|41860|41862|41870|41983|41986|41991|41994|41996|41998|42009|42014|42018|42149|42162|42169|42310|42311|42333|42335|42338|42340|48704|52275|52280|52410|52413|71235|71245|71249|71266|71289|71558|71673|71678|71682|71697|71825|71826|71827|71828|71840|71985|71986|72003|72136|72138|72144|72297|72305|72444|72448|72467|72477|72585|72593|72594|72595|72620|72625|72640|72722|72732|72733|72765|72766|72779|72780|72906|72912|72916|72927|73070|73072|73075|73077|73078|73089|73220|73224|73229|73232|73233|73244|73376|73378|73523|73534|73539|106808|107095|107096|107099|108874|109527|109761|109841|109842|110034|110220|110223|110684|110865|111031|111033|111034|111173|111174|111175|111176|111179|111353|112189|112325|112326|112397|112455|112456|112459|112460|112461|112905|112958|112976|113267|113271|113288|113320|113361|113362|113418|113419|113420|113508|113530|113532|113609|113611|113642|113644|113646|113648|113650|113652|113655|113656|113658|113661|113663|113664|113666|113673|113678|113679|113820|113823|114126|114137|114384|114392|114393|114394|114395|114396|114407|114415|114462|114561|114562|114563|114565|114575|114825|114833|114835|114839|114842|114848|114856|114857|114858|114859|115603|115612|115679|115682|115683|117077|117096|118787|118789|118793|119151|119152|119176|119177|119507|119508|119511|119693|119817|119818|119822|121847|121857|122474|122475|122716|122717|122718|122792|122803|122804|122850|122851|122852|122858|122926|122927|122928|122929|123129|123784|123785|123811|123952|124223|124298|124460|124461|124462|125041|125298|126491|126644|127702|127859|128035|128039|128041|128132|128134|128136|128166|128167|128173|128302|128305|129024|129139|129141|129287|129461|129965|129966|130033|130034|130038|130039|130126|131026|131235|131352|131353|131372|131394|131868|131889|132084|132086|132087|132088|132243|132416|132949|132962|133112|134240|134421|134938|135326|136091|137602|139100|139244|139245|140702|140869|165929|168589|169088|171057|171076|171214|171219|171371|172397|172398|172399|172406|172407|172408|172936|172969|173052|173249|175771|176151|176153|176300|176404|176407|177059|177740|177961|178135|178197|178307|179149|179150|179166|179167|179289|179291|179296|179298|179307|179309|179311|179313|179316|179318|179507|180359|180952|180953|180954|180955|180956|181673|184545|184649|184668|184685|184686|184687|184688|184689|184691|184838|184839|184846|184848|184849|185013|185021|185028|185031|185032|185051|185194|185198|187250|187603|187604|188916|188919|188920|189432|189570|189575|190263|190628|191851|191852|191853|191854|194131|194132|194134|195780|195941|196364|196544|205268|205269|210588|212016|212017|213410|217794|219782|219783|219947|219948|220128|220130|220296|220441|220443|220445|220446|220448|221056|221740|221741|221743|222195|222196|222198|222343|223126|223127|223134|223173|223176|224360|225355|226272|226274|226277|226427|226428|226435|226437|226438|226451|226454|226455|226526|227697|227698|227718|228469|229087|229422|229555|229769|229770|230747|231293|231333|232380|232605|232720|233756|235586|235587|235588|237585|239299|239563|239564|239565|239566|240426|240427|242870|243413|243414|243415|243416|246891|246933|247022|247046|247063|247081|252193|252929|252930|252931|253162|253365|253367|254367|254368|254369|254370|255280|256039|256040|256042|259129|259130|259131|259132|259133|259134|259135|260334|260336|260339|260364|261133|261135|261136|261137|261138|261139|261140|262560|262561|262562|262962|275980|275981|275986|275987|275989|275990|275992|280839|280846|282665|282666|282667|282668|282669|282670|283715|283717|287755|287756|287757|287758|287759|287760|287761|287765|287766|287767|288809|288810|288812|288813|288814|288815|288890|288899|288900|288905|288906|288911|288912|288913|288914|293418|293420|293422|293424|293426|293428|293430|293434|294268|294270|294276|294611|294612|294613|298031|298032|306149|306150|306151|306152|306153|306154|308065|308067|309507|309508|309510|310931|310933|311367|311524|318309|318310|327169|327170|327589|327591|327595|327599|327600|327619|327623|330911|340238|343089|343090|346025|346404|352385|352387|356502|356503|356504|356505|356530|356537|356538|365612|365618|365619|365626|365627|365644|365645|365922|365923|366630|368136|368137|368138|368139|371496|371915|371917|371918|371920|371922|371923|371924|371925|372157|373867|377464|377465|377469|377470|377473|377474|377479|377480|377482|377483|377496|377504|377508|378496|378502|378503|378504|378971|378974|380160|385606|386623|389440|389959|389960|393947|393950|393953|393956|395324|395325|395327|399385|401477|407366|407369|408747|418109|418110|418111|418112|419264|419268|419272|419278|419293|419305|421594|425652|425653|434959|444050|444051|444052|444053|444054|444055|444056|444057|444058|444876|448080|448081|448242|448243|448244|448245|448246|449467|449468|449469|449477|449478|449479|449539|449540|449541|455986|463254|463963|463966|463967|463968|467612|467613|476929|476981|476982|476983|481439|481442|485281|485290|485294|485297|485298|485313|485314|485341|485344|485347|485353|485358|485364|485367|488837|492947|492967|493014|493017|493056|493084|493162|494430|494431|494432|494435|494436|496764|496768|496772|496817|496818|496819|496820|496821|496823|496824|496825|496826|496827|496828|496829|496830|496831|496832|497005|504327|504332|504333|504651|504652|504660|504810|504812|504842|537201|537203|537204|537207|537208|537211|537212|537220|537221|539464|539470|540209|540210|540211|540212|540213|540275|540277|545726|545727|548170|548171|548172|548173|548175|548176|548177|548178|566246|566783|566784|566785|577020|588208|588211|588212|588213|588214|588215|588216|588217|588218|588219|588220|588342|592681|599144|602332|603953|604020|604021|604022|604023|604024|604025|604026|604738|604739|604741|604742|604743|604744|611348|623669|623671|624030|624101|624136|624137|624138|624139|624141|624151|624156|624170|624172|624173|624260|624349|624647|624652|624654|624657|625144|625145|625146|625147|625148|625149|625150|625151|625152|625153|625154|625155|625156|625157|625158|625159|625160|625161|625162|625163|625164|625165|625166|625167|625168|625169|625170|625171|625172|625173|625174|625175|625176|625177|625178|625179|625180|625181|625182|625183|625184|625185|625186|625187|625188|625189|625190|625191|625192|625193|625194|625195|625196|625197|625198|625199|625200|625201|625202|625203|625204|625205|625206|625207|625208|625209|625210|625211|625212|625213|625214|625215|625216|625217|625218|625219|625220|625221|625222|625223|625224|625225|625226|625227|625228|625229|625230|625231|625232|625233|625234|625235|625236|625237|625238|625239|625240|625241|625242|625243|625244|625245|625246|625247|625248|625249|625250|625251|625252|625253|625254|625255|625256|625257|625258|625259|625260|625261|625262|625263|625264|625265|625266|625267|625268|625269|625270|625271|625272|625273|625274|625275|625279|625280|625281|625282|625283|625284|625285|625286|625287|625288|625289|625290|625291|625292|625819|625820|626991|643207|643210|643215|643249|643252|643255|643383|646285|646286|646287|646295|646423|646424|651548|651631|651632|651633|651634|651635|651828|652048|652051|663662|663981|667598|668118|668119|668120|668121|668122|668123|668124|668125|668126|668130|668132|670591|678730|678731|679279|681154|681164|681165|681355|686978|686979|699539|699540|699541|701025|701032|705095|705105|708769|720516|720532|720533|720552|720554|720634|720635|720637|720641|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720717|720719|720725|726252|733582|733583|733586|733945|733947|735821|739951|739953|739956|739957|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743140|743191|743194|743199|743202|743203|743209|743210|743211|743212|743213|743215|743217|743218|743219|743220|743221|743222|743223|743224|743225|743226|743227|743228|743239|743240|743241|743242|743244|743262|743268|743270|743271|743272|743281|749877|749878|749885|749886|749887|749888|751091|751680|751745|751896|752257|764469|764472|772064|772065|772074|779429|779440|779441|779442|1068425|1068427|1070095|1070525|1072083|1072084|1072088|1079931|1079932|1079933|1079934|1079935|1079936|1079937|1079938|1079939|1079940|1079941|1079942|1079943|1079944|1079945|1079946|1079947|1079948|1079949|1083853|1083854|1083856|1083859|1083862|10,20050325,"A&J Pharmtech CO., LTD.|AbaChemScene|Abbott Labs|ABI Chem|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Chemistry|Alomone Labs|Alsachim|Amadis Chemical|AN PharmaTech|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|Beilstein Journals|BenchChem|BIDD|BindingDB|BioChemPartner|Biosynth|BOC Sciences|Broad Institute|C. David Weaver Laboratory, Vanderbilt University|Carcinogenic Potency Database (CPDB)|CATO Research Chemicals Inc.|CCSbase|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chem-Space.com Database|ChemBank|Chembase.cn|ChEMBL|ChemBlock|ChemBridge|ChemDB|ChemExper Chemical Directory|Chemhere|Chemical Carcinogenesis Research Information System (CCRIS)|chemical genetic matrix|Chemical Synthesis Database|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|Cheminformatics Friedrich-Schiller-University Jena|ChemMol|ChemoSapiens|ChemSpider|Clearsynth|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|Crystallography Open Database (COD)|CymitQuimica|Debye Scientific Co., Ltd|DiscoveryGate|Drug Induced Liver Injury Rank (DILIrank) Dataset|DrugBank|DrugCentral|DTP/NCI|EAWAG Biocatalysis/Biodegradation Database|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|eInhibitors|enviPath|EPA DSSTox|EPA Substance Registry Services|FDA Global Substance Registration System (GSRS)|Fisher Drug Discovery Resource Center|Genetic Toxicology Data Bank (GENE-TOX)|Google Patents|Hangzhou APIChem Technology|Horrigan Lab, Baylor College of Medicine|Human Metabolome Database (HMDB)|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|Innovapharm|ISpharm|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|LGC Standards|MassBank Europe|MassBank of North America (MoNA)|Mcule|MedChemexpress MCE|Metabolomics Workbench|Milwaukee Institute for Drug Discovery|MLSMR|Molepedia|MolGenie|National Center for Advancing Translational Sciences (NCATS)|Nature Chemical Biology|Nature Chemistry|NCBI Structure|NextBio|NextMove Software|NIAID ChemDB|NIH Clinical Collection|NINDS Approved Drug Screening Program|NIST Chemistry WebBook|NIST Mass Spectrometry Data Center|NMRShiftDB|NORMAN Suspect List Exchange|Novartis Institutes for BioMedical Research|NovoSeek|OChem|Parchem|PATENTSCOPE (WIPO)|Probes & Drugs portal|Protein Data Bank in Europe (PDBe)|PubChem Reference Collection|Public Access to Neuroactive & Anticonvulsant Chemical Evaluations (PANAChE)|RR Scientific|SCRIPDB|Sigma-Aldrich|Small Molecule Screening Facility, UW Madison|SMID|Springer Nature|SpringerMaterials|Starshine Chemical|SureChEMBL|Synblock Inc|THE BioTek|The Cambridge Structural Database|Therapeutic Target Database (TTD)|Thieme Chemistry|Thomson Pharma|Tocris Bioscience|Tox21|ToxPlanet|Vitas-M Laboratory|VWR, Part of Avantor|Wikidata|Wiley|xPharm: The Comprehensive Pharmacology Reference|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|ZeroPM - Zero Pollution of Persistent, Mobile Substances|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine|D002491 - Central Nervous System Agents > D000927 - Anticonvulsants|D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics|D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives|D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents|D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents|D005765 - Gastrointestinal Agents > D000932 - Antiemetics|D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents|D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents|D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators|N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives,"Diazepam is a benzodiazepine tranquilliser with anticonvulsant, sedative, muscle relaxant and amnesic properties.  Benzodiazepines, such as diazepam, bind to receptors in various regions of the brain and spinal cord. This binding increases the inhibitory effects of gamma-aminobutyric acid (GABA). GABAs functions include CNS involvement in sleep induction. Also involved in the control of hypnosis, memory, anxiety, epilepsy and neuronal excitability.","In general, diazepam is useful in the symptomatic management of mild to moderate degrees of anxiety in conditions dominated by tension, excitation, agitation, fear, or aggressiveness such as may occur in psychoneurosis, anxiety reactions due to stress conditions, and anxiety states with somatic expression.  Moreover, in acute alcoholic withdrawal, diazepam may be useful in the symptomatic relief of acute agitation, tremor, and impending acute delirium tremens.  Furthermore, diazepam is a useful adjunct for the relief of skeletal muscle spasm due to reflex spasm to local pathologies, such as inflammation of the muscle and joints or secondary to trauma; spasticity caused by upper motor neuron disorders, such as cerebral palsy and paraplegia; athetosis and the rare ""stiff man syndrome"".  Particular label information from the United Kingdom also lists particular age-specific indications, including for adults: (1) The short-term relief (2-4 weeks) only, of anxiety which is severe, disabling, or subjecting the individual to unacceptable distress, occurring alone or in association with insomnia or short-term psychosomatic, organic or psychotic illness, (2) cerebral palsy, (3) muscle spasm, (4) as an adjunct to certain types of epilepsy (eg. myoclonus), (5) symptomatic treatment of acute alcohol withdrawal, (6) as oral premedication for the nervous dental patient, and (7) for premedication before surgery.  In the same UK label information, diazepam is indicated in children for: (1) control of tension and irritability in cerebral spasticity in selected cases, (2) as an adjunct to the control of muscle spasm in tetanus, and for (3) oral premedication.  A diazepam nasal spray is indicated in patients 6 years and older to treat intermittent, stereotypic episodes of frequent seizure activity that are different than the patient's usual seizure pattern.",benzodiazepine
2802,Clonazepam,"clonazepam|Klonopin|Rivotril|1622-61-3|Chlonazepam|Iktorivil|Cloazepam|Clonazepamum|Ravotril|Rivatril|5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one|Ro 4-8180|Klonopin Rapidly Disintegrating|Clonazepam civ|5-(2-Chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one|2H-1,4-Benzodiazepin-2-one, 5-(2-chlorophenyl)-1,3-dihydro-7-nitro-|Ro-5-4023|1,3-Dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|Ro 54023|5-(o-Chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one|5PE9FDE8GB|7-Nitro-5-(2-chlorophenyl)-3H-1,4-benzodiazepin-2(1H)-one|Ro-54023|NSC-179913|DTXSID1022845|2H-1,4-Benzodiazepin-2-one, 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-|5-(2-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|5-(o-Chlorophenyl)-7-nitro-1H-1,4-benzodiazepin-2(3H)-one|5-(o-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|RO5-4023|CHEBI:3756|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(2-chlorophenyl)-7-nitro-2,3-dihydro-1H-1,4-benzodiazepin-2-one|5-(2-chlorophenyl)-7-nitro-1H-benzo(e)(1,4)diazepin-2(3H)-one|5-(2-chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo(e)(1,4)diazepin-2-one|RefChem:5697|DTXCID002845|N03AE01|216-596-2|Antelepsin|Clonopin|Landsen|Antilepsin|Lonazep|Kenoket|Paxam|Ro 5-4023|NSC 179913|CHEMBL452|Lktorivil|NIOSH/DF2374250|Solfidin|Alti-Clonazepam|NSC179913|Melzap|DF23742500|1,3-Dihydro-5-(o-chlorophenyl)-7-nitro-3H-1,4-benzodiazepin-2-one|2-H-1,4-Benzodiazepin-2-one, 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-|106955-87-7|Clonazepamum [INN-Latin]|Apetryl|3H-1,4-Benzodiazepin-2-one, 1,3-dihydro-5-(o-chlorophenyl)-7-nitro-|Clonazepam (1.0 mg/mL in Methanol)|Clonazepam (1.0mg/ml in Acetonitrile)|Klonopin (TN)|Ro 5-4023/B-7|HSDB 3265|EINECS 216-596-2|UNII-5PE9FDE8GB|BRN 0759557|DEA No. 2737|Clonazepam, powder|Ro 4023|RO4023|Clonazepam [USAN:USP:INN:BAN:JAN]|CLONAZEPAM [MI]|CLONAZEPAM [INN]|CLONAZEPAM [JAN]|CLONAZEPAM [HSDB]|CLONAZEPAM [USAN]|1,4.benzodiazepin-2-one|CLONAZEPAM [VANDF]|CLONAZEPAM [MART.]|CLONAZEPAM [WHO-DD]|BIDD:PXR0144|Oprea1_168772|SCHEMBL38899|5-24-04-00351 (Beilstein Handbook Reference)|MLS003899214|DivK1c_000973|Clonazepam (JP18/USP/INN)|GTPL6963|Clonazepam, 1mg/ml in Methanol|CLONAZEPAM [ORANGE BOOK]|CLONAZEPAM CIV [USP-RS]|SCHEMBL29361251|SCHEMBL29369721|SCHEMBL29743048|HMS503C07|KBio1_000973|CLONAZEPAM [EP MONOGRAPH]|NINDS_000973|CLONAZEPAM [USP MONOGRAPH]|HMS2093H22|Clonazepam 0.1 mg/ml in Methanol|Clonazepam 1.0 mg/ml in Methanol|VGA08215|BDBM50019213|AKOS015902192|CCG-213669|DB01068|IDI1_000973|WLN: T67 GMV JN IHJ CNW KR BG|AC-15733|SMR000058982|SBI-0206863.P001|NS00010427|5-(2-Chlorophenyl)-1,4-benzodiazepin-2-one|5-(o-Chlorophenyl)-1,4-benzodiazepin-2-one|D00280|AB01563349_01|622C613|A810362|Q407988|SR-01000937610|2-H-1, 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-|2H-1, 5-(2-chlorophenyl)-1,3-dihydro-7-nitro-|2H-1, 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-|Q-200880|SR-01000937610-2|BRD-K38183498-001-02-0|Clonazepam, European Pharmacopoeia (EP) Reference Standard|5-(2-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one #|7-nitro-1,3-dihydro-5-(o-chlorophenyl)-2H-1,4-benzodiazepin-2-one",315.71,C15H10ClN3O3,87.3,491.0,2.4,22,1,4,1,"InChI=1S/C15H10ClN3O3/c16-12-4-2-1-3-10(12)15-11-7-9(19(21)22)5-6-13(11)18-14(20)8-17-15/h1-7H,8H2,(H,18,20)",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3Cl,DGBIGWXXNGSACT-UHFFFAOYSA-N,"5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one",315.0410689,315.0410689,0,1,0,0,0,0,0,0,0,14456,47624,9140,Clonazepam,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Associated Disorders and Diseases|Spectral Information|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,17,248|423|424|1195|1580|1581|1582|1583|1584|1585|1586|1587|1588|1589|1590|1593|1594|1595|1596|1597|1598|1599|1600|1601|1602|1603|1604|1605|1606|1607|1608|1609|1610|1612|1613|1614|1616|22293|23479|26304|29360|29811|40817|40826|40987|40995|41741|41853|41871|41873|41988|52275|52280|52410|52413|71572|72312|72591|102218|131776|131910|131913|131925|131927|131932|219916|225156|226275|226431|227697|227698|227700|229422|232605|239299|280839|291617|306149|306150|306151|306152|306153|306154|311524|337891|338175|418131|418132|418133|418134|418135|418136|418137|418138|425652|425653|444050|444051|444052|444053|444054|444055|444056|444057|444058|492967|493162|539464|539470|540209|540210|540211|540212|540213|540214|540215|540216|540217|540218|540219|540220|540221|540230|540231|540232|540233|604741|604742|604743|604744|624349|625144|625145|625146|625147|625148|625149|625150|625151|625152|625153|625154|625155|625156|625157|625158|625159|625160|625161|625162|625163|625164|625165|625166|625167|625168|625169|625170|625171|625172|625173|625174|625175|625176|625177|625178|625179|625180|625181|625182|625183|625184|625185|625186|625187|625188|625189|625190|625191|625192|625193|625194|625195|625196|625197|625198|625199|625200|625201|625202|625203|625204|625205|625206|625207|625208|625209|625210|625211|625212|625213|625214|625215|625216|625217|625218|625219|625220|625221|625222|625223|625224|625225|625226|625227|625228|625229|625230|625231|625232|625233|625234|625235|625236|625237|625238|625239|625240|625241|625242|625243|625244|625245|625246|625247|625248|625249|625250|625251|625252|625253|625254|625255|625256|625257|625258|625259|625260|625261|625262|625263|625264|625265|625266|625267|625268|625269|625270|625271|625272|625273|625274|625275|625279|625280|625281|625282|625283|625284|625285|625286|625287|625288|625289|625290|625291|625292|720641|720717|1079931|1079932|1079933|1079934|1079935|1079936|1079937|1079938|1079939|1079940|1079941|1079942|1079943|1079944|1079945|1079946|1079947|1079948|1079949|1097336|1128799|1128800|1128801|1150161|1150162|1150163|1150164|1150165|1159387|1159388|1159396|1159580|1224863|1256679|1256680|1256681|1259251|1259318|1259408|1259416|1259421|1342825|1342826|1345086|1346496|1346504|1346520|1347080|1474166|1474167|1660982|1671498|1704779|1704780|1704781|1894694|1918969|1918990|1961681|1961683|1961684|1961686|1961689|1961691|1961692|1961694|1961695|1961697|1961698|1961699|1961700|1961701|1961705|1961707|1961708|1961709|1961710|1961711|1961712|1961714|1961715|1961720|1961721|1961722|1961724|1961727|1961728|1961730|1961732|1961733|1961734|1961738|1961740|1961742|1961743|1961748|1961750|1961755|1961758|1961759|1961760|1961761|1961762|1961763|1961764|1961765|1961766|1961767|1961768|1961770|1961771|1961773|1961774|1961775|1961776|1961778|1961779|1961780|1961781|1961785|1961788|1961789|1961790|1961791|1961792|1961807|1961808|1961809|1961810|1961815|1961819|1961825|1961827|1961837|1961841|1961846|1961847|1961848|1961849|1961850|1961851|1961852|1961853|1961855|1961856|1961857|1961858|1961859|1961868|1961878|1963987|2161948|2161949,20050325,"001Chemical|A2B Chem|ABI Chem|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alsachim|Amadis Chemical|Ambinter|AN PharmaTech|ASINEX|Aurora Fine Chemicals LLC|BIDD|BindingDB|Biosynth|Boerchem|Broad Institute|CATO Research Chemicals Inc.|CCSbase|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|ChEBI|ChemBank|Chembase.cn|ChEMBL|ChemDB|chemical genetic matrix|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemoSapiens|ChemSpider|ChemTik|Clearsynth|Clinivex|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|CymitQuimica|DiscoveryGate|Drug Induced Liver Injury Rank (DILIrank) Dataset|DrugBank|DrugCentral|DTP/NCI|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|EPA DSSTox|EPA Substance Registry Services|FDA Global Substance Registration System (GSRS)|Genetic Toxicology Data Bank (GENE-TOX)|Google Patents|Hangzhou APIChem Technology|Human Metabolome Database (HMDB)|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|Innovapharm|InvivoChem|ISpharm|IUPHAR/BPS Guide to PHARMACOLOGY|Jamson Pharmachem Technology|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|LGC Standards|MassBank Europe|MassBank of North America (MoNA)|Metabolomics Workbench|MLSMR|MolCore|MolGenie|NextBio|NextMove Software|NIAID ChemDB|NINDS Approved Drug Screening Program|NIST Chemistry WebBook|NIST Mass Spectrometry Data Center|NMRShiftDB|NORMAN Suspect List Exchange|Novartis Institutes for BioMedical Research|NovoSeek|OChem|PATENTSCOPE (WIPO)|Probes & Drugs portal|PubChem Reference Collection|Public Access to Neuroactive & Anticonvulsant Chemical Evaluations (PANAChE)|RR Scientific|Sanford-Burnham Center for Chemical Genomics|SCRIPDB|Sigma-Aldrich|Southern Research Institute|Springer Nature|Starshine Chemical|SureChEMBL|THE BioTek|The Scripps Research Institute Molecular Screening Center|Therapeutic Target Database (TTD)|Thieme Chemistry|Thomson Pharma|ToxPlanet|University of Iowa High-Throughput Screening Core (UIHTS)|VWR, Part of Avantor|Wikidata|Wiley|xPharm: The Comprehensive Pharmacology Reference|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|Yuhao Chemical|ZeroPM - Zero Pollution of Persistent, Mobile Substances|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent|C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine|D002491 - Central Nervous System Agents > D000927 - Anticonvulsants|D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators|N - Nervous system > N03 - Antiepileptics > N03A - Antiepileptics > N03AE - Benzodiazepine derivatives,"Gamma-Aminobutyric acid (GABA) is considered the principal inhibitory neurotransmitter in the human body. When GABA binds to GABA(a) receptors found in neuron synapses, chloride ions are conducted across neuron cell membranes via an ion channel in the receptors. With enough chloride ions conducted, the local, associated neuron membrane potentials are hyperpolarized - making it more difficult or less likely for action potentials to fire, ultimately resulting in less excitation of the neurons.   Subsequently, benzodiazepines like clonazepam can bind to benzodiazepine receptors that are components of various varieties of GABA(a) receptors. This binding acts to enhance the effects of GABA by increasing GABA affinity for the GABA(a) receptor, which ultimately enhances GABA ligand binding at the receptors. This enhanced ligand binding of the inhibitory neurotransmitter GABA to the receptors increases the aforementioned chloride ion conduction (perhaps reportedly via an increase in the frequency of the chloride channel opening), resulting in a hyperpolarized cell membrane that prevents further excitation of the associated neuron cells. Combined with the notion that such benzodiazepine receptor associated GABA(a) receptors exist both peripherally and in the CNS, this activity consequently facilitates various effects like sedation, hypnosis, skeletal muscle relaxation, anticonvulsant activity, and anxiolytic action.  In particular, when out of the ordinary rapid and repetitive electrical signals are released in the CNS, it is proposed that the brain can become over-stimulated and ordinary functions are disrupted - resulting in seizure activity. By enhancing the neuro-inhibitory activity of GABA, it is believed that clonazepam can facilitate in decreasing any excessive electrical nerve activity in the CNS that might be contributing to seizures. Concurrently, it is also believed that clonazepam's actions in enhancing GABA effects may inhibit neuronal activity proposed to occur in amygdala-centered fear circuits - therefore assisting in the management of anxiety or panic.","Clonazepam is indicated as monotherapy or as an adjunct in the treatment of Lennox-Gastaut syndrome (petit mal variant), akinetic, and myoclonic seizures. Furthermore, clonazepam may also be of some value in patients with absence spells (petit mal) who have failed to respond to succinimides. Additionally, clonazepam is also indicated for the treatment of panic disorder, with or without agoraphobia, as defined in the DSM-V.  Alternatively, some regional prescribing information note that clonazepam is indicated for all clinical forms of epileptic disease and seizures in adults, especially absence seizures (petit mal) including atypical absence; primary or secondarily generalised tonic-clonic (grand mal), tonic or clonic seizures; partial (focal) seizures with elementary or complex symptomatology; various forms of myoclonic seizures, myoclonus and associated abnormal movements. Such regional label data also has clonazepam indicated for most types of epilepsy in infants and children, especially absences (petit mal), myoclonic seizures and tonic-clonic fits, whether due to primary generalized epilepsy or to secondary generalization of partial epilepsy.",benzodiazepine
2118,Alprazolam,"alprazolam|Xanax|28981-97-7|Niravam|Solanax|Tranquinal|Alplax|Xanor|Alpronax|Xanax XR|Restyl|8-Chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine|Nu-Alpraz|TUS-1|Alprazolamum|Alprazolam civ|U-31889|8-Chloro-1-methyl-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine|U-31,889|DTXSID4022577|YU55MQ3IZY|NSC-760140|8-Chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine|4H-s-Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-1-methyl-6-phenyl-|4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-1-methyl-6-phenyl-|CHEBI:2611|DTXCID102577|Alprazolan|U 31,889|4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine, 8-chloro-1-methyl-6-phenyl-|Novo Alprazol|Apo Alpraz|Nu Alpraz|4H-(1,2,4)Triazolo(4,3-alpha)(1,4)benzodiazepine, 8-chloro-1-methyl-6-phenyl-|D65MT|Alprazolam ER|Alprazolam XR|Apo-Alpzar|8-chloro-1-methyl-6-phenyl-4h-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepine|Alprazolam C-IV|12-chloro-3-methyl-9-phenyl-2,4,5,8-tetraazatricyclo(8.4.0.0^(2,6))tetradeca-1(10),3,5,8,11,13-hexaene|12-chloro-3-methyl-9-phenyl-2,4,5,8-tetraazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,8,11,13-hexaene|U31,889|RefChem:6374|Alprazolam Extended Release|Alprazolam Extended-release|N05BA12|12-chloro-3-methyl-9-phenyl-2,4,5,8-tetraazatricyclo(8.4.0.02,6)tetradeca-1(10),3,5,8,11,13-hexaene|249-349-2|Trankimazin|Tafil|Constan|Frontal|Apo-Alpraz|Alcelam|Anpress|Relaxol|Tricalma|Valeans|Xanagis|Zolarem|Alpaz|Alpram|Alzam|Panix|Prinox|Zoldac|Zotran|Alprazolam intensol|Xanolam|Zolam|Zopax|Zopic|Tafil D|Xanax TS|D 65MT|Cassadan|Esparon|U 31889|Alzolam|AZ-002|Bestrol|Ralozam|Alprox|Neurol|CHEMBL661|Novo-Alprazol|Pharnax|Prazolan|Tensivan|Zacetin|Zanapam|Alprax|Ksalol|Mialin|Prazam|Unilan|Zoldax|Algad|Alzon|Helex|Zaxan|Zenax|Gen-Alprazolan|NCGC00159466-02|51339-48-1|Alprazolamum [INN-Latin]|Alprazolam (1mg/mL in Methanol)|Tus 1|Panistat|Alprazolam extended release tablets|Staccato-alprazolam|SMR000149316|Xanax (TN)|HSDB 7207|EINECS 249-349-2|UNII-YU55MQ3IZY|TGAR01P|BRN 1223125|DEA No. 2882|08H|Alprazolam [USAN:USP:INN:BAN:JAN]|AP-1002|3u5j|ALPRAZOLAM [MI]|ALPRAZOLAM [INN]|ALPRAZOLAM [JAN]|ALPRAZOLAM [HSDB]|ALPRAZOLAM [USAN]|ALPRAZOLAM [VANDF]|ALPRAZOLAM [MART.]|SCHEMBL8398|ALPRAZOLAM [WHO-DD]|BIDD:PXR0150|MLS000559000|MLS000759485|MLS001423979|BIDD:GT0475|Alprazolam (JP18/USP/INN)|GTPL7111|Alprazolam, 1mg/ml in Methanol|ALPRAZOLAM [EP IMPURITY]|ALPRAZOLAM [ORANGE BOOK]|SCHEMBL29381667|ALPRAZOLAM [EP MONOGRAPH]|ALPRAZOLAM [USP MONOGRAPH]|HMS2051A10|HMS3393A10|Pharmakon1600-01502395|Alprazolam 0.1 mg/ml in Methanol|Alprazolam 1.0 mg/ml in Methanol|MEA39364|Tox21_111692|BBL028160|BDBM50001728|NSC760140|STK590494|AKOS005066050|CCG-100855|DB00404|NC00105|NSC 760140|NCGC00159466-03|AC-18721|FA111888|BNZB - Human Serum, Benzodiazepine mix B|CAS-28981-97-7|DB-242959|NS00010452|C06817|D00225|981A977|A819702|Q319877|BRD-K32398298-001-01-4|Alprazolam, European Pharmacopoeia (EP) Reference Standard|8-chloro-1-methyl-6-phenyl-4H-s-triazolo [4,3-a] [1,4] benzodiazepine|8-chloro-1-methyl-6-phenyl-4H-s-triazolo [4,3-a][1,4] benzodiazepine|8-chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-alpha][1,4]benzodiazepine|8-chloro-6-phenyl-1-methyl-4H-s-triazolo-[4,3-a][1,4]benzodiazepine|4H-(1,2,4)TRIAZOLO(4,3-.ALPHA.)(1,4)BENZODIAZEPINE, 8-CHLORO-1-METHYL-6-PHENYL-|8-chloranyl-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine|1246182-61-5",308.8,C17H13ClN4,43.1,434.0,2.1,22,0,3,1,"InChI=1S/C17H13ClN4/c1-11-20-21-16-10-19-17(12-5-3-2-4-6-12)14-9-13(18)7-8-15(14)22(11)16/h2-9H,10H2,1H3",CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,VREFGVBLTWBCJP-UHFFFAOYSA-N,"8-chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine",308.0828741,308.0828741,0,1,0,0,0,0,0,0,0,8481,18236,6227,Alprazolam,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Associated Disorders and Diseases|Spectral Information|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,17,485|568|583|598|602|618|620|629|630|631|633|639|648|687|701|719|731|750|781|782|834|880|881|894|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1040|1048|1049|1051|1066|1085|1135|1136|1195|1203|1209|1214|1216|1217|1220|1222|1229|1236|1251|1274|1304|1321|1325|1359|1362|1379|1415|1416|1423|1424|1434|1439|1440|1441|1443|1445|1446|1448|1452|1454|1456|1457|1460|1461|1463|1466|1467|1468|1469|1471|1476|1477|1478|1479|1481|1486|1487|1490|1496|1509|1510|1515|1527|1529|1530|1531|1533|1556|1565|1566|1578|1619|1625|1626|1628|1631|1634|1654|1656|1665|1688|1700|1706|1721|1722|1766|1768|1775|1776|1777|1778|1779|1789|1800|1817|1822|1825|1845|1861|1863|1865|1868|1903|1948|1961|1984|1986|2006|2012|2013|2014|2058|2071|2073|2100|2101|2107|2112|2147|2242|2288|2289|2314|2315|2451|2472|2517|2528|2546|2549|2551|2662|2675|2676|2685|2732|7783|8002|19424|22293|26304|26380|28233|28235|28236|29359|29423|29811|29925|52403|52421|71232|71233|71237|71238|71246|71247|76083|112334|112343|112344|113321|113663|113664|113666|113678|113679|113820|113823|113894|113898|117406|117408|117410|117411|128826|129148|131236|131571|131572|131573|135326|167798|187152|188129|221773|221774|224180|224348|243422|384955|384956|425652|425653|444050|444051|444052|444053|444054|444055|444056|444057|444058|463254|467612|467613|476929|485281|485290|485294|485297|485298|485313|485314|485341|485344|485347|485353|485358|485364|485367|488837|492947|492961|493014|493056|493084|496817|496818|496819|496820|496821|496823|496824|496825|496826|496827|496828|496829|496830|496831|496832|497005|504327|504332|504333|504651|504652|504660|504749|504810|504812|504832|504834|504842|504847|504865|539464|539468|540209|540210|540211|540212|540213|540275|540277|588214|588215|588216|588217|588218|588219|588342|588579|588834|589039|602332|603953|624030|624031|624032|624044|624170|624172|624173|624296|624297|624349|625144|625145|625146|625147|625148|625149|625150|625151|625152|625153|625154|625155|625156|625157|625158|625159|625160|625161|625162|625163|625164|625165|625166|625167|625168|625169|625170|625171|625172|625173|625174|625175|625176|625177|625178|625179|625180|625181|625182|625183|625184|625185|625186|625187|625188|625189|625190|625191|625192|625193|625194|625195|625196|625197|625198|625199|625200|625201|625202|625203|625204|625205|625206|625207|625208|625209|625210|625211|625212|625213|625214|625215|625216|625217|625218|625219|625220|625221|625222|625223|625224|625225|625226|625227|625228|625229|625230|625231|625232|625233|625234|625235|625236|625237|625238|625239|625240|625241|625242|625243|625244|625245|625246|625247|625248|625249|625250|625251|625252|625253|625254|625255|625256|625257|625258|625259|625260|625261|625262|625263|625264|625265|625266|625267|625268|625269|625270|625271|625272|625273|625274|625275|625279|625280|625281|625282|625283|625284|625285|625286|625287|625288|625289|625290|625291|625292|648843|648844|648845|648846|648847|648848|648849|648850|648851|648852|648853|648857|648858|648859|651631|651632|651633|651634|651828|652048|652051|686978|686979|720516|720532|720533|720552|720554|720634|720635|720637|720641|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720717|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743140|743244|743268|743270|743271|743272|743281|977611|1079931|1079932|1079933|1079934|1079935|1079936|1079937|1079938|1079939|1079940|1079941|1079942|1079943|1079944|1079945|1079946|1079947|1079948|1079949|1097336|1117301|1117302|1117303|1117311|1117315|1117318|1117319|1129361|1136120|1136387|1136388|1136389|1136390|1136391|1136392|1136393|1136394|1136395|1136396|1136397|1137410|1137411|1137412|1137413|1137414|1137415|1137416|1137417|1137418|1137419|1148192|1148193|1148194|1150961|1150962|1150963|1150964|1150965|1150966|1150967|1150968|1150969|1159387|1159389|1159395|1159396|1159607|1209581|1209582|1209583|1209593|1259251|1259310|1259325|1259344|1259355|1259356|1259374|1259389|1259397|1259398|1259406|1259413|1259422|1259423|1296008|1314276|1314277|1342825|1345199|1346496|1346504|1346513|1346520|1346983|1346984|1346985|1346986|1346987|1347080|1383661|1409565|1409566|1409567|1409568|1409569|1409570|1409571|1474166|1474167|1508591|1508602|1508612|1533611|1533612|1552590|1645843|1645848|1645882|1645883|1645886|1645887|1660982|1671498|1727019|1794731|1794732|1794733|1794735|1794736|1794738|1794739|1794740|1794742|1794745|1794746|1794748|1794750|1794751|1794752|1794753|1794754|1794755|1794756|1794757|1794759|1794760|1794761|1794763|1794764|1794765|1794767|1794768|1794769|1794771|1794772|1794773|1794774|1794775|1794776|1794777|1794779|1794780|1794781|1794782|1794783|1794784|1794785|1794786|1794787|1794788|1794789|1794790|1794792|1794793|1794794|1794795|1794796|1794798|1794799|1794800|1847942|1847943|1847947|1847948|1889906|1889907|1889908|1889909|1890739|1917372|1918969|1961681|1961683|1961684|1961686|1961689|1961691|1961692|1961694|1961695|1961697|1961698|1961699|1961700|1961701|1961705|1961707|1961708|1961709|1961710|1961711|1961712|1961714|1961715|1961720|1961721|1961722|1961724|1961727|1961728|1961729|1961730|1961732|1961733|1961734|1961738|1961740|1961742|1961743|1961748|1961750|1961755|1961758|1961759|1961760|1961761|1961762|1961763|1961764|1961765|1961766|1961767|1961768|1961770|1961771|1961773|1961774|1961775|1961776|1961778|1961779|1961780|1961781|1961785|1961788|1961789|1961790|1961791|1961792|1961807|1961808|1961809|1961810|1961815|1961819|1961825|1961827|1961837|1961841|1961846|1961847|1961848|1961849|1961850|1961851|1961852|1961853|1961855|1961856|1961857|1961858|1961859|1961878|1964044|1964045|1967387|1967388|1967389|1967390|2060272|2061569,20050325,"A&J Pharmtech CO., LTD.|ABI Chem|Acorn PharmaTech Product List|AKos Consulting & Solutions|Amadis Chemical|Beilstein Journals|BenchChem|BIDD|BindingDB|BioChemPartner|Biosynth|Boerchem|Broad Institute|C. David Weaver Laboratory, Vanderbilt University|CATO Research Chemicals Inc.|CCSbase|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemDB|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|Cheminformatics Friedrich-Schiller-University Jena|ChemMol|ChemoSapiens|ChemSpider|Clearsynth|Clinivex|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|CymitQuimica|Debye Scientific Co., Ltd|DiscoveryGate|Drug Induced Liver Injury Rank (DILIrank) Dataset|DrugBank|DrugCentral|DTP/NCI|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|EPA DSSTox|EPA Substance Registry Services|FDA Global Substance Registration System (GSRS)|Fisher Drug Discovery Resource Center|Google Patents|Hangzhou APIChem Technology|Horrigan Lab, Baylor College of Medicine|Human Metabolome Database (HMDB)|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|InvivoChem|ISpharm|IUPHAR/BPS Guide to PHARMACOLOGY|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|LGC Standards|MassBank Europe|MassBank of North America (MoNA)|Mcule|Metabolomics Workbench|Midas Pharma GmbH|Milwaukee Institute for Drug Discovery|MLSMR|Molepedia|MolGenie|National Center for Advancing Translational Sciences (NCATS)|Nature Chemical Biology|NCBI Structure|NextBio|NextMove Software|NIH Clinical Collection|NIST Chemistry WebBook|NIST Mass Spectrometry Data Center|NORMAN Suspect List Exchange|Novartis Institutes for BioMedical Research|NovoSeek|OChem|PATENTSCOPE (WIPO)|Probes & Drugs portal|Protein Data Bank in Europe (PDBe)|Prous Science Drugs of the Future|PubChem Reference Collection|Public Access to Neuroactive & Anticonvulsant Chemical Evaluations (PANAChE)|RR Scientific|SCRIPDB|Shanghai Institute of Organic Chemistry|Sigma-Aldrich|Small Molecule Screening Facility, UW Madison|Springer Nature|Starshine Chemical|SureChEMBL|THE BioTek|Therapeutic Target Database (TTD)|Thieme Chemistry|Thomson Pharma|Tox21|ToxPlanet|Vitas-M Laboratory|VWR, Part of Avantor|Wikidata|Wiley|xPharm: The Comprehensive Pharmacology Reference|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|ZeroPM - Zero Pollution of Persistent, Mobile Substances|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine|D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives|D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents|D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents|D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators|N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives,"Neurotransmission relies on excitatory and inhibitory signalling. -aminobutyric acid (GABA) type-A receptors (GABA<sub>A</sub>Rs) are members of the pentameric ligand-gated ion channel (PLGIC) superfamily located synaptically and perisynaptically to mediate phasic inhibition and extrasynaptically to mediate tonic inhibition. GABA<sub>A</sub>Rs comprise a variety of subunits from a homologous family whose members are named based on sequence identity as one of 1-6, 1-3, 1-3, , , , , and 1-3. Each subunit possesses an extracellular (ECD), transmembrane (TMD), and intracellular (ICD) domain; inter-subunit interfaces are the primary points of neurotransmitter and modulator binding, described by coordination of the principal (+) and complementary (-) sites in each subunit. Binding of GABA to GABA<sub>A</sub>Rs induces pore opening, rapid flow of chloride ions, and synaptic hyperpolarization, which in turn manifests as an inhibitory signal.  The most prevalent GABA<sub>A</sub>Rs _in vivo_ are the 122 receptors, which contain both GABA (+/-) and benzodiazepine (BZD, +/-) binding sites in the intersubunit interfaces of the relevant subunits. In general, any receptors containing an <sub>x</sub>/<sub>z</sub> interface, where x = 1-3,5 and z = 1-3, have potential high-affinity BZD binding sites, although small sequence differences between subunits may alter binding affinity to individual molecules. The 4 and 6 subunits, in which an otherwise conserved histidine is replaced by arginine, do not bind traditional BZD ligands such as diazepam and hence are considered ""diazepam-insensitive"". GABA binding results in a series of conformational changes in the ECDs of GABA<sub>A</sub>R  subunits, ""locking"" each to its neighbouring - interface. The binding of alprazolam in the high-affinity BZD site stabilizes the +/- interface and facilitates the conformational changes that lead to pore opening, hence functioning as a positive allosteric modulator.  The exact manner in which GABA<sub>A</sub>R allosteric modulation mediates the therapeutic and unwanted effects of benzodiazepines remains unclear. Earlier studies suggested that the primary factor was the  subunit composition, with 1-containing receptors mediating the sedative effects, 2/3-containing receptors the anxiolytic effects, and 5-containing receptors the memory effects of benzodiazepines. More recent studies suggest a more complex set of factors including subunit composition, physiological location, neuronal circuit, and nerve cell type. To further complicate matters, there may be up to five distinct BZD binding sites on GABA<sub>A</sub>Rs, with site 1 corresponding to the classical high-affinity +/- interface. The effects of binding at sites 2-4 are not fully understood and likely impart greater complexity to benzodiazepine pharmacological action.","Alprazolam is indicated for the acute treatment of generalized anxiety disorder in adults. Alprazolam is also indicated, either as a standard or extended-release formulation, for the treatment of panic disorder with or without agoraphobia in adults.  Alprazolam may also be prescribed off-label for insomnia, premenstrual syndrome, and depression.",benzodiazepine
4506,Nitrazepam,"nitrazepam|Benzalin|146-22-5|Mogadon|Apodorm|Calsmin|Eunoctin|Neozepam|Neuchlonic|Nitrados|Radedorm|Sonebon|Hipsal|Imeson|Remnos|Surem|Somitran|Sonnolin|Trazenin|Unisomnia|Hipnax|Imesont|Nelbon|Nelmat|Pelson|Paxisyn|Eatan|Relact|N-Desmethylnimetazepam|Persopit|Gerson|Ibrovek|Nitrazepamum|Atempol|1,3-Dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Somnite|Ro 4-5360|Ro 5-3059|NSC-58775|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|7-nitro-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-nitro-5-phenyl-|DTXSID5023372|2,3-Dihydro-7-nitro-5-phenyl-1H-1,4-benzodiazepin-2-on|7-Nitro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one|9CLV70W7HS|N05CD02|NSC58775|2,3-dihydro-7-nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Nitrazadon|Nitrodiazepam|Ro-45360|Ro-53059|RO-4-5360|RO-5-3059|CHEBI:7581|DTXCID803372|Rhoxal Nitrazepam|Nitrazepam Neuraxpharm|RefChem:854223|205-665-2|Epibenzalin|Epinelbon|Nitrenpax|Dumolid|Cerson|Dormin-5|Mogadan|Mogadone|Magadon|Megadon|Nitrazepamum [INN-Latin]|LA 1|S 2000|Mitidin|Dormo-Puren|CHEMBL13209|Eatan N|Somnased|Somnibel|NCGC00159358-02|Calsamin|Eunoktin|Ipersed|Nitravet|Nitrempax|Noctesed|Pacisyn|LA 1 (VAN)|Dormicum (anticonvulsant)|7-Nitro-5-phenyl-1,3-dihydro-benzo[e][1,4]diazepin-2-one|Nitrazepam [USAN:INN:BAN:JAN]|Nitrazepam (100?g/ml in Acetonitrile)|Nitrazepam (TN)|Benzalin (TN)|CAS-146-22-5|Nitrazepam (1.0 mg/mL in Acetonitrile)|SMR000058302|CCRIS 1931|EINECS 205-665-2|NSC 58775|UNII-9CLV70W7HS|BRN 0757185|DEA No. 2834|ISOPROPYLACETATE/NITRAZEPAM|Ro 53-60|NITRAZEPAM [MI]|NITRAZEPAM [INN]|NITRAZEPAM [JAN]|NITRAZEPAM [USAN]|ChemDiv1_022312|NITRAZEPAM [MART.]|NITRAZEPAM [WHO-DD]|NITRAZEPAM [WHO-IP]|Oprea1_476234|SCHEMBL35202|5-24-04-00344 (Beilstein Handbook Reference)|MLS001304053|MLS001424061|Nitrazepam (JP18/USAN/INN)|SCHEMBL29408437|HMS650G04|KJONHKAYOJNZEC-UHFFFAOYSA-|NITRAZEPAM [EP MONOGRAPH]|1, 3-Dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|HMS2051F19|HMS2272G03|HMS3393F19|7-Nitro-1,4-benzodiazepin-2-one|LFA76545|Nitrazepam, 1mg/ml in Acetonitrile|NITRAZEPAMUM [WHO-IP LATIN]|Tox21_111601|BDBM50020856|PDSP1_000120|PDSP2_000120|STK806322|AKOS002254707|Nitrazepam 0.1 mg/ml in Acetonitrile|Nitrazepam 1.0 mg/ml in Acetonitrile|Tox21_111601_1|WLN: T67 GMV JN IHJ CNW KR|AB02342|AC-4537|CCG-100977|DB01595|FN59698|NC00227|NCGC00159358-03|2H-1, 1,3-dihydro-7-nitro-5-phenyl-|7-Nitro-5-phenyl-2,4-benzodiazepin-2-one|DB-042832|NS00000041|C07487|D00531|146N225|A808471|Q410078|7-nitro-5-phenyl-1H-benzo[e][1,4]diazepin-2(3H)-one|Nitrazepam, British Pharmacopoeia (BP) Reference Standard|Nitrazepam, European Pharmacopoeia (EP) Reference Standard|1,3-Dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepine-2-one|7-Nitro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one #|InChI=1/C15H11N3O3/c19-14-9-16-15(10-4-2-1-3-5-10)12-8-11(18(20)21)6-7-13(12)17-14/h1-8H,9H2,(H,17,19)",281.27,C15H11N3O3,87.3,452.0,2.2,21,1,4,1,"InChI=1S/C15H11N3O3/c19-14-9-16-15(10-4-2-1-3-5-10)12-8-11(18(20)21)6-7-13(12)17-14/h1-8H,9H2,(H,17,19)",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,KJONHKAYOJNZEC-UHFFFAOYSA-N,"7-nitro-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one",281.08004122,281.08004122,0,1,0,0,0,0,0,0,0,3983,25019,6301,Nitrazepam,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Associated Disorders and Diseases|Spectral Information|Taxonomy|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,17,192|248|880|881|894|1030|1195|1379|1452|1457|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1688|1766|1768|1865|1948|1996|2016|2023|2025|2029|2052|2066|2101|2107|2112|2280|2314|2315|2380|2435|2445|2451|2472|2517|2520|2521|2524|2528|2540|2544|2546|2549|2551|2557|2599|2606|2662|2690|2751|2796|2797|2805|2806|2825|13304|13305|13306|13307|13308|22293|23479|26304|29360|29811|40987|40995|41996|128035|131235|139100|194131|194133|194135|227697|227698|227699|228469|311524|346025|425652|425653|434955|434962|434973|434989|435003|435022|435030|444050|444051|444052|444053|444054|444055|444056|444057|444058|449728|449762|449763|463079|463082|463104|463141|463190|463195|463210|463212|463254|485270|485272|485273|485275|485281|485290|485341|485346|485349|485353|485360|485367|488837|488839|488847|488862|488890|488895|488896|488899|488965|488966|489030|489031|492947|492953|492956|492961|492967|492972|493005|493008|493011|493012|493014|493036|493087|493091|493098|493131|493160|493187|493244|504326|504327|504329|504332|504339|504357|504411|504414|504423|504441|504444|504454|504462|504466|504467|504490|504523|504558|504577|504582|504634|504648|504690|504692|504700|504706|504707|504720|504734|504749|504766|504775|504803|504810|504812|504832|504834|504842|504845|504847|504865|504884|504891|504894|504937|540209|540210|540211|540212|540213|540253|540263|540267|540295|540303|540308|540317|540336|540364|588211|588212|588213|588220|588334|588335|588352|588354|588358|588391|588405|588413|588436|588453|588456|588458|588473|588475|588478|588489|588492|588493|588497|588499|588501|588549|588579|588590|588591|588621|588664|588674|588689|588692|588726|588727|588795|588814|588819|588834|588850|588852|588855|588856|602123|602141|602162|602163|602179|602229|602233|602244|602247|602248|602250|602252|602261|602274|602281|602310|602313|602329|602332|602340|602342|602346|602363|602393|602396|602399|602405|602410|602429|602438|602440|602449|602481|603955|623870|623877|623901|624030|624031|624032|624037|624038|624040|624044|624125|624126|624127|624168|624169|624170|624171|624172|624173|624178|624202|624204|624246|624263|624267|624268|624288|624296|624297|624304|624330|624349|624352|624354|624377|624414|624415|624416|624417|624418|624463|624464|624465|624466|624467|624483|625144|625145|625146|625147|625148|625149|625150|625151|625152|625153|625154|625155|625156|625157|625158|625159|625160|625161|625162|625163|625164|625165|625166|625167|625168|625169|625170|625171|625172|625173|625174|625175|625176|625177|625178|625179|625180|625181|625182|625183|625184|625185|625186|625187|625188|625189|625190|625191|625192|625193|625194|625195|625196|625197|625198|625199|625200|625201|625202|625203|625204|625205|625206|625207|625208|625209|625210|625211|625212|625213|625214|625215|625216|625217|625218|625219|625220|625221|625222|625223|625224|625225|625226|625227|625228|625229|625230|625231|625232|625233|625234|625235|625236|625237|625238|625239|625240|625241|625242|625243|625244|625245|625246|625247|625248|625249|625250|625251|625252|625253|625254|625255|625256|625257|625258|625259|625260|625261|625262|625263|625264|625265|625266|625267|625268|625269|625270|625271|625272|625273|625274|625275|625279|625280|625281|625282|625283|625284|625285|625286|625287|625288|625289|625290|625291|625292|651550|651560|651572|651602|651631|651632|651633|651634|651635|651636|651640|651644|651647|651654|651658|651661|651687|651699|651702|651710|651711|651718|651719|651723|651724|651725|651768|651800|651819|651820|651821|651828|651957|651958|651965|651999|652010|652017|652025|652039|652048|652051|652054|652067|652104|652105|652106|652126|652162|652163|652197|652257|678707|679757|681116|686940|686964|686970|686971|686978|686979|686996|687014|687016|720504|720508|720509|720511|720513|720514|720516|720532|720533|720542|720543|720551|720552|720553|720554|720579|720580|720582|720596|720634|720635|720637|720641|720647|720648|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720700|720702|720704|720706|720707|720708|720709|720711|720717|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743126|743139|743140|743191|743194|743199|743202|743203|743209|743210|743211|743212|743213|743215|743217|743218|743219|743220|743221|743222|743223|743224|743225|743226|743227|743228|743239|743240|743241|743242|743244|743255|743266|743268|743269|743270|743271|743272|743279|743281|743287|743398|1053175|1053197|1097336|1117267|1117298|1117301|1117302|1117303|1117304|1117305|1117310|1117311|1117312|1117314|1117315|1117318|1149718|1149719|1149720|1149721|1149722|1149728|1149729|1149730|1150161|1150162|1150163|1150164|1150165|1159509|1159515|1159516|1159517|1159518|1159519|1159520|1159521|1159523|1159524|1159525|1159526|1159527|1159528|1159529|1159531|1159551|1159552|1159553|1159555|1159606|1159607|1159614|1224834|1224835|1224836|1224837|1224838|1224839|1224840|1224841|1224842|1224843|1224844|1224845|1224846|1224847|1224848|1224849|1224857|1224859|1224865|1224867|1224868|1224869|1224870|1224871|1224872|1224873|1224874|1224875|1224876|1224877|1224878|1224879|1224880|1224881|1224882|1224883|1224884|1224885|1224886|1224887|1224888|1224889|1224890|1224892|1224893|1224894|1224895|1224896|1224905|1259241|1259242|1259243|1259244|1259247|1259248|1259251|1259309|1259310|1259311|1259313|1259318|1259325|1259344|1259355|1259356|1259364|1259365|1259366|1259367|1259368|1259369|1259374|1259377|1259378|1259379|1259380|1259381|1259382|1259383|1259384|1259385|1259386|1259387|1259388|1259389|1259390|1259391|1259392|1259393|1259394|1259395|1259396|1259397|1259398|1259400|1259401|1259402|1259403|1259404|1259406|1259407|1259408|1259413|1259415|1259422|1259423|1272365|1296008|1296009|1342825|1345084|1345199|1346378|1346428|1346784|1346795|1346798|1346799|1346824|1346829|1346859|1346877|1346891|1346924|1346977|1346978|1346979|1346980|1346981|1346982|1346983|1346984|1346985|1346986|1346987|1347030|1347031|1347032|1347033|1347034|1347035|1347036|1347037|1347038|1347041|1347053|1347055|1347056|1347071|1347075|1347076|1347080|1347082|1347083|1347085|1347086|1347089|1347090|1347091|1347092|1347093|1347094|1347095|1347096|1347097|1347098|1347099|1347100|1347101|1347102|1347103|1347104|1347105|1347106|1347107|1347108|1347120|1347131|1347154|1347395|1347397|1347398|1347399|1347407|1347424|1347425|1409565|1409566|1409567|1409568|1409569|1409570|1409571|1443980|1473738|1473739|1473740|1473741|1508602|1508616|1508620|1508623|1508624|1508630|1529184|1529185|1529186|1529187|1645839|1645840|1645841|1645842|1645843|1645851|1645870|1645876|1645877|1645882|1645883|1645886|1645887|1671188|1671190|1671193|1671194|1671196|1671197|1671198|1671199|1671200|1671201|1671463|1671498|1745845|1745856|1745857|1918969|1919968|1919969|1919970|1920062|1920063|1920064|1920065|1920067|1920068|1961681|1961683|1961684|1961689|1961691|1961692|1961694|1961695|1961697|1961699|1961701|1961705|1961707|1961708|1961710|1961712|1961714|1961720|1961721|1961722|1961724|1961727|1961730|1961734|1961738|1961748|1961755|1961758|1961760|1961762|1961766|1961767|1961770|1961771|1961773|1961774|1961776|1961778|1961780|1961781|1961785|1961788|1961789|1961790|1961791|1961803|1961807|1961809|1961810|1961811|1961815|1961817|1961818|1961825|1961827|1961837|1961846|1961847|1961848|1961849|1961851|1961852|1961855|1961856|1963577|1963578|1963579|1963580|1963581|1963582|1963583|1963584|1963585|1963586|1963587|1963588|1963589|1963590|1963591|1963592|1963593|1963594|1963595|1963596|1963823|1963824|1963987|2060913|2060914|2061098|2061099|2061100|2061101|2061102|2061103|2061104|2061105|2061106|2061107,20050325,"ABI Chem|AHH Chemical co.,ltd|AiFChem, an XtalPi Company|AKos Consulting & Solutions|Alsachim|Amadis Chemical|Ambinter|AN PharmaTech|Angene Chemical|Aurora Fine Chemicals LLC|BenchChem|BindingDB|Biosynth|BLD Pharm|Boerchem|C. David Weaver Laboratory, Vanderbilt University|CATO Research Chemicals Inc.|CCSbase|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chem-Space.com Database|ChemBank|Chembase.cn|ChEMBL|ChemBridge|ChemDB|Chemhere|Chemical Carcinogenesis Research Information System (CCRIS)|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemoSapiens|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|CymitQuimica|Debye Scientific Co., Ltd|DiscoveryGate|DrugBank|DrugCentral|DTP/NCI|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|EPA DSSTox|EPA Substance Registry Services|FDA Global Substance Registration System (GSRS)|Fisher Drug Discovery Resource Center|Genetic Toxicology Data Bank (GENE-TOX)|Google Patents|Hangzhou APIChem Technology|Horrigan Lab, Baylor College of Medicine|Human Metabolome Database (HMDB)|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|Innovapharm|InvivoChem|ISpharm|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|LGC Standards|MassBank Europe|MassBank of North America (MoNA)|Mcule|Metabolomics Workbench|Milwaukee Institute for Drug Discovery|MLSMR|MolGenie|MuseChem|National Center for Advancing Translational Sciences (NCATS)|Nature Chemical Biology|NextBio|NextMove Software|NIAID ChemDB|NIH Clinical Collection|NIST Chemistry WebBook|NIST Mass Spectrometry Data Center|NMRShiftDB|NORMAN Suspect List Exchange|NovoSeek|OChem|PATENTSCOPE (WIPO)|Probes & Drugs portal|PubChem Reference Collection|Public Access to Neuroactive & Anticonvulsant Chemical Evaluations (PANAChE)|RR Scientific|Sigma-Aldrich|Small Molecule Screening Facility, UW Madison|Springer Nature|SureChEMBL|Synblock Inc|THE BioTek|Therapeutic Target Database (TTD)|Thieme Chemistry|Thomson Pharma|Tox21|ToxPlanet|Vitas-M Laboratory|VWR, Part of Avantor|Wikidata|Wiley|xPharm: The Comprehensive Pharmacology Reference|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|Yuhao Chemical|ZeroPM - Zero Pollution of Persistent, Mobile Substances|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine|D002491 - Central Nervous System Agents > D000927 - Anticonvulsants|D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives|D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents|D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents|D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators|N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives,"Nitrazepam belongs to a group of medicines called benzodiazepines. This drug affects central benzodiazepine receptors, which are associated with inhibitory GABA (gamma amino butyric acid)receptors, leading to enhanced GABA binding activity. GABA is a major neurotransmitter in the brain, which causes somnolence, relaxation of muscles, a decrease in anxiety and general central nervous system depression. Nitrazepam has anticonvulsant properties that may be attributed to its ability to bind to voltage-dependent sodium channels. Sustained repetitive firing seems to be limited by benzodiazepines effect of slowing recovery of sodium channels from inactivation.","Used to treat short-term sleeping problems (insomnia), such as difficulty falling asleep, frequent awakenings during the night, and early-morning awakening.",benzodiazepine
5556,Triazolam,"triazolam|Halcion|28911-01-5|Clorazolam|Songar|Novidorm|Triazolamum|U-33,030|Triazolam civ|8-Chloro-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine|U-33030|DTXSID6046763|U 33030|8-Chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine|N05CD05|4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-6-(2-chlorophenyl)-1-methyl-|1HM943223R|8-Chloro-6-(2-chlorophenyl)-1-methyl-4H-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepine|CHEBI:9674|DTXCID4026763|4H-s-Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-6-(o-chlorophenyl)-1-methyl-|Gen Triazolam|Apo Triazo|8-Chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine|4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine, 8-chloro-6-(2-chlorophenyl)-1-methyl-|8-Chloro-6-[2-chlorophenyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine|U33,030|U 33,030|Kention|12-chloro-9-(2-chlorophenyl)-3-methyl-2,4,5,8-tetraazatricyclo(8.4.0.0^(2,6))tetradeca-1(10),3,5,8,11,13-hexaene|12-chloro-9-(2-chlorophenyl)-3-methyl-2,4,5,8-tetraazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,8,11,13-hexaene|RefChem:58531|12-chloro-9-(2-chlorophenyl)-3-methyl-2,4,5,8-tetraazatricyclo(8.4.0.02,6)tetradeca-1(10),3,5,8,11,13-hexaene|249-307-3|Triazolamum [INN-Latin]|DEA No. 2887|CHEMBL646|MFCD00079623|NCGC00168258-01|Novodorm|Trilam|Hypnostat|Triazolam (100 ug/mL in Methanol)|Halcion (TN)|Halcion (triazolam)|C17H12Cl2N4|CCRIS 1932|HSDB 6759|EINECS 249-307-3|TGAR01H|BRN 1226643|Hypam|UNII-1HM943223R|Triazolam [USAN:USP:INN:BAN:JAN]|TRIAZOLAM [INN]|TRIAZOLAM [JAN]|TRIAZOLAM [MI]|TRIAZOLAM [HSDB]|TRIAZOLAM [USAN]|TRIAZOLAM [VANDF]|TRIAZOLAM [MART.]|TRIAZOLAM [WHO-DD]|SCHEMBL29228|MLS003899243|Triazolam (JP18/USP/INN)|Triazolam, 1mg/ml in Methanol|GTPL7313|TRIAZOLAM [ORANGE BOOK]|TRIAZOLAM CIV [USP-RS]|SCHEMBL29349744|SCHEMBL29368430|SCHEMBL29382425|TRIAZOLAM [USP MONOGRAPH]|Triazolam 0.1 mg/ml in Methanol|Triazolam 1.0 mg/ml in Methanol|Triazolam, 0.1mg/ml in Methanol|HY-B0694|Tox21_112617|28911-01-5 (free)|BDBM50001765|DB00897|FT137319|SMR000058837|CAS-28911-01-5|NS00010468|D00387|U33030|911T015|L000796|Q412143|SR-01000937604|SR-01000937604-2|BRD-K76890464-001-02-3|Triazolam, European Pharmacopoeia (EP) Reference Standard|8-chloro-1-methyl-6-(o-chlorophenyl)-4H-s-triazolo-[4,3-a][1,4] benzodiazepine|8-chloro-1-methyl-6-(o-chlorophenyl)-4H-s-triazolo[4,3-a][1,4]benzodiazepine|8-chloro-6-(2-chlorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine|8-Chloro-6-(2-chlorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]-benzodiazepine",343.2,C17H12Cl2N4,43.1,472.0,2.4,23,0,3,1,"InChI=1S/C17H12Cl2N4/c1-10-21-22-16-9-20-17(12-4-2-3-5-14(12)19)13-8-11(18)6-7-15(13)23(10)16/h2-8H,9H2,1H3",CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,JOFWLTCLBGQGBO-UHFFFAOYSA-N,"8-chloro-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine",342.0439018,342.0439018,0,1,0,0,0,0,0,0,0,4593,31585,6250,Triazolam,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Associated Disorders and Diseases|Spectral Information|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,17,1471|1490|1688|1766|1768|2528|2546|2551|2662|7783|8002|22293|26304|26362|29359|29811|40376|40377|52403|52421|71266|72927|73089|73244|73523|76083|128826|129148|131236|131571|131572|131573|167798|224180|224348|233962|311524|343089|343090|384955|384956|389440|425652|425653|444050|444051|444052|444053|444054|444055|444056|444057|444058|467611|467612|467613|492961|493017|496817|496818|496819|496820|496821|496823|496824|496825|496826|496827|496828|496829|496830|496831|496832|497005|504327|504332|504749|504832|504834|504847|504865|520313|539464|540209|540210|540211|540212|540213|588214|588215|588216|588217|588218|588219|588579|588834|589039|602332|611614|624030|624031|624032|624044|624170|624172|624173|624296|624297|625279|625280|625281|625282|625283|625284|625285|625286|625287|625288|625289|625290|625291|625292|648843|648844|648845|648846|648847|648848|648849|648850|648851|648857|648858|648859|651631|651632|651633|651634|652048|652051|686978|686979|688286|688292|699539|699540|699541|720516|720532|720533|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743140|743244|1079931|1079932|1079933|1079934|1079935|1079936|1079937|1079938|1079939|1079940|1079941|1079942|1079943|1079944|1079945|1079946|1079947|1079948|1079949|1097336|1117301|1117302|1117303|1117311|1117315|1117318|1136110|1136111|1136112|1136113|1136114|1136115|1136116|1136117|1136119|1136120|1136121|1136124|1136125|1136387|1136388|1136389|1136390|1136391|1136392|1136393|1136394|1136395|1136396|1136397|1137410|1137411|1137412|1137413|1137414|1137415|1137416|1137417|1137418|1137419|1150961|1150962|1150963|1150964|1150965|1150966|1150967|1150968|1150969|1159387|1159389|1159395|1218474|1218475|1218476|1218477|1218478|1218479|1218480|1218481|1218482|1218483|1218484|1218485|1218486|1218487|1218488|1218489|1259251|1259344|1259355|1259356|1259407|1259416|1259421|1296008|1342823|1342824|1345199|1346496|1346504|1346513|1346520|1346983|1346984|1346985|1346986|1346987|1399089|1399090|1399091|1474166|1474167|1645882|1645883|1645886|1645887|1671498|1961681|1961683|1961684|1961686|1961689|1961691|1961692|1961694|1961695|1961697|1961699|1961701|1961705|1961707|1961708|1961710|1961712|1961714|1961715|1961720|1961721|1961722|1961724|1961727|1961728|1961729|1961734|1961738|1961748|1961755|1961758|1961760|1961762|1961766|1961767|1961770|1961771|1961773|1961774|1961775|1961776|1961778|1961780|1961781|1961785|1961788|1961789|1961790|1961791|1961803|1961807|1961809|1961810|1961815|1961819|1961825|1961827|1961837|1961846|1961847|1961848|1961849|1961851|1961852|1961853|1961855|1961856|1961858|1961878|1964044|1964045|2060272|2061569,20050325,"A&J Pharmtech CO., LTD.|AbaChemScene|Abbott Labs|ABI Chem|AHH Chemical co.,ltd|Alsachim|Ambinter|Aurora Fine Chemicals LLC|BindingDB|BioCrick|Biosynth|Broad Institute|CCSbase|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chembase.cn|ChEMBL|ChemDB|Chemical Carcinogenesis Research Information System (CCRIS)|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemoSapiens|ChemSpider|Clearsynth|Clinivex|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|CymitQuimica|DiscoveryGate|Drug Induced Liver Injury Rank (DILIrank) Dataset|DrugBank|DrugCentral|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|EPA DSSTox|EPA Substance Registry Services|FDA Global Substance Registration System (GSRS)|Glentham Life Sciences Ltd.|GLIDA, GPCR-Ligand Database|Google Patents|Human Metabolome Database (HMDB)|IBM|InvivoChem|IUPHAR/BPS Guide to PHARMACOLOGY|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|LGC Standards|MassBank Europe|MassBank of North America (MoNA)|MedChemexpress MCE|Metabolomics Workbench|MLSMR|MolGenie|National Center for Advancing Translational Sciences (NCATS)|Nature Chemical Biology|NextBio|NextMove Software|NIST Chemistry WebBook|NIST Mass Spectrometry Data Center|NORMAN Suspect List Exchange|NovoSeek|OChem|PATENTSCOPE (WIPO)|Probes & Drugs portal|Prous Science Drugs of the Future|PubChem Reference Collection|Public Access to Neuroactive & Anticonvulsant Chemical Evaluations (PANAChE)|RR Scientific|SCRIPDB|Sigma-Aldrich|Springer Nature|SureChEMBL|THE BioTek|The Scripps Research Institute Molecular Screening Center|Therapeutic Target Database (TTD)|Thieme Chemistry|Thomson Pharma|Tox21|ToxPlanet|VWR, Part of Avantor|Wikidata|Wiley|xPharm: The Comprehensive Pharmacology Reference|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|ZeroPM - Zero Pollution of Persistent, Mobile Substances|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine|D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants|D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents|D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents|D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators|N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives,"Benzodiazepines bind nonspecifically to bezodiazepine receptors BNZ1, which mediates sleep, and BNZ2, which affects affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABA<sub>A</sub>) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell.",For the short-term treatment of insomnia.,benzodiazepine
3958,Lorazepam,"lorazepam|Ativan|846-49-1|Temesta|Loraz|Wypax|Almazine|Anxiedin|Lorabenz|Orfidal|Lorazepam Intensol|Wy-4036|Lorazepamum|Wy 4036|7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one|Lorazepam preservative free|Lorazepam civ|2H-1,4-Benzodiazepin-2-one, 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-|DTXSID7023225|7-Chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one|O26FZP769L|LOREEV XR|NSC289758|DTXCID303225|Durazolam|Apo Lorazepam|Orfidal Wyeth|Novo Lorazem|Wyeth, Orfidal|7-chloro-5-(2-chlorophenyl)-3-hydroxy-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Medical, Lorazepam|Lorazepam ratiopharm|Lorazepam neuraxpharm|Von Ct, Lorazep|WY4036|Abbloraz|RefChem:5962|N05BA06|(3RS)-7-Chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-one|7-Chloro-5-(2-chlorophenyl)-1, 3-Dihydro-3-Hydroxy-1,4-Benzodiazepin-2-one|212-687-6|(+-)-Lorazepam|o-Chloroxazepam|o-Chlorooxazepam|Tavor|Delormetazepam|Norlormetazepam|Bonatranquan|Duralozam|Emotival|Rocosgen|Sedatival|Laubeel|Punktyl|Lorax|Quait|Apo-Lorazepam|Anzepam|Aplacasse|Azurogen|Efasedan|Equitam|Kalmalin|Larpose|Lorapam|Lorazene|Lorazep|Lorazin|Lorenin|Loridem|Lorsedal|Lozepam|Novhepar|Renaquil|Sedizepan|Sidenar|Silence|Tranqipam|Anxira|Aripax|Bonton|Loram|Lorat|Merlit|Stapam|Trapax|Upan|Nervistop L|Demethyllormetazepam|(+/-)-Lorazepam|NSC 289758|7-Chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one|Idalprem|Aplacassee|Sinestron|Donix|Tolid|CHEMBL580|7-Chloro-5-(2-chlorophenyl)-3-hydroxy-1H-1,4-benzodiazepin-2(3H)-one|Lorazepam Medical|Nu Loraz|Nervistopl|Novolorazem|Emotion|Lomesta|Lorafen|Lorazon|Lorivan|Somagerol|Vigiten|Lorans|Lorzem|Lopam|Lorazepam Fabra|Lorazepam-Efeka|Lorazepan Chobet|Lorazepan Richet|Max Pax|Lorazepam Genericon|Lorazepam Lannacher|NSC-289758|NCGC00159439-02|Lorsilan|Securit|Sedazin|Pro dorm|2H-1,4-Benzodiazepin-2-one, 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-|Lorazepamum [INN-Latin]|7-Chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Lorazepam (1.0 mg/mL in Acetonitrile)|Lorazepam (100 ug/mL in Acetonitrile)|Ativan (TN)|EINECS 212-687-6|BRN 0759084|UNII-O26FZP769L|DEA No. 2885|Lorazepam [USAN:USP:INN:BAN:JAN]|LORAZEPAM [INN]|LORAZEPAM [JAN]|LORAZEPAM [MI]|LORAZEPAM [USAN]|(.+/-.)-Lorazepam|LORAZEPAM [VANDF]|LORAZEPAM [MART.]|LORAZEPAM [WHO-DD]|(+-)-7-Chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one|SCHEMBL26961|5-25-02-00248 (Beilstein Handbook Reference)|MLS001424236|DivK1c_000965|Lorazepam (JP18/USP/INN)|CHEBI:6539|GTPL5884|LORAZEPAM [EP IMPURITY]|LORAZEPAM [ORANGE BOOK]|LORAZEPAM CIV [USP-RS]|LORAZEPAM [EP MONOGRAPH]|SCHEMBL29358033|SCHEMBL29388543|SCHEMBL29516559|HMS503A11|KBio1_000965|LORAZEPAM [USP MONOGRAPH]|NINDS_000965|HMS2052H07|HMS3394H07|Lorazepam, 1mg/ml in Acetonitrile|Tox21_111669|BDBM50292627|Lorazepam 0.1 mg/ml in Acetonitrile|Lorazepam 1.0 mg/ml in Acetonitrile|AKOS015904303|CCG-101170|DB00186|FL24937|NC00420|2H-1,4-Benzodiazepin-2-one, 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-, (+-)-|IDI1_000965|CAS-846-49-1|SMR000058410|WLN: T67 GMV JN IHJ CG IQ KR BG|NS00000034|D00365|846L491|A840886|Q408265|7-Chloro-5-(o-chlorophenyl)-1,4-benzodiazepin-2-one|BRD-A11990600-001-01-8|BRD-A11990600-001-03-4|Lorazepam, British Pharmacopoeia (BP) Reference Standard|Lorazepam, European Pharmacopoeia (EP) Reference Standard|2H-1, 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-|2H-1, 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-|Lorazepam, United States Pharmacopeia (USP) Reference Standard|7-chloranyl-5-(2-chlorophenyl)-3-oxidanyl-1,3-dihydro-1,4-benzodiazepin-2-one|7-chloro-3-hydroxy-5-(2'-chloro-phenyl)-1,3-dihydro-2H-1,4-benzodiazepine-2-one|7-chloro-3-hydroxy-5-(2'-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepine-2-one|7-Chloro-5-(2-chloro-phenyl)-3-hydroxy-1,3-dihydro-benzo[e][1,4]diazepin-2-one|7-Chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-one #|7-Chloro-5-(2-chlorophenyl)-3-hydroxy-1H-benzo[e][1,4]diazepin-2(3H)-one|Lorazepam for system suitability, European Pharmacopoeia (EP) Reference Standard|LORAZEPAM7-Chloro-5-(2-chloro-phenyl)-3-hydroxy-1,3-dihydro-benzo[e][1,4]diazepin-2-one|(+/-)-7-CHLORO-5-(O-CHLOROPHENYL)-1,3-DIHYDRO-3-HYDROXY-2H-1,4-BENZODIAZEPIN-2-ONE|(RS)-9-chloro-6-(2-chlorophenyl)-4-hydroxy-2,5-diazabicyclo[5.4.0]undeca-5,8,10,12-tetraen-3-one|2H-1,4-BENZODIAZEPIN-2-ONE, 7-CHLORO-5-(2-CHLOROPHENYL)-1,3-DIHYDRO-3-HYDROXY-, (+/-)-|7-Chloro-5-(2-chloro-phenyl)-3-hydroxy-1,3-dihydro-benzo[e][1,4]diazepin-2-one (lorazepam)|7-Chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one;Ativan;Emotival",321.2,C15H10Cl2N2O2,61.7,443.0,2.4,21,2,3,1,"InChI=1S/C15H10Cl2N2O2/c16-8-5-6-12-10(7-8)13(19-15(21)14(20)18-12)9-3-1-2-4-11(9)17/h1-7,15,21H,(H,18,20)",C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,DIWRORZWFLOCLC-UHFFFAOYSA-N,"7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one",320.011933,320.011933,0,1,0,1,0,1,0,0,0,18021,41636,11763,Lorazepam,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Associated Disorders and Diseases|Spectral Information|Taxonomy|Biological Test Results: Active|Biological Test Results: Micromolar,16,179|330|880|881|894|1030|1195|1379|1452|1457|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1580|1581|1582|1583|1584|1585|1586|1587|1588|1589|1590|1593|1594|1595|1596|1597|1598|1599|1600|1601|1602|1603|1604|1605|1606|1607|1608|1609|1610|1612|1613|1614|1616|1688|1766|1768|1865|1948|2101|2107|2112|2314|2315|2451|2472|2517|2528|2546|2549|2551|2662|7783|8002|19262|19424|21849|21851|21852|21853|21856|21858|23479|26380|27167|27575|27580|28233|28235|28236|28681|29344|29363|29421|29423|29811|29925|40987|40994|194131|194132|194134|227718|373867|384955|384956|407366|407369|425652|425653|444050|444051|444052|444053|444054|444055|444056|444057|444058|485281|485290|492961|492967|493162|496817|496818|496819|496820|496821|496823|496824|496825|496826|496827|496828|496829|496830|496831|496832|497005|504327|504332|504749|504832|504834|504847|504865|539464|539470|540209|540210|540211|540212|540213|588220|588579|588834|602332|603953|624030|624031|624032|624044|624170|624172|624173|624296|624297|624349|624606|624609|624612|624615|624618|624647|624652|624657|625144|625145|625146|625147|625148|625149|625150|625151|625152|625153|625154|625155|625156|625157|625158|625159|625160|625161|625162|625163|625164|625165|625166|625167|625168|625169|625170|625171|625172|625173|625174|625175|625176|625177|625178|625179|625180|625181|625182|625183|625184|625185|625186|625187|625188|625189|625190|625191|625192|625193|625194|625195|625196|625197|625198|625199|625200|625201|625202|625203|625204|625205|625206|625207|625208|625209|625210|625211|625212|625213|625214|625215|625216|625217|625218|625219|625220|625221|625222|625223|625224|625225|625226|625227|625228|625229|625230|625231|625232|625233|625234|625235|625236|625237|625238|625239|625240|625241|625242|625243|625244|625245|625246|625247|625248|625249|625250|625251|625252|625253|625254|625255|625256|625257|625258|625259|625260|625261|625262|625263|625264|625265|625266|625267|625268|625269|625270|625271|625272|625273|625274|625275|625279|625280|625281|625282|625283|625284|625285|625286|625287|625288|625289|625290|625291|625292|651631|651632|651633|651634|651828|652048|652051|686978|686979|720516|720532|720533|720552|720554|720634|720635|720637|720641|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720717|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743140|743244|743268|743270|743271|743272|743281|1079931|1079932|1079933|1079934|1079935|1079936|1079937|1079938|1079939|1079940|1079941|1079942|1079943|1079944|1079945|1079946|1079947|1079948|1079949|1097336|1117301|1117302|1117303|1117311|1117315|1117318|1123466|1159387|1159388|1159389|1159394|1159395|1159396|1159607|1190308|1190314|1220783|1220784|1220785|1220786|1220787|1220788|1220789|1220790|1220791|1220792|1220793|1220794|1220795|1220796|1220797|1220798|1220799|1220800|1220801|1259251|1259310|1259325|1259344|1259355|1259356|1259374|1259389|1259397|1259398|1259413|1259416|1259421|1259422|1259423|1296008|1342825|1342826|1345165|1345199|1345993|1346983|1346984|1346985|1346986|1346987|1347080|1409565|1409566|1409567|1409568|1409569|1409570|1409571|1474166|1474167|1508602|1508609|1508611|1645843|1645882|1645883|1645886|1645887|1660982|1671498|1918969|1961681|1961683|1961684|1961686|1961689|1961691|1961692|1961694|1961695|1961697|1961698|1961699|1961700|1961701|1961702|1961705|1961707|1961708|1961709|1961710|1961711|1961712|1961714|1961715|1961720|1961721|1961722|1961724|1961727|1961728|1961729|1961730|1961732|1961733|1961734|1961738|1961740|1961742|1961743|1961748|1961750|1961755|1961758|1961759|1961760|1961761|1961762|1961763|1961764|1961765|1961766|1961767|1961768|1961770|1961771|1961773|1961774|1961775|1961776|1961778|1961779|1961780|1961781|1961785|1961788|1961789|1961790|1961791|1961792|1961807|1961808|1961809|1961810|1961815|1961819|1961825|1961827|1961837|1961841|1961846|1961847|1961848|1961849|1961850|1961851|1961852|1961853|1961855|1961856|1961857|1961858|1961859|1961868|1961878|1963987|2161909|2161911|2161912|2161939|2161948|2161949|2161950|2161951,20050325,"ABI Chem|AKos Consulting & Solutions|Alomone Labs|Alsachim|Amadis Chemical|Ambinter|AN PharmaTech|Angene Chemical|Aurora Fine Chemicals LLC|BenchChem|BindingDB|BioChemPartner|BioCrick|Biosynth|Broad Institute|C. David Weaver Laboratory, Vanderbilt University|CATO Research Chemicals Inc.|CCSbase|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|ChEBI|ChemBank|Chembase.cn|ChEMBL|ChemDB|ChemExper Chemical Directory|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|Cheminformatics Friedrich-Schiller-University Jena|ChemMol|ChemoSapiens|ChemSpider|ChemTik|Clearsynth|Clinivex|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|CymitQuimica|DiscoveryGate|Drug Induced Liver Injury Rank (DILIrank) Dataset|DrugBank|DrugCentral|DTP/NCI|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|EPA DSSTox|EPA Substance Registry Services|FDA Global Substance Registration System (GSRS)|Fisher Drug Discovery Resource Center|Google Patents|Hairui Chemical|Human Metabolome Database (HMDB)|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|InvivoChem|ISpharm|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|LGC Standards|MassBank Europe|MassBank of North America (MoNA)|Metabolomics Workbench|Milwaukee Institute for Drug Discovery|MLSMR|Molecule Market|MolGenie|MuseChem|National Center for Advancing Translational Sciences (NCATS)|Nature Chemical Biology|NextBio|NextMove Software|NIAID ChemDB|NIH Clinical Collection|NINDS Approved Drug Screening Program|NIST Chemistry WebBook|NIST Mass Spectrometry Data Center|NORMAN Suspect List Exchange|NovoSeek|OChem|PATENTSCOPE (WIPO)|Probes & Drugs portal|PubChem Reference Collection|Public Access to Neuroactive & Anticonvulsant Chemical Evaluations (PANAChE)|RR Scientific|SCRIPDB|Sigma-Aldrich|Small Molecule Screening Facility, UW Madison|Springer Nature|Starshine Chemical|SureChEMBL|THE BioTek|Therapeutic Target Database (TTD)|Thieme Chemistry|Thomson Pharma|Tocris Bioscience|Tox21|ToxPlanet|VWR, Part of Avantor|Wikidata|Wiley|xPharm: The Comprehensive Pharmacology Reference|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|ZeroPM - Zero Pollution of Persistent, Mobile Substances",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent|C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine|D002491 - Central Nervous System Agents > D000927 - Anticonvulsants|D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives|D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents|D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents|D005765 - Gastrointestinal Agents > D000932 - Antiemetics|D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents|D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators|N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives,"Lorazepam allosterically binds on the benzodiazepine receptors in the post-synaptic GABA-A ligand-gated chloride channel in different sites of the central nervous system (CNS). This binding will result in an increase on the GABA inhibitory effects which is translated as an increase in the flow of chloride ions into the cell causing hyperpolarization and stabilization of the cellular plasma membrane.  According to the binding site of lorazepam, we can observe different activities as the binding in the amygdala is known to help mainly in anxiety disorders while the binding in the cerebral cortex helps in seizure disorders.","Lorazepam is FDA-approved for the short-term relief of anxiety symptoms related to anxiety disorders and anxiety associated with depressive symptoms such as anxiety-associated insomnia. It is as well used as an anesthesia premedication in adults to relieve anxiety or to produce sedation/amnesia and for the treatment of status epilepticus.  Some off-label indications of lorazepam include rapid tranquilization of an agitated patient, alcohol withdrawal delirium, alcohol withdrawal syndrome, muscle spasms, insomnia, panic disorder, delirium, chemotherapy-associated anticipatory nausea and vomiting, and psychogenic catatonia.",benzodiazepine
4616,Oxazepam,"oxazepam|Serax|Tazepam|604-75-1|Adumbran|Droxacepam|Rondar|Serenid|Serepax|Seresta|Sobril|Zaxopam|Ansioxacepam|Durazepam|Noctazepam|Psiquiwas|Quilibrex|Anxiolit|Aplakil|Astress|Drimuel|Limbial|Murelax|Nesontil|Pacienx|Praxiten|Sigacalm|Bonare|Isodin|Propax|Serpax|Vaben|Hi-Long|Psicopax|(RS)-Oxazepam|Nortemazepam|Tarchomin|Nozepam|Serenid-D|(+-)-Oxazepam|Oxazepamum|Lederpam|Oxozepam|Alepam|Anxiolit retard|WY-3498|QUEN|Tranquo-buscopan-wirkstoff|Z10-Tr|N-Desmethyltemazepam|Notaral|Ro 5-6789|Z 10 tr|Oxazepam civ|2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-|Wy 3498|7-Chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one|7-Chloro-3-hydroxy-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one|DTXSID1021087|6GOW6DWN2A|NSC-169448|J3.308A|CHEBI:7823|DTXCID301087|NSC169448|Hilong|7-Chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepine-2-one|7-chloro-3-hydroxy-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|7-chloro-5-phenyl-3H-1,4-benzodiazepine-2,3-diol|Serenid fte|RefChem:55789|N05BA04|210-076-9|Sedigoa|Azutranquil|Uskan|Tacepam|CB 8092|7-chloro-3-hydroxy-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one|Abboxapam|NIOSH/DF2371850|Oxanid|Oxa-puren|Ossazepam [DCIT]|NCGC00159323-02|NCGC00159323-03|Ossazepam|Oxazipam|DF23718500|1,3-Dihydro-7-chloro-3-hydroxy-5-phenyl-3H-1,4-benzodiazepin-2-one|Oxazepamum [INN-Latin]|3H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-chloro-3-hydroxy-5-phenyl-|CAS-604-75-1|CCRIS 488|Serax (TN)|HSDB 3140|EINECS 210-076-9|UNII-6GOW6DWN2A|NSC 169448|Oxazepam (JAN/USP/INN)|DEA No. 2835|1,3-Dihydro-7-chloro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one|52432-54-9|Oxazepam [USAN:USP:INN:BAN:JAN]|OXAZEPAM [HSDB]|OXAZEPAM [IARC]|OXAZEPAM [USAN]|OXAZEPAM [INN]|OXAZEPAM [JAN]|OXAZEPAM [MI]|OXAZEPAM [VANDF]|(.+/-.)-Oxazepam|OXAZEPAM [MART.]|CHEMBL568|OXAZEPAM [WHO-DD]|(+-)-7-Chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one|Oprea1_501459|SCHEMBL27435|Temazepam impurity, oxazepam-|DivK1c_000986|OXAZEPAM [ORANGE BOOK]|OXAZEPAM CIV [USP-RS]|GTPL7253|OXAZEPAM [EP MONOGRAPH]|OXAZEPAM [USP MONOGRAPH]|SCHEMBL29803925|ADIMAYPTOBDMTL-UHFFFAOYSA-|BDBM85031|HMS503E13|KBio1_000986|Oxazepam 0.1 mg/ml in Methanol|Oxazepam 1.0 mg/ml in Methanol|NINDS_000986|Oxazepam, 1mg/ml in Acetonitrile|NSC_4616|Tox21_111572|Tox21_112819|Tox21_200700|Tox21_303501|7-Chloro-1,4-benzodiazepine-2-one|MFCD00057903|AKOS016347293|DB00842|FO26616|2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-, (+-)-|IDI1_000986|WLN: T67 GMV JN IHJ CG IQ KR|NCGC00159323-04|NCGC00257352-01|NCGC00258254-01|CAS_604-75-1|TEMAZEPAM IMPURITY B [EP IMPURITY]|DB-242912|NS00007748|C07359|D00464|604O751|Q412299|SR-01000942251|2H-1, 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-|SR-01000942251-1|TEMAZEPAM IMPURITY, OXAZEPAM- [USP IMPURITY]|7-Chloro-3-hydroxy-5-phenyl-1,4-benzodiazepin-2-one|BRD-A50049929-001-01-9|Oxazepam, European Pharmacopoeia (EP) Reference Standard|3-hydroxy-1,3-dihydro-7-chloro-5-phenyl-2H-1,4-benzodiazepin-2-one|3-hydroxy-5-phenyl-7-chloro-2,3-dihydro-1H-1,4-benzodiazepin-2-one|7-Chloro-3-hydroxy-5-phenyl-1,3-dihydro-benzo[e][1,4]diazepin-2-one|(+/-)-7-CHLORO-1,3-DIHYDRO-3-HYDROXY-5-PHENYL-2H-1,4-BENZODIAZEPIN-2-ONE|2H-1,4-BENZODIAZEPIN-2-ONE, 7-CHLORO-1,3-DIHYDRO-3-HYDROXY-5-PHENYL-, (+/-)-|Oxazepam for peak identification, European Pharmacopoeia (EP) Reference Standard|InChI=1/C15H11ClN2O2/c16-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)18-15(20)14(19)17-12/h1-8,15,20H,(H,17,19)",286.71,C15H11ClN2O2,61.7,407.0,2.2,20,2,3,1,"InChI=1S/C15H11ClN2O2/c16-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)18-15(20)14(19)17-12/h1-8,15,20H,(H,17,19)",C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,ADIMAYPTOBDMTL-UHFFFAOYSA-N,"7-chloro-3-hydroxy-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one",286.0509053,286.0509053,0,1,0,1,0,1,0,0,0,5757,37971,7345,Oxazepam,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Associated Disorders and Diseases|Spectral Information|Biological Test Results: Active|Biological Test Results: Micromolar,16,192|248|330|880|881|894|1030|1189|1194|1195|1199|1205|1208|1379|1452|1457|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1580|1581|1582|1583|1584|1585|1586|1587|1588|1589|1590|1593|1594|1595|1596|1597|1598|1599|1600|1601|1602|1603|1604|1605|1606|1607|1608|1609|1610|1612|1613|1614|1616|1688|1766|1768|1865|1948|2101|2107|2112|2314|2315|2451|2472|2517|2528|2546|2549|2551|2662|7783|8002|15120|18847|19262|21849|21851|21852|21854|21857|21859|23479|26380|27167|28392|28399|28681|29363|29811|29844|40987|40994|127660|127661|127662|127663|127664|127694|127695|127696|127697|127830|129361|129363|129365|129367|129370|129372|129374|135326|194131|194132|194134|231333|237585|310931|310933|327169|327170|373867|384955|404304|425652|425653|444050|444051|444052|444053|444054|444055|444056|444057|444058|467612|467613|476929|485281|485290|492961|492967|493162|496817|496818|496819|496820|496821|496823|496824|496825|496826|496827|496828|496829|496830|496831|496832|497005|504327|504332|504749|504832|504834|504847|504865|540209|540210|540211|540212|540213|588211|588212|588213|588579|588834|589078|592681|599144|602332|624030|624031|624032|624044|624170|624172|624173|624296|624297|624606|624609|624612|624615|624618|624619|624641|624647|624652|624656|625279|625280|625281|625282|625283|625284|625285|625286|625287|625288|625289|625290|625291|625292|651631|651632|651633|651634|651635|652048|652051|686978|686979|720516|720532|720533|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743140|743191|743194|743199|743202|743203|743209|743210|743211|743212|743213|743215|743217|743218|743219|743220|743221|743222|743223|743224|743225|743226|743227|743228|743239|743240|743241|743242|743244|1079931|1079932|1079933|1079934|1079935|1079936|1079937|1079938|1079939|1079940|1079941|1079942|1079943|1079944|1079945|1079946|1079947|1079948|1079949|1097336|1117301|1117302|1117303|1117311|1117315|1117318|1129361|1130718|1130720|1130721|1130724|1130726|1130727|1130728|1130729|1131184|1131185|1131186|1131187|1131188|1131208|1131228|1131230|1136387|1136388|1136389|1136390|1136391|1136392|1136393|1136394|1136395|1136396|1136397|1138124|1159389|1159396|1159509|1159515|1159516|1159517|1159518|1159519|1159520|1159521|1159523|1159525|1159526|1159527|1159528|1159529|1159531|1159551|1159552|1159553|1159555|1192730|1192731|1224834|1224835|1224836|1224837|1224838|1224839|1224840|1224841|1224842|1224843|1224844|1224845|1224846|1224847|1224848|1224849|1224867|1224868|1224869|1224870|1224871|1224872|1224873|1224874|1224875|1224876|1224877|1224878|1224879|1224880|1224881|1224882|1224883|1224884|1224885|1224886|1224887|1224888|1224889|1224890|1224892|1224893|1224894|1224895|1224896|1259241|1259242|1259243|1259244|1259247|1259248|1259251|1259344|1259355|1259356|1259364|1259365|1259366|1259367|1259368|1259369|1259377|1259378|1259379|1259380|1259381|1259382|1259383|1259384|1259385|1259386|1259387|1259388|1259390|1259391|1259392|1259393|1259394|1259395|1259396|1259401|1259402|1259403|1259404|1259407|1259411|1259416|1259421|1292330|1292332|1296008|1334753|1334754|1336731|1345199|1346784|1346795|1346798|1346799|1346824|1346829|1346859|1346877|1346891|1346924|1346977|1346978|1346979|1346980|1346981|1346982|1346983|1346984|1346985|1346986|1346987|1347030|1347031|1347032|1347033|1347034|1347035|1347036|1347037|1347038|1347395|1347397|1347398|1347399|1360429|1360444|1374214|1374215|1383661|1390040|1390042|1411091|1427527|1427528|1436078|1436079|1437174|1437175|1444094|1444095|1453097|1465293|1465314|1474166|1474167|1496040|1496041|1517838|1517867|1529182|1529184|1529185|1529186|1529187|1533611|1533612|1552590|1557178|1557184|1568812|1568822|1570001|1585850|1585851|1625122|1625123|1645882|1645883|1645886|1645887|1660982|1671196|1671197|1671198|1671199|1671200|1671201|1671498|1727019|1745844|1890739|1919968|1919969|1919970|1920063|1920064|1920065|1920067|1920068|1961681|1961683|1961684|1961686|1961691|1961692|1961694|1961695|1961697|1961698|1961699|1961700|1961701|1961705|1961707|1961708|1961709|1961710|1961711|1961712|1961714|1961715|1961720|1961721|1961722|1961724|1961725|1961726|1961727|1961728|1961729|1961730|1961731|1961732|1961733|1961734|1961738|1961740|1961741|1961742|1961743|1961748|1961750|1961752|1961755|1961758|1961759|1961760|1961761|1961762|1961764|1961765|1961766|1961767|1961768|1961770|1961771|1961773|1961774|1961775|1961776|1961778|1961780|1961781|1961782|1961783|1961784|1961785|1961788|1961789|1961790|1961791|1961792|1961807|1961808|1961809|1961810|1961815|1961816|1961819|1961825|1961827|1961837|1961841|1961842|1961846|1961847|1961848|1961849|1961850|1961851|1961852|1961853|1961855|1961856|1961857|1961858|1961859|1961868|1961878|1963577|1963578|1963579|1963580|1963581|1963582|1963583|1963584|1963585|1963586|1963587|1963588|1963589|1963590|1963591|1963592|1963593|1963594|1963595|2060913|2060914|2061098|2061099|2061100|2061101|2061102|2061103|2061104|2061105|2061106|2061107,20040916,"AbaChemScene|ABI Chem|Acadechem|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alsachim|AN PharmaTech|Aurora Fine Chemicals LLC|Baker Lab, Chemistry Department, The University of North Carolina at Chapel Hill|BindingDB|Biosynth|Broad Institute|Carcinogenic Potency Database (CPDB)|CATO Research Chemicals Inc.|CCSbase|ChEBI|ChemBank|Chembase.cn|ChEMBL|ChemDB|ChemExper Chemical Directory|Chemical Carcinogenesis Research Information System (CCRIS)|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|Cheminformatics Friedrich-Schiller-University Jena|ChemMol|ChemoSapiens|ChemSpider|ChemTik|Clearsynth|Clinivex|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|CymitQuimica|Debye Scientific Co., Ltd|DiscoveryGate|Drug Induced Liver Injury Rank (DILIrank) Dataset|DrugBank|DrugCentral|DTP/NCI|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|EPA DSSTox|EPA Substance Registry Services|FDA Global Substance Registration System (GSRS)|Google Patents|Human Metabolome Database (HMDB)|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|IUPHAR/BPS Guide to PHARMACOLOGY|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|LGC Standards|MassBank Europe|MassBank of North America (MoNA)|Mcule|MedChemexpress MCE|Metabolomics Workbench|Midas Pharma GmbH|Molepedia|MolGenie|National Center for Advancing Translational Sciences (NCATS)|Nature Chemical Biology|NextBio|NextMove Software|NINDS Approved Drug Screening Program|NIST Chemistry WebBook|NIST Mass Spectrometry Data Center|NMRShiftDB|NORMAN Suspect List Exchange|NovoSeek|OChem|PATENTSCOPE (WIPO)|Probes & Drugs portal|PubChem Reference Collection|Public Access to Neuroactive & Anticonvulsant Chemical Evaluations (PANAChE)|RR Scientific|SCRIPDB|Sigma-Aldrich|Sinfoo Biotech|Springer Nature|Starshine Chemical|SureChEMBL|THE BioTek|The Scripps Research Institute Molecular Screening Center|Therapeutic Target Database (TTD)|Thieme Chemistry|Thomson Pharma|Tox21|ToxPlanet|Veeprho|VWR, Part of Avantor|Wikidata|Wiley|Wubei-Biochem|xPharm: The Comprehensive Pharmacology Reference|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|ZeroPM - Zero Pollution of Persistent, Mobile Substances",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine|D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives|D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents|D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents|D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators|N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives,"Like other benzodiazepines, oxazepam exerts its anxiolytic effects by potentiating the effect of gamma-aminobutyric acid (GABA) on GABA(A) receptors, the main inhibitory neurotransmitter receptors in the mammalian brain. GABA(A) receptors are a component of GABA-gated ionotropic chloride channels that produce inhibitory postsynaptic potentials - following activation by GABA, the channel undergoes a conformational change that allows the passage of chloride ions through the channel. The inhibitory potentials produced by GABA neurotransmission play an integral role in the suppression and control of epileptiform nerve firing such as that seen in epilepsy, which makes the GABA system a desirable target in the treatment of epilepsy.  Benzodiazepines are positive allosteric modulators of GABA(A) function. They bind to the interface between alpha () and gamma () subunits on the receptor, commonly referred to as the benzodiazepine binding site, and modulate the receptor such that its inhibitory response to GABA binding is dramatically increased.",Oxazepam is indicated for the management of anxiety disorders and for the short-term relief of symptoms of anxiety. It may also be used in the management of alcohol withdrawal symptoms.,benzodiazepine
3393,Flurazepam,"flurazepam|17617-23-1|Insumin|Flurazepamum|Dalmane-R|Felison|Ro-5-6901/3|DTXSID1023071|IHP475989U|7-Chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one|7-Chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one|CHEBI:5128|DTXCID803071|2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-chloro-1-(2-(diethylamino)ethyl)-5-(o-fluorophenyl)-|2H-1,4-Benzodiazepin-2-one, 7-chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1,3-dihydro-|2H-1,4-Benzodiazepin-2-one, 7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-1,3-dihydro-|7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Dormodor|Apo Flurazepam|7-chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepin-2-one|RefChem:56331|Flurazepam Mono Perchlorate|Mono-Perchlorate, Flurazepam|N05CD01|241-591-7|Dalmane|7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one|7-Chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1H-1,4-benzodiazepin-2(3H)-one|Stauroderm|Noctosom|DEA No. 2767|NCGC00164573-01|Felmane|2H-1,4-Benzodiazepin-2-one, 7-chloro-1-[2-(diethylamino)ethyl]-5-(o-fluorophenyl)-1,3-dihydro-|Flurazepamum [INN-Latin]|Flurazepam [INN:BAN:JAN]|Insumin (TN)|CAS-17617-23-1|HSDB 3085|EINECS 241-591-7|N'-[2-[2,4-(Dimethylphenyl)thio]phenyl] Vortioxetine|BRN 0767925|UNII-IHP475989U|7-CHLORO-1-(2-(DIETHYLAMINO)ETHYL)-5-(O-FLUOROPHENYL)-1,3-DIHYDRO-2H-1,4-BENZODIAZEPIN-2-ONE|7-Chloro-1-[2-(diethylamino)ethyl]-5-(o-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one|N,N'-Bis[2-[(2,4-imethylphenyl)thio]phenyl]-piperazine; 1,4-Bis(2-((2,4-dimethylphenyl)thio)phenyl)piperazine|FLURAZEPAM [MI]|Flurazepam (JAN/INN)|FLURAZEPAM [INN]|FLURAZEPAM [JAN]|FLURAZEPAM [HSDB]|FLURAZEPAM [VANDF]|CHEMBL968|FLURAZEPAM [MART.]|FLURAZEPAM [WHO-DD]|SCHEMBL29793|5-24-04-00322 (Beilstein Handbook Reference)|GTPL7188|Flurazepam, 1mg/ml in Methanol|SCHEMBL29565153|17617-23-1(free base)|Flurazepam 0.1 mg/ml in Methanol|Flurazepam 1.0 mg/ml in Methanol|Tox21_112201|Ro-56901|AKOS015889971|Tox21_112201_1|DB00690|NCGC00164573-02|Ro 56901/3|DB-044253|NS00010460|D00329|617F231|A812156|Q418998|7-chloranyl-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one|2H-1,4-BENZODIAZEPIN-2-ONE, 7-CHLORO-1-(2-(DIETHYLAMINO)ETHYL)-5-(2-FLUOROPHENYL)-1,3-DIHYDRO|7-Chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1H-benzo[e][1,4]diazepin-2(3H)-one|7-Chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one #|FL7",387.9,C21H23ClFN3O,35.9,540.0,3.0,27,0,4,6,"InChI=1S/C21H23ClFN3O/c1-3-25(4-2)11-12-26-19-10-9-15(22)13-17(19)21(24-14-20(26)27)16-7-5-6-8-18(16)23/h5-10,13H,3-4,11-12,14H2,1-2H3",CCN(CC)CCN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3F,SAADBVWGJQAEFS-UHFFFAOYSA-N,"7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one",387.1513682,387.1513682,0,1,0,0,0,0,0,0,0,3077,24116,4721,Flurazepam,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Associated Disorders and Diseases|Spectral Information|Biological Test Results: Active|Biological Test Results: Micromolar,16,880|1195|1469|1471|1479|1487|1490|1688|1766|1768|2528|2546|2551|2662|23479|127314|127315|127316|127437|127438|127441|127442|127445|127447|127448|127449|127450|127451|127453|127456|127461|127464|127467|127469|127470|194131|194132|194134|227697|227698|228469|338214|485290|492961|504327|504332|504749|504832|504834|504847|504865|588220|588579|588834|602332|604740|604741|604742|604743|604744|624030|624031|624032|624044|624170|624172|624173|624296|624297|625279|625280|625281|625282|625283|625284|625285|625286|625287|625288|625289|625290|625291|625292|651631|651632|651633|651634|651635|652048|652051|679766|681116|686978|686979|720516|720532|720533|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743140|743191|743194|743199|743202|743203|743209|743210|743211|743212|743213|743215|743217|743218|743219|743220|743221|743222|743223|743224|743225|743226|743227|743228|743239|743240|743241|743242|743244|1079931|1079932|1079933|1079934|1079935|1079936|1079937|1079938|1079939|1079940|1079941|1079942|1079943|1079944|1079945|1079946|1079947|1079948|1079949|1097336|1117298|1117301|1117302|1117303|1117304|1117305|1117310|1117311|1117312|1117314|1117315|1117318|1159387|1159509|1159515|1159516|1159517|1159518|1159519|1159520|1159521|1159523|1159525|1159526|1159527|1159528|1159529|1159531|1159551|1159552|1159553|1159555|1159614|1224834|1224835|1224836|1224837|1224838|1224839|1224840|1224841|1224842|1224843|1224844|1224845|1224846|1224847|1224848|1224849|1224857|1224859|1224867|1224868|1224869|1224870|1224871|1224872|1224873|1224874|1224875|1224876|1224877|1224878|1224879|1224880|1224881|1224882|1224883|1224884|1224885|1224886|1224887|1224888|1224889|1224890|1224892|1224893|1224894|1224895|1224896|1259241|1259242|1259243|1259244|1259247|1259248|1259344|1259355|1259356|1259364|1259365|1259366|1259367|1259368|1259369|1259377|1259378|1259379|1259380|1259381|1259382|1259383|1259384|1259385|1259386|1259387|1259388|1259390|1259391|1259392|1259393|1259394|1259395|1259396|1259400|1259401|1259402|1259403|1259404|1296008|1296009|1345084|1345199|1346378|1346428|1346784|1346795|1346798|1346799|1346824|1346829|1346859|1346877|1346891|1346924|1346977|1346978|1346979|1346980|1346981|1346982|1346983|1346984|1346985|1346986|1346987|1347030|1347031|1347032|1347033|1347034|1347035|1347036|1347037|1347038|1347053|1347055|1347082|1347083|1347085|1347086|1347089|1347090|1347091|1347092|1347093|1347094|1347095|1347096|1347097|1347098|1347099|1347100|1347101|1347102|1347103|1347104|1347105|1347106|1347107|1347108|1347154|1347395|1347397|1347398|1347399|1347407|1347424|1347425|1472423|1474166|1474167|1508616|1508620|1508623|1508624|1508630|1645839|1645840|1645841|1645842|1645851|1645870|1645876|1645877|1645882|1645883|1645886|1645887|1671188|1671190|1671193|1671194|1671196|1671197|1671198|1671199|1671200|1671201|1671498|1725854|1745845|1745856|1745857|1919968|1919969|1919970|1920063|1920064|1920065|1920067|1920068|1961681|1961683|1961684|1961686|1961689|1961691|1961692|1961694|1961695|1961697|1961698|1961699|1961701|1961705|1961707|1961708|1961710|1961712|1961714|1961715|1961720|1961721|1961722|1961724|1961727|1961730|1961734|1961738|1961748|1961755|1961758|1961760|1961762|1961766|1961767|1961770|1961773|1961774|1961775|1961776|1961778|1961780|1961781|1961785|1961788|1961789|1961790|1961791|1961807|1961809|1961810|1961815|1961825|1961827|1961837|1961846|1961847|1961848|1961849|1961851|1961852|1961853|1961855|1961856|1961858|1961878|1963577|1963578|1963579|1963580|1963581|1963582|1963583|1963584|1963585|1963586|1963587|1963588|1963589|1963590|1963591|1963592|1963593|1963594|1963595|1963596|1963823|1963824|2060913|2060914|2061098|2061099|2061100|2061101|2061102|2061103|2061104|2061105|2061106|2061107,20050325,"3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|ABI Chem|Adooq BioScience|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Amadis Chemical|Ambinter|AN PharmaTech|Aurora Fine Chemicals LLC|BenchChem|Biosynth|CATO Research Chemicals Inc.|CCSbase|ChEBI|Chembase.cn|ChEMBL|ChemDB|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|Cheminformatics Friedrich-Schiller-University Jena|ChemMol|ChemoSapiens|ChemSpider|Clearsynth|Collaborative Drug Discovery, Inc.|CymitQuimica|Debye Scientific Co., Ltd|DiscoveryGate|Drug Induced Liver Injury Rank (DILIrank) Dataset|DrugBank|DrugCentral|DTP/NCI|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|eInhibitors|EPA DSSTox|EPA Substance Registry Services|FDA Global Substance Registration System (GSRS)|Google Patents|Human Metabolome Database (HMDB)|IBM|InvivoChem|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|LGC Standards|MassBank Europe|MassBank of North America (MoNA)|Metabolomics Workbench|MolGenie|National Center for Advancing Translational Sciences (NCATS)|Nature Chemical Biology|NCBI Structure|NextBio|NextMove Software|NIST Chemistry WebBook|NIST Mass Spectrometry Data Center|NORMAN Suspect List Exchange|NovoSeek|OChem|PATENTSCOPE (WIPO)|Probes & Drugs portal|Protein Data Bank in Europe (PDBe)|PubChem Reference Collection|Public Access to Neuroactive & Anticonvulsant Chemical Evaluations (PANAChE)|RR Scientific|SCRIPDB|Sigma-Aldrich|SLING Consortium|Smolecule|Springer Nature|SureChEMBL|THE BioTek|Therapeutic Target Database (TTD)|Thieme Chemistry|Thomson Pharma|Tox21|ToxPlanet|VWR, Part of Avantor|Wikidata|xPharm: The Comprehensive Pharmacology Reference|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|ZeroPM - Zero Pollution of Persistent, Mobile Substances|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine|D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives|D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents|D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents|D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators|N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives,"Flurazepam binds to an allosteric site on GABA-A receptors. Binding potentiates the action of GABA on GABA-A receptors by opening the chloride channel within the receptor, causing chloride influx and hyperpolarization.",For short-term and intermittent use in patients with recurring insomnia and poor sleeping habits,benzodiazepine
4192,Midazolam,"midazolam|59467-70-8|Buccolam|Midazolamum|8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine|mezolam|Nayzilam|Midazolam civ|USL261|R60L0SM5BC|USL-261|8-Chlor-6-(2-fluorphenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepin|8-Chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepine|CHEBI:6931|DTXSID5023320|4H-Imidazo(1,5-a)(1,4)benzodiazepine, 8-chloro-6-(2-fluorophenyl)-1-methyl-|4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-chloro-6-(2-fluorophenyl)-1-methyl-|8-chloro-6-(2-fluorophenyl)-1-methyl-4h-imidazo(1,5-a)(1,4)benzodiazepine|Epistatus|Maleate, Midazolam|12-chloro-9-(2-fluorophenyl)-3-methyl-2,4,8-triazatricyclo(8.4.0.0^(2,6))tetradeca-1(14),3,5,8,10,12-hexaene|12-chloro-9-(2-fluorophenyl)-3-methyl-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(14),3,5,8,10,12-hexaene|RefChem:6038|Hydrochloride, Midazolam|Midazolam in Sodium Chloride|Midazolam Injection, 10 mg|DTXCID503320|N05CD08|Ro 213981|Ro 21 3981|MIDAZOLAM IN 0.8% SODIUM CHLORIDE|MIDAZOLAM IN 0.9% SODIUM CHLORIDE|12-chloro-9-(2-fluorophenyl)-3-methyl-2,4,8-triazatricyclo(8.4.0.02,6)tetradeca-1(10),3,5,8,11,13-hexaene|261-774-5|Dormicum|Versed|Midazolamum [INN-Latin]|Midazolam Base|DEA No. 2884|Ro 21-3981|CHEMBL655|8-Chloro-6-(O-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]-benzodiazepine|Midazolam (1.0 mg/mL in methanol)|Dormicum (TN)|12-chloro-9-(2-fluorophenyl)-3-methyl-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,8,11,13-hexaene|NCGC00168254-01|EINECS 261-774-5|UNII-R60L0SM5BC|BRN 0625572|Medazolam|Midazolam [USP:INN:BAN:JAN]|Buccolam (TN)|Nayzilam (TN)|08J|Versed (Salt/Mix)|Dormonid (Salt/Mix)|Hypnovel (Salt/Mix)|Flormidal (Salt/Mix)|MIDAZOLAM [INN]|MIDAZOLAM [JAN]|MIDAZOLAM [MI]|MIDAZOLAM [VANDF]|MIDAZOLAM [MART.]|MIDAZOLAM [WHO-DD]|Midazolam (JAN/USP/INN)|SCHEMBL35061|BIDD:GT0647|Midazolam hydrochloride, solid|Midazolam, 1mg/ml in Methanol|GTPL3342|MIDAZOLAM [ORANGE BOOK]|MIDAZOLAM CIV [USP-RS]|MIDAZOLAM [EP MONOGRAPH]|SCHEMBL29357425|SCHEMBL29480459|SCHEMBL29565146|BDBM21363|HSDB 6751|MIDAZOLAM [USP MONOGRAPH]|Midazolam 0.1 mg/ml in Methanol|Midazolam 1.0 mg/ml in Methanol|USL261 (nasal spray formulation)|HY-B0676|59467-70-8 (free)|AKOS015842580|DB00683|FM25999|4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-chloro-6-(2-fluoro-phenyl)-1-methyl-, (Z)-2-butenedioate|DB-015270|NS00000476|C07524|D00550|467M640|A832332|Q423071|Midazolam hydrochloride, United States Pharmacopeia (USP) Reference Standard|4H-IMIDAZO(1,5-A)(1,4)BENZODIAZEPINE, 8-CHLORO-6-(2-FLUOROPHENYL)-1-METHYL|8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine;Dazolam;Dormicum",325.8,C18H13ClFN3,30.2,471.0,2.5,23,0,3,1,"InChI=1S/C18H13ClFN3/c1-11-21-9-13-10-22-18(14-4-2-3-5-16(14)20)15-8-12(19)6-7-17(15)23(11)13/h2-9H,10H2,1H3",CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F,DDLIGBOFAVUZHB-UHFFFAOYSA-N,"8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine",325.0782033,325.0782033,0,1,0,0,0,0,0,0,0,41923,47004,9054,Midazolam,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Associated Disorders and Diseases|Spectral Information|Biological Test Results: Active|Biological Test Results: Micromolar,16,1195|1471|1490|1688|1766|1768|2528|2546|2551|2662|7783|8002|19468|20881|21850|21851|21852|21855|21857|21859|26380|27167|28681|29359|29812|39933|41742|54923|150751|150752|150753|150754|150755|150756|187598|187601|187603|187604|298031|298032|311524|373867|395324|395325|395327|411793|425652|425653|444050|444051|444052|444053|444054|444055|444056|444057|444058|455986|467612|467613|492961|504327|504332|504749|504832|504834|504847|504865|520313|539464|539474|540209|540210|540211|540212|540213|540222|540223|540224|540225|540226|540227|540228|540229|540230|540231|540232|540233|577298|577579|588211|588212|588213|588214|588215|588216|588217|588218|588219|588220|588579|589039|600037|600038|600039|600041|600042|600043|600044|600045|600046|600334|600335|600336|602332|603954|611614|624030|624031|624032|624044|624170|624172|624173|624296|624297|624622|624623|624626|624628|624629|625279|625280|625281|625282|625283|625284|625285|625286|625287|625288|625289|625290|625291|625292|648843|648844|648845|648846|648847|648848|648849|648850|648851|648857|648858|648859|678835|679459|679595|679619|679925|680525|681116|681119|681120|681122|681128|681132|681146|681166|688286|688292|699539|699540|699541|715119|715120|715121|732420|760238|760239|1097336|1129361|1159386|1159387|1159388|1159389|1159390|1159391|1159395|1159396|1159607|1189508|1190367|1209244|1209245|1209247|1209248|1209249|1209250|1209251|1209258|1209259|1209581|1209582|1209583|1209593|1211293|1211294|1211295|1211296|1211297|1211298|1215121|1215122|1215125|1215127|1215128|1215671|1215672|1216347|1216348|1216349|1216350|1219215|1219216|1219217|1219218|1219219|1219220|1219221|1219222|1219223|1219224|1219225|1219226|1219227|1219228|1219232|1219233|1219234|1219235|1220241|1221732|1221733|1221735|1221736|1221738|1221739|1222398|1222399|1222400|1222401|1222402|1222403|1222404|1222405|1222406|1222407|1222408|1222409|1222410|1222411|1222412|1222413|1222414|1222415|1222416|1222417|1222793|1259325|1259397|1259398|1259423|1272365|1345993|1346296|1409858|1422306|1422307|1422308|1422309|1422310|1422311|1422312|1422313|1429807|1429808|1443980|1443989|1443991|1443992|1443995|1446381|1446382|1446385|1446386|1446389|1446390|1446393|1446394|1446397|1446398|1446420|1446421|1446764|1446765|1446766|1446767|1457811|1457812|1472101|1472102|1472103|1472620|1472621|1472622|1473738|1473739|1473740|1473741|1473799|1473800|1473801|1474166|1474167|1529088|1529095|1529097|1534316|1534317|1534318|1534319|1602381|1602382|1611225|1611226|1611240|1611241|1611242|1611243|1611244|1611245|1611246|1611247|1652315|1702158|1702159|1702160|1702161|1739201|1739202|1739203|1739204|1739205|1739206|1739207|1739208|1744238|1744239|1744240|1744241|1756359|1756360|1756362|1756363|1769106|1769113|1769114|1769115|1772562|1802994|1862578|1884506|1899994|1900019|1900020|1900021|1900022|1900023|1900024|1900025|1900026|1900027|1920125|1949499|1949500|1949501|1949502|1953333|1953334|1953335|1953336|1961681|1961683|1961684|1961686|1961689|1961691|1961692|1961694|1961695|1961697|1961698|1961699|1961701|1961705|1961707|1961708|1961710|1961712|1961714|1961715|1961720|1961721|1961722|1961724|1961727|1961730|1961734|1961738|1961748|1961755|1961758|1961760|1961762|1961766|1961767|1961770|1961773|1961774|1961775|1961776|1961778|1961780|1961781|1961785|1961788|1961789|1961790|1961791|1961807|1961809|1961810|1961815|1961819|1961825|1961827|1961837|1961846|1961847|1961848|1961849|1961850|1961851|1961852|1961853|1961855|1961856|1961858|1961878|1964044|1964045|1979767|1984685|1984686|1984687|1984688|1984689|1984690|2002926|2012326|2012327|2012328|2012329|2060272|2061569|2062930|2062931|2062932|2062933|2062934|2062935|2062936|2062937|2062938|2062939|2087864|2087865|2088032|2088033|2088034|2090424|2090425|2107233|2115277|2115325|2115326|2115327|2115328|2125250|2126676|2126677|2131808|2131809,20050325,"3WAY PHARM INC|AbaChemScene|ABI Chem|Acadechem|Acorn PharmaTech Product List|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Amadis Chemical|Ambinter|AN PharmaTech|Aurora Fine Chemicals LLC|BenchChem|BIDD|BindingDB|BioChemPartner|BioCyc|Biosynth|C. David Weaver Laboratory, Vanderbilt University|CATO Research Chemicals Inc.|CCSbase|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chembase.cn|ChEMBL|ChemDB|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|Cheminformatics Friedrich-Schiller-University Jena|ChemMol|ChemoSapiens|ChemSpider|Clearsynth|Clinivex|Collaborative Drug Discovery, Inc.|Crystallography Open Database (COD)|CymitQuimica|DC Chemicals|Debye Scientific Co., Ltd|DiscoveryGate|Drug Induced Liver Injury Rank (DILIrank) Dataset|DrugBank|DrugCentral|DTP/NCI|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|EPA DSSTox|EPA Substance Registry Services|FDA Global Substance Registration System (GSRS)|Fisher Drug Discovery Resource Center|Glentham Life Sciences Ltd.|Google Patents|Hairui Chemical|Hangzhou Trylead Chemical Technology|Horrigan Lab, Baylor College of Medicine|Human Metabolome Database (HMDB)|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|iChemical Technology USA Inc|InvivoChem|IUPHAR/BPS Guide to PHARMACOLOGY|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|labseeker|LeadScope|LGC Standards|MassBank Europe|MassBank of North America (MoNA)|MedChemexpress MCE|Metabolomics Workbench|Milwaukee Institute for Drug Discovery|MLSMR|Molecule Market|MolGenie|MuseChem|National Center for Advancing Translational Sciences (NCATS)|Nature Chemical Biology|NCBI Structure|NextBio|NextMove Software|NIH Clinical Collection|NIST Chemistry WebBook|NIST Mass Spectrometry Data Center|NORMAN Suspect List Exchange|NovoSeek|OChem|Parchem|PATENTSCOPE (WIPO)|Probes & Drugs portal|Protein Data Bank in Europe (PDBe)|Prous Science Drugs of the Future|PubChem Reference Collection|RR Scientific|SCRIPDB|Sigma-Aldrich|Small Molecule Screening Facility, UW Madison|Springer Nature|Starshine Chemical|SureChEMBL|THE BioTek|Therapeutic Target Database (TTD)|Thieme Chemistry|Thomson Pharma|Tocris Bioscience|Tox21|ToxPlanet|Wikidata|Wiley|Wubei-Biochem|xPharm: The Comprehensive Pharmacology Reference|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|Yuhao Chemical|ZeroPM - Zero Pollution of Persistent, Mobile Substances|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives|D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics|C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine|D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents|D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents|N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives|D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators,"The actions of benzodiazepines such as midazolam are mediated through the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), which is one of the major inhibitory neurotransmitters in the central nervous system. Benzodiazepines increase the activity of GABA, thereby producing a sedating effect, relaxing skeletal muscles, and inducing sleep, anesthesia, and amnesia. Benzodiazepines bind to the benzodiazepine site on GABA-A receptors, which potentiates the effects of GABA by increasing the frequency of chloride channel opening. These receptors have been identified in different body tissues including the heart and skeletal muscle, although mainly appear to be present in the central nervous system.","Midazolam has different indications depending on its formulation by the FDA.   **Nasal**   For the nasal spray formulation, midazolam is indicated for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive seizures) that are distinct from a patients usual seizure pattern in patients with epilepsy 12 years of age and older.   **Intravenous**   For the intravenous injection formulation, midazolam is indicated as an agent for sedation/anxiolysis/amnesia and prior to or during diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography, cardiac catheterization, oncology procedures, radiologic procedures, suture of lacerations and other procedures either alone or in combination with other CNS depressants. The sedative, anxiolytic and amnestic use of midazolam can also be employed pre-operatively. It can also be indicated for induction of general anesthesia, before administration of other anesthetic agents or as a component of intravenous supplementation of nitrous oxide and oxygen for a balanced anesthesia. A relatively narrower dose range of midazolam and a shorter period of induction can be achieved if midazolam is combined with narcotic premedication. Finally, midazolam can be indicated as a continous intravenous infusion for sedation of intubated and mechanically ventilated patients as a component of anesthesia or during treatment in a critical care setting.  **Intramuscular**   For the intramusuclar injection formulation, midazolam is indicated for preoperative sedation/anxiolysis/amnesia or for treatment of status epilepticus in adults.  **Oral**  Midazolam syrup is indicated for use in pediatric patients for sedation, anxiolysis and amnesia prior to diagnostic, therapeutic or endoscopic procedures or before induction of anesthesia. It is only approved in monitored settings only and not for chronic or home use.  In Europe, a buccal formulation of midazolam is also approved for the treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). For infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available.",benzodiazepine
3261,Estazolam,"estazolam|Eurodin|29975-16-4|ProSom|Esilgan|D 40TA|Estazolamum|8-Chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine|Abbott-47631|Estazolam civ|8-Chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine|DTXSID5020572|NSC-290818|36S3EQV54C|4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-6-phenyl-|8-Chloro-6-phenyl-4H-(1,2,4)triazolo-(4,3-a)(1,4)benzodiazepine|DTXCID50572|CHEBI:4858|8-Chloro-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine|NSC290818|4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine, 8-chloro-6-phenyl-|D40TA|8-Chloro-6-phenyl-4H-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepine|12-chloro-9-phenyl-2,4,5,8-tetraazatricyclo(8.4.0.0^(2,6))tetradeca-1(10),3,5,8,11,13-hexaene|12-chloro-9-phenyl-2,4,5,8-tetraazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,8,11,13-hexaene|RefChem:58778|N05CD04|12-chloro-9-phenyl-2,4,5,8-tetraazatricyclo(8.4.0.02,6)tetradeca-1(10),3,5,8,11,13-hexaene|249-982-4|Julodin|Nuctalon|D-40TA|NSC 290818|U 33737|53180-72-6|8-Chloro-6-phenyl-4H-2,3,5,10b-tetraaza-benzo[e]azulene|Somnatrol|NCGC00168250-01|Nemurel|Cannoc|4H-s-Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-6-phenyl-|8-CHLORO-6-PHENYL-4H-BENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE|Abbott 47631|Estazolamum [INN-Latin]|Estazolam [USAN:INN:JAN]|Prosom (TN)|CCRIS 1955|EINECS 249-982-4|BRN 1220868|UNII-36S3EQV54C|DEA No. 2756|8-Chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine (IUPAC)|ESTAZOLAM [INN]|ESTAZOLAM [JAN]|ESTAZOLAM [MI]|ESTAZOLAM [IARC]|ESTAZOLAM [USAN]|ESTAZOLAM [VANDF]|ESTAZOLAM [MART.]|ESTAZOLAM [WHO-DD]|SCHEMBL28766|MLS003899222|BIDD:GT0481|Estazolam (JP18/USP/INN)|Estazolam, 1mg/ml in Methanol|CHEMBL285674|GTPL7550|ESTAZOLAM [ORANGE BOOK]|ESTAZOLAM CIV [USP-RS]|SCHEMBL29357458|CDCHDCWJMGXXRH-UHFFFAOYSA-|ESTAZOLAM [USP MONOGRAPH]|Estazolam 0.1 mg/ml in Methanol|Estazolam 1.0 mg/ml in Methanol|BDBM755053|US12344614, Example Estazolam|Tox21_112609|MFCD00867537|AKOS005064373|AB07556|DB01215|SMR000238168|CAS-29975-16-4|DB-264178|NS00003946|WLN: T B576 BN DNN HN GHJ IR& LG|C06981|D00311|975E164|A820132|Q3045264|8-Chloro-6-phenyl-4H-s-triazolo[4,4]benzodiazepine|4H-s-Triazolo[4,4]benzodiazepine, 8-chloro-6-phenyl-|8-chloro-6-phenyl-4H-s-triazolo [4,3-a][1,4] benzodiazepine|8-chloro-6-phenyl-4H-s-triazolo-[4,3-a][1,4]benzodiazepine|Estazolam, United States Pharmacopeia (USP) Reference Standard|4H-[1,4]Triazolo[4,3-a][1,4]benzodiazepine, 8-chloro-6-phenyl-|8-Chloro-6-phenyl-4H-[1,4]triazolo[4,3-a][1,4]benzodiazepine|InChI=1/C16H11ClN4/c17-12-6-7-14-13(8-12)16(11-4-2-1-3-5-11)18-9-15-20-19-10-21(14)15/h1-8,10H,9H2",294.74,C16H11ClN4,43.1,407.0,1.7,21,0,3,1,"InChI=1S/C16H11ClN4/c17-12-6-7-14-13(8-12)16(11-4-2-1-3-5-11)18-9-15-20-19-10-21(14)15/h1-8,10H,9H2",C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,CDCHDCWJMGXXRH-UHFFFAOYSA-N,"8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine",294.0672241,294.0672241,0,1,0,0,0,0,0,0,0,784,17364,3470,Estazolam,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Associated Disorders and Diseases|Spectral Information|Biological Test Results: Active|Biological Test Results: Micromolar,15,330|1189|1195|1199|1205|1208|1471|1490|1688|1766|1768|2528|2546|2551|2662|128826|129148|131236|131571|131572|131573|389440|492961|504327|504332|504749|504832|504834|504847|504865|588211|588212|588213|588214|588215|588216|588217|588218|588219|588579|588834|602332|624030|624031|624032|624044|624170|624172|624173|624296|624297|625279|625280|625281|625282|625283|625284|625285|625286|625287|625288|625289|625290|625291|625292|648843|648844|648845|648846|648847|648848|648849|648850|648851|648857|648858|648859|651631|651632|651633|651634|652048|652051|686978|686979|720516|720532|720533|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743140|743244|1097336|1117301|1117302|1117303|1117311|1117315|1117318|1148192|1148193|1148194|1259251|1259344|1259355|1259356|1259407|1259411|1296008|1345199|1346983|1346984|1346985|1346986|1346987|1474166|1474167|1597743|1645882|1645883|1645886|1645887|1708407|1708411|1708415|1708419|1745844|1961681|1961683|1961684|1961686|1961689|1961691|1961692|1961694|1961695|1961697|1961699|1961701|1961705|1961707|1961708|1961710|1961712|1961714|1961715|1961720|1961721|1961722|1961724|1961727|1961728|1961729|1961734|1961738|1961748|1961755|1961758|1961760|1961762|1961766|1961767|1961770|1961771|1961773|1961774|1961775|1961776|1961778|1961780|1961781|1961785|1961788|1961789|1961790|1961791|1961803|1961807|1961809|1961810|1961815|1961819|1961825|1961827|1961837|1961846|1961847|1961848|1961849|1961851|1961852|1961853|1961855|1961856|1961858|1961878,20050325,"001Chemical|ABI Chem|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Amadis Chemical|AN PharmaTech|Aurora Fine Chemicals LLC|BenchChem|BIDD|BindingDB|BioChemPartner|BOC Sciences|Carcinogenic Potency Database (CPDB)|CCSbase|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chembase.cn|ChEMBL|ChemDB|Chemical Carcinogenesis Research Information System (CCRIS)|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Clearsynth|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|CymitQuimica|Debye Scientific Co., Ltd|DiscoveryGate|Drug Induced Liver Injury Rank (DILIrank) Dataset|DrugBank|DrugCentral|DTP/NCI|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|eInhibitors|EPA DSSTox|FDA Global Substance Registration System (GSRS)|Glentham Life Sciences Ltd.|Google Patents|Human Metabolome Database (HMDB)|IBM|iChemical Technology USA Inc|ISpharm|IUPHAR/BPS Guide to PHARMACOLOGY|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|LGC Standards|MassBank Europe|MassBank of North America (MoNA)|Metabolomics Workbench|MLSMR|MolCore|MolGenie|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NextBio|NextMove Software|NIST Chemistry WebBook|NIST Mass Spectrometry Data Center|NMRShiftDB|NORMAN Suspect List Exchange|NovoSeek|OChem|PATENTSCOPE (WIPO)|Probes & Drugs portal|PubChem Reference Collection|RR Scientific|SCRIPDB|Sigma-Aldrich|Springer Nature|Starshine Chemical|SureChEMBL|Synblock Inc|THE BioTek|Therapeutic Target Database (TTD)|Thieme Chemistry|Thomson Pharma|Tox21|ToxPlanet|Wikidata|Wiley|xPharm: The Comprehensive Pharmacology Reference|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|ZeroPM - Zero Pollution of Persistent, Mobile Substances|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine|D002491 - Central Nervous System Agents > D000927 - Anticonvulsants|D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants|D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents|D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents|D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators|N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives,"Benzodiazepines bind nonspecifically to benzodiazepine receptors, which affects affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABA<sub>A</sub>) receptors, this enhances the effects GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell.","For the short-term management of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings.",benzodiazepine
4041,Medazepam,"medazepam|Pamnace|2898-12-6|Medazepamum|DTXSID1048708|P0J3387W3S|DTXCID8028634|7-Chloro-1-methyl-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepine|RefChem:810832|N05BA03|Ro 54556|Ro 5 4556|220-783-4|Resmit|Nobrium|Rudotel|Enobrin|Nivelton|Narsis|7-Chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepine|1H-1,4-BENZODIAZEPINE, 7-CHLORO-2,3-DIHYDRO-1-METHYL-5-PHENYL-|CHEMBL28333|7-chloro-1-methyl-5-phenyl-2,3-dihydro-1,4-benzodiazepine|Ansius|Elbrus|Nobrium HCl|NCGC00164523-01|Mezapam|2,3-Dihydro-7-chloro-1-methyl-5-phenyl-1H-1,4-benzodiazepine|7-Chloro-2,3-dihydro-1-methyl-5-phenyl-3H-1,4-benzodiazepine|1H-1,4-Benzodiazepine, 2,3-dihydro-7-chloro-1-methyl-5-phenyl-|Nobrium hydrochloride|Aensius|Azepamide|Lerisum|Medaurin|Navizil|Nobraksin|Stratium|Benaon|Nobral|NSC169896|RB-252|Medazepamum [INN-Latin]|Medazepam [INN:BAN:JAN]|Psiquium|DEA No. 2836|EINECS 220-783-4|Pamnace (TN)|Diepin (Salt/Mix)|Elbrus (Salt/Mix)|Esmail (Salt/Mix)|RB 252|BRN 0407983|Medazepol (Salt/Mix)|Megasedan (Salt/Mix)|MEDAZEPAM [INN]|MEDAZEPAM [JAN]|MEDAZEPAM [MI]|Medazepam (JP18/INN)|MEDAZEPAM [MART.]|MEDAZEPAM [WHO-DD]|SCHEMBL18472|UNII-P0J3387W3S|SCHEMBL29642025|CHEBI:31807|Medazepam, 1mg/ml in Acetonitrile|1-methyl-5-phenyl-7-chloro-2,3-dihydro-1H-1,4-benzodiazepine|Tox21_113107|BDBM50021058|STL257370|AKOS002254761|DB13437|CAS-2898-12-6|DB-047498|NS00010390|ST45180212|D01292|5-23-09-00037 (Beilstein Handbook Reference)|Q572796|7-chloro-1-methyl-5-phenyl-2H,3H-benzo[f]1,4-diazepine|7-chloro-1-methyl-5-phenyl-2,3-dihydro-1H-[1,4]benzodiazepine|7-Chloro-1-methyl-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepine #|7-Chloro-1-methyl-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepine|1H-1,4-Benzodiazepine, 7-chloro-2, 3-dihydro-1-methyl-5-phenyl, monohydrochloride|1H-1,4-Benzodiazepine, 7-chloro-2,3-dihydro-1-methyl-5-phenyl-, monohydrochloride|7-Chloro-2, 3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepine, hydrochloride|7-Chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1, 4-benzodiazepine monohydrochloride",270.75,C16H15ClN2,15.6,336.0,4.4,19,0,2,1,"InChI=1S/C16H15ClN2/c1-19-10-9-18-16(12-5-3-2-4-6-12)14-11-13(17)7-8-15(14)19/h2-8,11H,9-10H2,1H3",CN1CCN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,YLCXGBZIZBEVPZ-UHFFFAOYSA-N,"7-chloro-1-methyl-5-phenyl-2,3-dihydro-1,4-benzodiazepine",270.0923762,270.0923762,0,1,0,0,0,0,0,0,0,761,7650,2650,Medazepam,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Associated Disorders and Diseases|Spectral Information|Biological Test Results: Active|Biological Test Results: Micromolar,15,23479|39918|40970|194131|194133|194135|226432|346025|599144|602332|624030|624170|624172|624173|651631|651632|651633|651634|651635|652048|652051|686978|686979|720516|720532|720533|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743140|743244|743262|1097336|1130718|1130720|1130721|1130724|1130726|1130727|1130728|1130729|1259344|1259397|1259398|1259423|1296008|1345199|1346986|1346987|1645882|1645883|1645886|1645887|1961681|1961683|1961684|1961686|1961691|1961692|1961694|1961695|1961696|1961697|1961698|1961699|1961701|1961703|1961704|1961707|1961708|1961710|1961712|1961714|1961715|1961720|1961721|1961722|1961724|1961727|1961728|1961729|1961734|1961738|1961742|1961748|1961755|1961758|1961760|1961762|1961766|1961767|1961770|1961771|1961773|1961774|1961776|1961778|1961780|1961781|1961788|1961790|1961791|1961801|1961802|1961803|1961807|1961809|1961810|1961811|1961815|1961817|1961825|1961827|1961846|1961847|1961848|1961849|1961852|1961855|1961856|1961858|1961878|1963987,20050325,"ABI Chem|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Ambinter|BenchChem|BindingDB|BOC Sciences|CCSbase|ChEBI|Chembase.cn|ChEMBL|ChemDB|Chemical Carcinogenesis Research Information System (CCRIS)|Chemical Synthesis Database|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|Cheminformatics Friedrich-Schiller-University Jena|ChemMol|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|CymitQuimica|Debye Scientific Co., Ltd|DiscoveryGate|DrugBank|DrugCentral|DTP/NCI|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|EPA DSSTox|EvitaChem|FDA Global Substance Registration System (GSRS)|Fisher Drug Discovery Resource Center|Google Patents|IBM|InvivoChem|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|LGC Standards|MassBank Europe|MassBank of North America (MoNA)|MolGenie|National Center for Advancing Translational Sciences (NCATS)|NextBio|NextMove Software|NIAID ChemDB|NIST Chemistry WebBook|NIST Mass Spectrometry Data Center|NORMAN Suspect List Exchange|NovoSeek|PATENTSCOPE (WIPO)|Probes & Drugs portal|PubChem Reference Collection|RR Scientific|SCRIPDB|Springer Nature|SpringerMaterials|Starshine Chemical|SureChEMBL|THE BioTek|Thieme Chemistry|Thomson Pharma|TimTec|Tox21|ToxPlanet|Vitas-M Laboratory|Wikidata|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|ZeroPM - Zero Pollution of Persistent, Mobile Substances|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine|D002491 - Central Nervous System Agents > D000927 - Anticonvulsants|D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives|D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents|D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents|D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents|D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators|N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives,,,benzodiazepine
5391,Temazepam,"temazepam|Restoril|Hydroxydiazepam|Methyloxazepam|Oxydiazepam|Normison|N-Methyloxazepam|846-50-4|3-Hydroxydiazepam|Temaz|Nocturne|Temtabs|Wy-3917|Temazepamum|(RS)-Temazepam|Ro 5-5345|Temazepam civ|WY 3917|2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-|CHB1QD2QSS|DTXSID8021309|NSC-246303|DTXCID301309|7-chloro-3-hydroxy-1-methyl-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|NSC246303|Apo Temazepam|Gen Temazepam|Novo Temazepam|Nu Temazepam|Tema, Norkotral|PMS Temazepam|3 Hydroxydiazepam|Von Ct, Temazep|SaH 47603|Ro55345|SaH 47 603|WY3917|Ro 5 5345|Kentepam|RefChem:56101|TEMAZEPAM, CHOLINE|N05CD07|10-chloro-4-hydroxy-6-methyl-2-phenyl-3,6-diazabicyclo(5.4.0)undeca-2,8,10,12-tetraen-5-one|212-688-1|Levanxol|Euhypnos|Levanxene|Signopam|Crisonar|Remestan|Planum|Mabertin|Cerepax|Euipnos|Tenox|ER 115|K-3917|Temazepam, pharmaceutical grade|NSC 246303|Normitab|Dasuen|Nortem|Norkotral Tema|temazep von ct|Pronervon T|1,3-Dihydro-7-chloro-3-hydroxy-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Nomapam|Temador|Lenal|Uvamin Retard|Neodorm SP|NCGC00159440-02|Gelthix|Levanzene|Perdorm|7-Chloro-3-hydroxy-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Temazepamum [INN-Latin]|Strazepam|Temazepam (100?g/ml in Methanol)|Temazepam (1.0 mg/mL in Methanol)|Restoril (TN)|CAS-846-50-4|CCRIS 1954|Temazepam (USP/INN)|K3917|UNII-CHB1QD2QSS|EINECS 212-688-1|7-chloro-3-hydroxy-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one|BRN 0759300|DEA No. 2925|Temazepam [USAN:USP:INN:BAN]|Diazepam, 3-hydroxy|(+/-)-Temazepam|WY 2917|TEMAZEPAM [INN]|TEMAZEPAM [MI]|TEMAZEPAM [IARC]|TEMAZEPAM [USAN]|TEMAZEPAM [VANDF]|CHEMBL967|TEMAZEPAM [MART.]|TEMAZEPAM [WHO-DD]|SCHEMBL29463|5-25-02-00242 (Beilstein Handbook Reference)|MLS003899242|DivK1c_000989|Temazepam, analytical standard|Temazepam, 1mg/ml in Methanol|CHEBI:9435|GTPL7300|TEMAZEPAM [ORANGE BOOK]|TEMAZEPAM CIV [USP-RS]|SCHEMBL29398512|TEMAZEPAM [EP MONOGRAPH]|HMS503E19|KBio1_000989|TEMAZEPAM [USP MONOGRAPH]|NINDS_000989|Temazepam 1.0 mg/ml in Methanol|Tox21_111670|Tox21_200044|BDBM50408032|CCG-213642|DB00231|Ro-5-5354|IDI1_000989|NCGC00159440-03|NCGC00257598-01|SMR000238146|WLN: T67 GNV JN IHJ CG G1 IQ KR|NS00010416|C07125|D00370|AB01563160_01|Q414796|BRD-A93093700-001-02-9|Temazepam, British Pharmacopoeia (BP) Reference Standard|2H-1, 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-|Temazepam, United States Pharmacopeia (USP) Reference Standard|Temazepam; T8275_Sigma; Divk1c_000989; Ninds_000989|1-methyl-7-chloro-3-hydroxy-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepine-2-one|2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-chloro-3-hydroxy-1-methyl-5-phenyl-|3-hydroxy-1,3-dihydro-1-methyl-7-chloro-5-phenyl-2H-1,4-benzodiazepin-2-one|7-Chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one;|7-Chloro-3-hydroxy-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one #|7-chloro-3-hydroxy-1-methyl-5-phenyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one",300.74,C16H13ClN2O2,52.9,434.0,2.2,21,1,3,1,"InChI=1S/C16H13ClN2O2/c1-19-13-8-7-11(17)9-12(13)14(18-15(20)16(19)21)10-5-3-2-4-6-10/h2-9,15,20H,1H3",CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,SEQDDYPDSLOBDC-UHFFFAOYSA-N,"7-chloro-3-hydroxy-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one",300.0665554,300.0665554,0,1,0,1,0,1,0,0,0,3622,38170,10252,Temazepam,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Associated Disorders and Diseases|Spectral Information|Biological Test Results: Active|Biological Test Results: Micromolar,15,330|880|881|894|1030|1189|1195|1199|1205|1379|1452|1457|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1580|1581|1582|1583|1584|1585|1586|1587|1588|1589|1590|1593|1594|1595|1596|1597|1598|1599|1600|1601|1602|1603|1604|1605|1606|1607|1608|1609|1610|1612|1613|1614|1616|1688|1766|1768|1865|1948|2101|2107|2112|2314|2315|2451|2472|2517|2528|2546|2549|2551|2662|22293|23479|26304|29360|29811|40987|40995|194131|194132|194134|485281|485290|492961|492967|493162|504327|504332|504749|504832|504834|504847|504865|588211|588212|588213|588214|588215|588216|588217|588218|588219|588579|588834|599144|602332|624030|624031|624032|624044|624170|624172|624173|624296|624297|624606|624609|624612|624615|624618|624619|624641|624647|625279|625280|625281|625282|625283|625284|625285|625286|625287|625288|625289|625290|625291|625292|651631|651632|651633|651634|652048|652051|686978|686979|720516|720532|720533|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743140|743191|743194|743199|743202|743203|743209|743210|743211|743212|743213|743215|743217|743218|743219|743220|743221|743222|743223|743224|743225|743226|743227|743228|743239|743240|743241|743242|743244|1097336|1117301|1117302|1117303|1117311|1117315|1117318|1136387|1136388|1136389|1136390|1136391|1136392|1136393|1136394|1136395|1136396|1136397|1159509|1159515|1159516|1159517|1159518|1159519|1159520|1159521|1159523|1159525|1159526|1159527|1159528|1159529|1159531|1159551|1159552|1159553|1159555|1224834|1224835|1224836|1224837|1224838|1224839|1224840|1224841|1224842|1224843|1224844|1224845|1224846|1224847|1224848|1224849|1224863|1224867|1224868|1224869|1224870|1224871|1224872|1224873|1224874|1224875|1224876|1224877|1224878|1224879|1224880|1224881|1224882|1224883|1224884|1224885|1224886|1224887|1224888|1224889|1224890|1224892|1224893|1224894|1224895|1224896|1259241|1259242|1259243|1259244|1259247|1259248|1259251|1259344|1259355|1259356|1259364|1259365|1259366|1259367|1259368|1259369|1259377|1259378|1259379|1259380|1259381|1259382|1259383|1259384|1259385|1259386|1259387|1259388|1259390|1259391|1259392|1259393|1259394|1259395|1259396|1259401|1259402|1259403|1259404|1259411|1259416|1259421|1296008|1345199|1346784|1346795|1346798|1346799|1346824|1346829|1346859|1346877|1346891|1346924|1346977|1346978|1346979|1346980|1346981|1346982|1346983|1346984|1346985|1346986|1346987|1347030|1347031|1347032|1347033|1347034|1347035|1347036|1347037|1347038|1347395|1347397|1347398|1347399|1474166|1474167|1645882|1645883|1645886|1645887|1671196|1671197|1671198|1671199|1671200|1671201|1671498|1727019|1745844|1919968|1919969|1919970|1920063|1920064|1920065|1920067|1920068|1961681|1961683|1961684|1961686|1961689|1961691|1961692|1961694|1961695|1961697|1961698|1961699|1961700|1961701|1961705|1961707|1961708|1961709|1961710|1961711|1961712|1961714|1961715|1961720|1961721|1961722|1961724|1961727|1961728|1961729|1961730|1961732|1961733|1961734|1961738|1961740|1961742|1961743|1961748|1961750|1961755|1961758|1961759|1961760|1961761|1961762|1961763|1961766|1961767|1961768|1961770|1961771|1961773|1961774|1961775|1961776|1961778|1961779|1961780|1961781|1961785|1961788|1961789|1961790|1961791|1961792|1961807|1961808|1961809|1961810|1961815|1961819|1961825|1961827|1961837|1961841|1961846|1961847|1961848|1961849|1961850|1961851|1961852|1961853|1961855|1961856|1961857|1961859|1961868|1961878|1963577|1963578|1963579|1963580|1963581|1963582|1963583|1963584|1963585|1963586|1963587|1963588|1963589|1963590|1963591|1963592|1963593|1963594|1963595|2060913|2060914|2061098|2061099|2061100|2061101|2061102|2061103|2061104|2061105|2061106|2061107,20050325,"ABI Chem|Alsachim|Ambinter|AN PharmaTech|Aurora Fine Chemicals LLC|BenchChem|BindingDB|Broad Institute|Carcinogenic Potency Database (CPDB)|CCSbase|Center for Chemical Genomics, University of Michigan|ChEBI|ChemBank|Chembase.cn|ChEMBL|ChemDB|ChemExper Chemical Directory|Chemical Carcinogenesis Research Information System (CCRIS)|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|Cheminformatics Friedrich-Schiller-University Jena|ChemMol|ChemSpider|ChemTik|Clearsynth|Clinivex|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|CymitQuimica|DiscoveryGate|Drug Induced Liver Injury Rank (DILIrank) Dataset|DrugBank|DrugCentral|DTP/NCI|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|enviPath|EPA DSSTox|EPA Substance Registry Services|FDA Global Substance Registration System (GSRS)|Google Patents|Human Metabolome Database (HMDB)|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|iChemical Technology USA Inc|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|LGC Standards|MassBank Europe|MassBank of North America (MoNA)|Metabolomics Workbench|MLSMR|MolGenie|National Center for Advancing Translational Sciences (NCATS)|NextBio|NextMove Software|NINDS Approved Drug Screening Program|NIST Chemistry WebBook|NIST Mass Spectrometry Data Center|NORMAN Suspect List Exchange|NovoSeek|Parchem|PATENTSCOPE (WIPO)|Probes & Drugs portal|PubChem Reference Collection|RR Scientific|SCRIPDB|Sigma-Aldrich|Southern Research Institute|Springer Nature|Starshine Chemical|SureChEMBL|THE BioTek|Therapeutic Target Database (TTD)|Thieme Chemistry|Thomson Pharma|Tox21|ToxPlanet|VWR, Part of Avantor|Wikidata|Wiley|xPharm: The Comprehensive Pharmacology Reference|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|ZeroPM - Zero Pollution of Persistent, Mobile Substances",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine|D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives|D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents|D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents|D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators|N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives,"Gamma-Aminobutyric acid (GABA) is considered the principal inhibitory neurotransmitter in the human body. When GABA binds to GABA(a) receptors found in neuron synapses, chloride ions are conducted across neuron cell membranes via an ion channel in the receptors. With enough chloride ions conducted, the local, associated neuron membrane potentials are hyperpolarized - making it more difficult or less likely for action potentials to fire, ultimately resulting in less excitation of the neurons.   Subsequently, benzodiazepines like temazepam can bind to benzodiazepine receptors that are components of various varieties of GABA(a) receptors. This binding acts to enhance the effects of GABA by increasing GABA affinity for the GABA(a) receptor, which ultimately enhances GABA ligand binding at the receptors. This enhanced ligand binding of the inhibitory neurotransmitter GABA to the receptors increases the aforementioned chloride ion conduction (perhaps reportedly via an increase in the frequency of the chloride channel opening), resulting in a hyperpolarized cell membrane that prevents further excitation of the associated neuron cells. Combined with the notion that such benzodiazepine receptor associated GABA(a) receptors exist both peripherally and in the CNS, this activity consequently facilitates various effects like sedation, hypnosis, skeletal muscle relaxation, anticonvulsant activity, and anxiolytic action.","Temazepam is specifically indicated only for the short-term management of insomnia,. Furthermore, such management is generally predominantly associated with the symptomatic relief of transient and short-term insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings and/or early morning awakenings. In particular, the official prescribing information for temazepam typically specifies that the instructions issued for dispensed prescriptions of the medication should indicate specifically that patients are only expected to use the therapy for short periods of time - usually 7-10 days in general. Subsequently, treatment with temazepam should usually not exceed 7 to 10 consecutive days and nor should it be prescribed in quantities exceeding a one-month supply.  Some regional prescribing information also notes that temazepam may be used for premedication prior to minor surgery or other related procedures.",benzodiazepine
3380,Flunitrazepam,"flunitrazepam|Rohypnol|Narcozep|1622-62-4|Roipnol|Primun|flunipam|Flunitrazepamum|Fluridrazepam|Silece|Ro 5-4200|RO-5-4200|RO54200|2H-1,4-Benzodiazepin-2-one, 5-(2-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-|5-(o-Fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one|Hipnosedon|Hypnodorm|Ro-54200|1-Methyl-7-nitro-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2(1H)-one|1,3-Dihydro-5-(o-fluorophenyl)-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one|DTXSID7023065|N05CD03|620X0222FQ|5-(2-fluorophenyl)-1-methyl-7-nitro-2,3-dihydro-1H-1,4-benzodiazepin-2-one|2H-1,4-BENZODIAZEPIN-2-ONE, 1,3-DIHYDRO-5-(2-FLUOROPHENYL)-1-METHYL-7-NITRO-|CHEBI:31622|5-(2-Fluorophenyl)-1-methyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Rohipnol|Flunitrazepam Teva|Flunitrazepam ratiopharm|Flunitrazepam neuraxpharm|Von Ct, Flunizep|RefChem:388983|DTXCID103065|216-597-8|Fluninoc|Flunitrazepamum [INN-Latin]|[3H]flunitrazepam|5-(2-fluorophenyl)-1-methyl-7-nitro-3H-1,4-benzodiazepin-2-one|CHEMBL13280|flunidazepam|Primum|Flunitrazepam (1.0 mg/mL in Methanol)|Flunitrazepam [USAN:INN:BAN:JAN]|Rohypnol (TN)|Flunitrazepam (1.0mg/ml in Acetonitrile)|CCRIS 5287|HSDB 6960|EINECS 216-597-8|BRN 0702691|Flunita|Fluscand|Valsera|Hypnor|DEA No. 2763|UNII-620X0222FQ|[3H]Rohypnol|FLUNITRAZEPAM [MI]|5-(2-Fluorophenyl)-1-methyl-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|FLUNITRAZEPAM [INN]|FLUNITRAZEPAM [JAN]|FLUNITRAZEPAM [HSDB]|FLUNITRAZEPAM [USAN]|SCHEMBL44169|5-24-04-00350 (Beilstein Handbook Reference)|MLS003899224|DivK1c_000981|FLUNITRAZEPAM [MART.]|FLUNITRAZEPAM [WHO-DD]|GTPL4193|GTPL4360|SCHEMBL29372584|SCHEMBL29902314|BDBM25878|HMS503E03|KBio1_000981|NINDS_000981|Flunitrazepam (JP18/USAN/INN)|Flunitrazepam, 1mg/ml in Methanol|LBC44808|UIA53364|FLUNITRAZEPAM [EP MONOGRAPH]|NSC708829|Flunitrazepam 0.1 mg/ml in Methanol|Flunitrazepam 1.0 mg/ml in Methanol|1,3-dihydro-5-(2-fluorophenyl)-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one|AKOS005066009|DB01544|NSC-708829|IDI1_000981|SMR000058981|DB-043520|NS00007996|D01230|Q62947|622F624|A810363|Flunitrazepam, European Pharmacopoeia (EP) Reference Standard|Flunitrazepam-13C6, 100 mug/mL in methanol, certified reference material|5-(2-Fluorophenyl)-1-methyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one #|5-(2-Fluorophenyl)-1-methyl-7-nitro-1,3-dihydrobenzo[e][1,4]diazepin-2-one",313.28,C16H12FN3O3,78.5,519.0,2.1,23,0,5,1,"InChI=1S/C16H12FN3O3/c1-19-14-7-6-10(20(22)23)8-12(14)16(18-9-15(19)21)11-4-2-3-5-13(11)17/h2-8H,9H2,1H3",CN1C(=O)CN=C(C2=C1C=CC(=C2)[N+](=O)[O-])C3=CC=CC=C3F,PPTYJKAXVCCBDU-UHFFFAOYSA-N,"5-(2-fluorophenyl)-1-methyl-7-nitro-3H-1,4-benzodiazepin-2-one",313.08626942,313.08626942,0,1,0,0,0,0,0,0,0,6355,20205,4403,Flunitrazepam,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Associated Disorders and Diseases|Spectral Information|Biological Test Results: Active|Biological Test Results: Micromolar,15,1195|1580|1581|1582|1583|1584|1585|1586|1587|1588|1589|1590|1593|1594|1595|1596|1597|1598|1599|1600|1601|1602|1603|1604|1605|1606|1607|1608|1609|1610|1612|1613|1614|1616|13304|13305|13306|13307|13308|22293|26304|29360|29811|40817|40826|40827|40987|40995|42335|52275|52280|52410|52413|71266|71267|72448|72640|72927|73077|73089|73232|73244|73523|73529|139100|219791|219938|219953|226385|227697|227698|228469|229422|232605|232720|243422|343089|343090|365608|365609|365610|365611|385592|385593|385594|385595|385596|385600|385601|385602|385603|385604|492967|493162|539464|540209|540210|540211|540212|540213|588211|588212|588213|624647|672795|701021|701022|701023|701024|701026|1097336|1150161|1150162|1150163|1150164|1150165|1159387|1159396|1259251|1259407|1301529|1301531|1301534|1301535|1301538|1346496|1346504|1346513|1346520|1671498|1849525|1889906|1889907|1889908|1889909|1961681|1961683|1961684|1961686|1961689|1961691|1961692|1961694|1961695|1961697|1961699|1961700|1961701|1961705|1961707|1961708|1961709|1961710|1961711|1961712|1961714|1961715|1961720|1961721|1961722|1961724|1961727|1961728|1961729|1961730|1961732|1961733|1961734|1961738|1961740|1961742|1961743|1961748|1961750|1961755|1961758|1961759|1961760|1961761|1961762|1961766|1961767|1961768|1961770|1961771|1961775|1961776|1961778|1961779|1961780|1961781|1961785|1961788|1961789|1961790|1961791|1961792|1961807|1961808|1961809|1961810|1961815|1961819|1961825|1961827|1961837|1961841|1961846|1961847|1961848|1961849|1961850|1961851|1961852|1961853|1961855|1961856|1961857|1961858|1961859|1961868|1961878,20050325,"ABI Chem|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alsachim|Amadis Chemical|AN PharmaTech|Anward|ApexBio Technology|Aurora Fine Chemicals LLC|BenchChem|BindingDB|BioCrick|Biosynth|CCSbase|ChEBI|ChemBank|Chembase.cn|ChEMBL|ChemDB|Chemical Carcinogenesis Research Information System (CCRIS)|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|CymitQuimica|Debye Scientific Co., Ltd|DiscoveryGate|DrugBank|DrugCentral|DTP/NCI|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|EPA DSSTox|EPA Substance Registry Services|FDA Global Substance Registration System (GSRS)|Google Patents|Hairui Chemical|Human Metabolome Database (HMDB)|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|iChemical Technology USA Inc|Innovapharm|InvivoChem|IUPHAR/BPS Guide to PHARMACOLOGY|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|LGC Standards|MassBank Europe|MassBank of North America (MoNA)|Mcule|Metabolomics Workbench|MLSMR|MolGenie|MuseChem|Nature Chemical Biology|NextBio|NextMove Software|NINDS Approved Drug Screening Program|NIST Chemistry WebBook|NIST Mass Spectrometry Data Center|NMRShiftDB|NORMAN Suspect List Exchange|Novartis Institutes for BioMedical Research|NovoSeek|OChem|PATENTSCOPE (WIPO)|Probes & Drugs portal|PubChem Reference Collection|RR Scientific|SCRIPDB|Sigma-Aldrich|Springer Nature|Starshine Chemical|SureChEMBL|THE BioTek|Therapeutic Target Database (TTD)|Thieme Chemistry|Thomson Pharma|Tocris Bioscience|ToxPlanet|Tractus|VWR, Part of Avantor|Wikidata|Wiley|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|ZeroPM - Zero Pollution of Persistent, Mobile Substances|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine|D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants|D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents|D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents|D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators|N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives,"Benzodiazepines bind nonspecifically to benzodiazepine receptors BNZ1, which mediates sleep, and BNZ2, which affects affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell.","For short-term treatment of severe insomnias, that are not responsive to other hypnotics.",benzodiazepine
4890,Prazepam,"prazepam|Centrax|Demetrin|Trepidan|2955-38-6|Prazepamum|W 4020|Prazepam civ|2H-1,4-Benzodiazepin-2-one, 7-chloro-1-(cyclopropylmethyl)-1,3-dihydro-5-phenyl-|DTXSID4021181|7-Chloro-1-(cyclopropylmethyl)-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|W-4020|NSC-277179|Q30VCC064M|DTXCID101181|7-Chloro-1-(cyclopropylmethyl)-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one|7-chloro-1-(cyclopropylmethyl)-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Mono Demetrin|RefChem:55907|N05BA11|220-975-8|Lysanxia|Verstran|Prazepamum [INN-Latin]|K-373|NSC 277179|Sedapran|7-chloro-1-(cyclopropylmethyl)-5-phenyl-3H-1,4-benzodiazepin-2-one|7-Chloro-1-cyclopropylmethyl-5-phenyl-1H-1,4-benzodiazepin-2(3H)-one|Prazene|NCGC00168256-01|Prazeene|Settima|2H-1,4-BENZODIAZEPIN-2-ONE, 1,3-DIHYDRO-7-CHLORO-1-(CYCLOPROPYLMETHYL)-5-PHENYL-|Prazepam (1mg/ml in Methanol)|Prazepam (1.0mg/ml in Acetonitrile)|Centrax (TN)|CAS-2955-38-6|EINECS 220-975-8|BRN 0895797|UNII-Q30VCC064M|DEA No. 2764|Prazepam [USAN:USP:INN:BAN:JAN]|PRAZEPAM [IARC]|PRAZEPAM [USAN]|PRAZEPAM [INN]|PRAZEPAM [JAN]|PRAZEPAM [MI]|PRAZEPAM [VANDF]|PRAZEPAM [MART.]|CHEMBL969|PRAZEPAM [WHO-DD]|SCHEMBL78272|MLS003899231|Prazepam, 1mg/ml in Methanol|PRAZEPAM [ORANGE BOOK]|PRAZEPAM CIV [USP-RS]|CHEBI:8362|GTPL7275|Prazepam (JP18/USAN/INN)|PRAZEPAM [EP MONOGRAPH]|SCHEMBL29565880|Prazepam 0.1 mg/ml in Methanol|Prazepam 1.0 mg/ml in Methanol|Tox21_112615|Tox21_200076|NSC277179|Prazepam 1000 microg/mL in Methanol|DB01588|NCGC00168256-02|NCGC00257630-01|SMR000058725|DB-047601|NS00010420|C07366|D00470|WLN: T67 GNV JN IHJ CG KR& G1- AL3TJ|Q2149443|7-Chloro-1-(cyclopropylmethyl)-1,4-benzodiazepin-2-one|Prazepam, European Pharmacopoeia (EP) Reference Standard|2H-1, 1,3-dihydro-7-chloro-1-(cyclopropylmethyl)-5-phenyl-|2H-1, 7-chloro-1-(cyclopropylmethyl)-1,3-dihydro-5-phenyl-|Prazepam, United States Pharmacopeia (USP) Reference Standard|7-Chloro-1-(cyclopropylmethyl)-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one #",324.8,C19H17ClN2O,32.7,482.0,3.6,23,0,2,3,"InChI=1S/C19H17ClN2O/c20-15-8-9-17-16(10-15)19(14-4-2-1-3-5-14)21-11-18(23)22(17)12-13-6-7-13/h1-5,8-10,13H,6-7,11-12H2",C1CC1CN2C(=O)CN=C(C3=C2C=CC(=C3)Cl)C4=CC=CC=C4,MWQCHHACWWAQLJ-UHFFFAOYSA-N,"7-chloro-1-(cyclopropylmethyl)-5-phenyl-3H-1,4-benzodiazepin-2-one",324.1029409,324.1029409,0,1,0,0,0,0,0,0,0,794,17187,3166,Prazepam,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Associated Disorders and Diseases|Spectral Information|Biological Test Results: Active|Biological Test Results: Micromolar,15,330|1189|1195|1199|1205|1208|1471|1490|1688|1766|1768|2528|2546|2551|2662|23479|113281|113676|114460|194131|227697|227698|228469|235587|235588|492961|504327|504332|504749|504832|504834|504847|504865|588214|588215|588216|588217|588218|588219|588579|588834|599144|602332|624030|624031|624032|624044|624170|624172|624173|624296|624297|651631|651632|651633|651634|652048|652051|686978|686979|720516|720532|720533|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743140|743191|743194|743199|743202|743203|743209|743210|743211|743212|743213|743215|743217|743218|743219|743220|743221|743222|743223|743224|743225|743226|743227|743228|743239|743240|743241|743242|743244|1097336|1159509|1159515|1159516|1159517|1159518|1159519|1159520|1159521|1159523|1159525|1159526|1159527|1159528|1159529|1159531|1159551|1159552|1159553|1159555|1224834|1224835|1224836|1224837|1224838|1224839|1224840|1224841|1224842|1224843|1224844|1224845|1224846|1224847|1224848|1224849|1224867|1224868|1224869|1224870|1224871|1224872|1224873|1224874|1224875|1224876|1224877|1224878|1224879|1224880|1224881|1224882|1224883|1224884|1224885|1224886|1224887|1224888|1224889|1224890|1224892|1224893|1224894|1224895|1224896|1259241|1259242|1259243|1259244|1259247|1259248|1259251|1259344|1259355|1259356|1259364|1259365|1259366|1259367|1259368|1259369|1259377|1259378|1259379|1259380|1259381|1259382|1259383|1259384|1259385|1259386|1259387|1259388|1259390|1259391|1259392|1259393|1259394|1259395|1259396|1259401|1259402|1259403|1259404|1296008|1345199|1346784|1346795|1346798|1346799|1346824|1346829|1346859|1346877|1346891|1346924|1346977|1346978|1346979|1346980|1346981|1346982|1346983|1346984|1346985|1346986|1346987|1347030|1347031|1347032|1347033|1347034|1347035|1347036|1347037|1347038|1347395|1347397|1347398|1347399|1645880|1645881|1645882|1645883|1645884|1645885|1645886|1645887|1660982|1671196|1671197|1671198|1671199|1671200|1671201|1745844|1919968|1919969|1919970|1920063|1920064|1920065|1920067|1920068|1963577|1963578|1963579|1963580|1963581|1963582|1963583|1963584|1963585|1963586|1963587|1963588|1963589|1963590|1963591|1963592|1963593|1963594|1963595|2060913|2060914|2061098|2061099|2061100|2061101|2061102|2061103|2061104|2061105|2061106|2061107,20050325,"ABI Chem|AHH Chemical co.,ltd|Alsachim|Ambinter|Aurora Fine Chemicals LLC|Carcinogenic Potency Database (CPDB)|CCSbase|ChEBI|Chembase.cn|ChEMBL|ChemDB|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Clearsynth|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|CymitQuimica|Debye Scientific Co., Ltd|DiscoveryGate|DrugBank|DrugCentral|DTP/NCI|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|EPA DSSTox|EPA Substance Registry Services|FDA Global Substance Registration System (GSRS)|Google Patents|Human Metabolome Database (HMDB)|IBM|InvivoChem|IUPHAR/BPS Guide to PHARMACOLOGY|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|LGC Standards|MassBank Europe|MassBank of North America (MoNA)|Mcule|Metabolomics Workbench|MLSMR|MolGenie|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NextBio|NextMove Software|NIST Chemistry WebBook|NIST Mass Spectrometry Data Center|NORMAN Suspect List Exchange|NovoSeek|PATENTSCOPE (WIPO)|Probes & Drugs portal|PubChem Reference Collection|RR Scientific|SCRIPDB|Sigma-Aldrich|Springer Nature|SureChEMBL|THE BioTek|Therapeutic Target Database (TTD)|Thieme Chemistry|Thomson Pharma|Tox21|ToxPlanet|VWR, Part of Avantor|Wikidata|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|ZeroPM - Zero Pollution of Persistent, Mobile Substances|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine|D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants|D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents|D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents|D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators|N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives,"Prazepam is believed to stimulate GABA receptors in the ascending reticular activating system. Since GABA is inhibitory, receptor stimulation increases inhibition and blocks both cortical and limbic arousal following stimulation of the brain stem reticular formation.",For the treatment of anxiety disorders.,benzodiazepine
13314,Lormetazepam,"Lormetazepam|Methyllorazepam|N-Methyllorazepam|Loramet|848-75-9|Lormetazepamum|Chlorotemazepam|WY-4082|7-Chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-1-methyl-2H-1,4-benzodiazepin-2-one|7-Chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-1-methyl-2H-1,4-benzodiazepin-2-one|7-Chloro-5-(2-chlorophenyl)-3-hydroxy-1-methyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|GU56C842ZA|2H-1,4-Benzodiazepin-2-one, 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-1-methyl-|DTXSID40862442|7-chloro-5-(2-chlorophenyl)-3-hydroxy-1-methyl-3H-1,4-benzodiazepin-2-one|2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-chloro-5-(o-chlorophenyl)-3-hydroxy-1-methyl-|CHEBI:52993|7-Chloro-5-(2-chlorophenyl)-3-hydroxy-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one|(+-)-Lormetazepam|RefChem:800047|DTXCID10811205|N05CD06|212-700-5|Noctamid|Ergocalm|Noctamide|Loramet (TN)|Ro 5-5516|WY 4082|CHEMBL22097|Loretam|Lormetazepamum [INN-Latin]|Lormetazepam (1.0mg/ml in Acetonitrile)|(RS)-Lormetazepam|(+/-)-Lormetazepam|Lormetazepam [USAN:INN:BAN:JAN]|EINECS 212-700-5|BRN 0759821|UNII-GU56C842ZA|Dormagen|DEA No. 2774|()-Lorazepam|ZK-65997|LORMETAZEPAM [MI]|LORMETAZEPAM [INN]|LORMETAZEPAM [JAN]|LORMETAZEPAM [USAN]|SCHEMBL43267|LORMETAZEPAM [MART.]|LORMETAZEPAM [WHO-DD]|GTPL7553|Lormetazepam (JAN/USAN/INN)|SCHEMBL29484438|SCHEMBL29565149|Lormetazepam 0.1 mg/ml in Methanol|Lormetazepam 1.0 mg/ml in Methanol|Lormetazepam, 1mg/ml in Acetonitrile|DB13872|FL24939|NS00010067|D01657|Q186257|7-Chloro-1,3-dihydro-5-(o-chlorophenyl)-3-hydroxy-1-methyl-2H-1,4-benzodiazepin-2-one|7-Chloro-5-(2-chlorophenyl)-3-hydroxy-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one #",335.2,C16H12Cl2N2O2,52.9,471.0,2.4,22,1,3,1,"InChI=1S/C16H12Cl2N2O2/c1-20-13-7-6-9(17)8-11(13)14(19-15(21)16(20)22)10-4-2-3-5-12(10)18/h2-8,15,21H,1H3",CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3Cl,FJIKWRGCXUCUIG-UHFFFAOYSA-N,"7-chloro-5-(2-chlorophenyl)-3-hydroxy-1-methyl-3H-1,4-benzodiazepin-2-one",334.027583,334.027583,0,1,0,1,0,1,0,0,0,1257,6817,1763,lormetazepam,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Associated Disorders and Diseases|Spectral Information|Taxonomy,15,7783|8002|19424|19427|23479|26380|27580|28233|28235|28236|29421|29423|29925|194131|194132|194134|425652|425653|444050|444051|444052|444053|444054|444055|444056|444057|444058|476929|540209|540210|540211|540212|540213|1097336|1671498|1961681|1961683|1961684|1961686|1961691|1961694|1961695|1961697|1961699|1961701|1961703|1961704|1961707|1961708|1961710|1961712|1961714|1961715|1961720|1961721|1961724|1961727|1961728|1961729|1961734|1961738|1961742|1961748|1961755|1961758|1961760|1961762|1961766|1961767|1961770|1961771|1961773|1961774|1961776|1961778|1961780|1961781|1961785|1961788|1961790|1961791|1961801|1961803|1961807|1961809|1961810|1961811|1961815|1961817|1961818|1961825|1961827|1961837|1961846|1961847|1961848|1961849|1961852|1961855|1961856|1961858|1961878,20050327,"ABI Chem|Alsachim|Ambinter|Aurora Fine Chemicals LLC|BindingDB|Biosynth|CCSbase|ChEBI|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|Cheminformatics Friedrich-Schiller-University Jena|ChemoSapiens|ChemSpider|Clearsynth|Clinivex|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|CymitQuimica|DiscoveryGate|DrugBank|DrugCentral|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|EPA DSSTox|FDA Global Substance Registration System (GSRS)|Google Patents|Human Metabolome Database (HMDB)|IBM|InvivoChem|IUPHAR/BPS Guide to PHARMACOLOGY|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|LGC Standards|MassBank Europe|MassBank of North America (MoNA)|Metabolomics Workbench|MolGenie|Nature Chemical Biology|NextBio|NextMove Software|NIST Chemistry WebBook|NIST Mass Spectrometry Data Center|NORMAN Suspect List Exchange|NovoSeek|PATENTSCOPE (WIPO)|Probes & Drugs portal|Prous Science Drugs of the Future|PubChem Reference Collection|RR Scientific|SCRIPDB|Sigma-Aldrich|Springer Nature|SureChEMBL|THE BioTek|Therapeutic Target Database (TTD)|Thieme Chemistry|Thomson Pharma|ToxPlanet|Wikidata|Wiley|ZeroPM - Zero Pollution of Persistent, Mobile Substances",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine|D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives|N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives,"Lormetazepam, as a benzodiazepine, binds to the regulatory site between the  and  subunits of -aminobutryic acid (GABA) A receptors with 2 and 1, 2, 3, or 5 subunits. This facilitates the opening of the chloride channel allowing chloride ions to flow into the neuron resulting in hyperpolarization. Hyperpolarized neurons require greater simulation to reach their action potential threshold. The general inhibitory effect on neuronal depolarization produces the effects of lormetazepam.",For the treatment of short-term insomnia,benzodiazepine
4999,Quazepam,"quazepam|Doral|Selepam|Dormalin|36735-22-5|Sch 16134|Quazepamum|Sch-16134|Quazepam civ|NSC-309702|JF8V0828ZI|2H-1,4-Benzodiazepine-2-thione, 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-|DTXSID60190193|NSC309702|7-chloro-5-(2-fluorophenyl)-1-(2,2,2-trifluoroethyl)-2,3-dihydro-1H-1,4-benzodiazepine-2-thione|RefChem:55956|DTXCID70112684|N05CD10|253-179-4|7-Chloro-5-(2-fluorophenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepine-2-thione|Prosedar|Quazium|Oniria|Quazepamum [INN-Latin]|7-chloro-5-(2-fluorophenyl)-1-(2,2,2-trifluoroethyl)-3H-1,4-benzodiazepine-2-thione|7-Chloro-5-(o-fluorophenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepine-2-thione|Quazapam|Cetrane|Selepam (1.0mg/ml in Acetonitrile)|Selepam (100?g/ml in Acetonitrile)|Doral [Sedative]|Sch-161|Doral (TN)|EINECS 253-179-4|NSC 309702|Quazepam (JAN/USP/INN)|BRN 0901084|UNII-JF8V0828ZI|DEA No. 2881|Quazepam [USAN:USP:INN:BAN]|QUAZEPAM [USAN]|QUAZEPAM [INN]|QUAZEPAM [JAN]|QUAZEPAM [MI]|QUAZEPAM [VANDF]|Quazepam civ(200 mg)|QUAZEPAM [MART.]|QUAZEPAM [WHO-DD]|SCHEMBL29504|5-24-04-00356 (Beilstein Handbook Reference)|QUAZEPAM [ORANGE BOOK]|QUAZEPAM CIV [USP-RS]|CHEBI:8694|GTPL7288|CHEMBL1200472|QUAZEPAM [USP MONOGRAPH]|SCHEMBL29534458|DB01589|NS00001083|C07336|D00457|735Q225|Q3927403|2H-1, 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-|7-Chloro-5-(o-fluorophenyl)-1,2,2-trifluoroethyl)-2H-1,4-benzodiazepine-2-thione",386.8,C17H11ClF4N2S,47.7,539.0,4.0,25,0,6,2,"InChI=1S/C17H11ClF4N2S/c18-10-5-6-14-12(7-10)16(11-3-1-2-4-13(11)19)23-8-15(25)24(14)9-17(20,21)22/h1-7H,8-9H2",C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F,IKMPWMZBZSAONZ-UHFFFAOYSA-N,"7-chloro-5-(2-fluorophenyl)-1-(2,2,2-trifluoroethyl)-3H-1,4-benzodiazepine-2-thione",386.0267599,386.0267599,0,1,0,0,0,0,0,0,0,763,11567,2167,quazepam,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Associated Disorders and Diseases|Spectral Information|Biological Test Results: Active|Biological Test Results: Micromolar,15,328|539464|588214|588215|588216|588217|588218|588219|1079931|1079932|1079933|1079934|1079935|1079936|1079937|1079938|1079939|1079940|1079941|1079942|1079943|1079944|1079945|1079946|1079947|1079948|1079949|1097336|1474166|1474167,20050325,"ABI Chem|Alfa Chemistry|Ambinter|BenchChem|CCSbase|ChEBI|Chembase.cn|ChEMBL|ChemDB|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Clearsynth|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|Cooke Chemical Co., Ltd|CymitQuimica|DiscoveryGate|Drug Induced Liver Injury Rank (DILIrank) Dataset|DrugBank|DrugCentral|DTP/NCI|ECI Group, LCSB, University of Luxembourg|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|EPA DSSTox|FDA Global Substance Registration System (GSRS)|Google Patents|Human Metabolome Database (HMDB)|IBM|iChemical Technology USA Inc|InvivoChem|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|LGC Standards|MassBank Europe|MassBank of North America (MoNA)|Metabolomics Workbench|MolGenie|NextBio|NIST Mass Spectrometry Data Center|NORMAN Suspect List Exchange|NovoSeek|OChem|PATENTSCOPE (WIPO)|Probes & Drugs portal|Prous Science Drugs of the Future|PubChem Reference Collection|RR Scientific|SCRIPDB|Smolecule|Springer Nature|SureChEMBL|THE BioTek|Therapeutic Target Database (TTD)|Thieme Chemistry|Thomson Pharma|ToxPlanet|Wikidata|Wiley|xPharm: The Comprehensive Pharmacology Reference|ZeroPM - Zero Pollution of Persistent, Mobile Substances|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine|D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives|N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives,"Like other benzodiazepines, quazepam likely exerts its effects by potentiating the effect of gamma-aminobutyric acid (GABA) on GABA(A) receptors, the main inhibitory neurotransmitter receptors in the mammalian brain. GABA(A) receptors are a component of GABA-gated ionotropic chloride channels that produce inhibitory postsynaptic potentials - following activation by GABA, the channel undergoes a conformational change that allows the passage of chloride ions through the channel. The inhibitory potentials produced by GABA neurotransmission play an integral role in the suppression and control of epileptiform nerve firing such as that seen in epilepsy, which makes the GABA system a desirable target in the treatment of epilepsy.  Benzodiazepines are positive allosteric modulators of GABA(A) function. They bind to the interface between alpha () and gamma () subunits on the receptor, commonly referred to as the benzodiazepine binding site, and modulate the receptor such that its inhibitory response to GABA binding is dramatically increased.","Quazepam is indicated for the treatment of insomnia characterized by difficulty falling asleep, frequent nocturnal awakenings, and/or early morning awakenings.",benzodiazepine
2789,Clobazam,"Clobazam|Frisium|Urbanyl|Clorepin|Urbadan|22316-47-8|Onfi|Mystan|LM-2717|HR 376|Clobazamum|Caastilium|Noiafren|Odipam|Urbanil|H-4723|LM 2717|H 4723|HR-376|1H-1,5-Benzodiazepine-2,4(3H,5H)-dione, 7-chloro-1-methyl-5-phenyl-|Colbazam|Perizam|Tapclob|Urbanol|DTXSID2046759|1-Phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|7-Chloro-1-methyl-5-phenyl-1H-1,5-benzodiazepine-2,4-(3H,5H)-dione|NSC-336279|SYMPAZAN|2MRO291B4U|CHEBI:31413|DTXCID0026759|7-chloro-1-methyl-5-phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-2,4-dione|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo(b)(1,4)diazepine-2,4-dione|LM2717|RefChem:57844|N05BA09|244-908-7|Chlorepin|RU-4723|7-Chloro-1-methyl-5-phenyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione|7-chloro-1-methyl-5-phenyl-1,5-benzodiazepine-2,4-dione|NSC 336279|NSC336279|NCGC00168249-01|Clobazamum [INN-Latin]|Clobazam (1mg/ml in Methanol)|Clobazepam|Clobazam (1mg/ml in Acetonitrile)|Mystan (TN)|CCRIS 7506|EINECS 244-908-7|BRN 0758410|UNII-2MRO291B4U|Clobazam (JAN/USAN/INN)|Clobazam [USAN:INN:BAN]|DEA No. 2751|Onfi (TN)|CLOBAZAM [USAN]|CLOBAZAM [INN]|CLOBAZAM [JAN]|CLOBAZAM [MI]|CLOBAZAM [VANDF]|COLBAZAM [VANDF]|CLOBAZAM [MART.]|CLOBAZAM [WHO-DD]|1-Phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-diketo-3H-1,5-benzodiazepine|SCHEMBL43038|5-24-08-00034 (Beilstein Handbook Reference)|MLS003899217|CHEMBL70418|Clobazam, 1mg/ml in Methanol|CLOBAZAM [ORANGE BOOK]|GTPL7149|CLOBAZAM [EP MONOGRAPH]|SCHEMBL29360325|HSDB 8343|Clobazam 0.1 mg/ml in Methanol|Clobazam 1.0 mg/ml in Methanol|HY-A0041|Tox21_112608|BDBM50247888|AKOS025401921|CS-6756|DB00349|SMR000058811|WLN: T67 GNV JVN IHJ CG G1 KR|CAS-22316-47-8|DB-045870|NS00010408|C-2991|D01253|Q412164|SR-01000937603|SR-01000937603-2|7-Chloro-1-methyl-5-phenyl-1H-1,4(3H,5H)-dione|7-Chloro-1-methyl-5-phenyl-1H-1,4-(3H,5H)-dione|BRD-K52408781-001-02-8|1H-1,4(3H,5H)-dione, 7-chloro-1-methyl-5-phenyl-|7-Chloro-1-methyl-5-phenyl-1,5-benzodiazepine-2,4(3H)-dione|1-phenyl 5-methyl 8-chloro 1,2,4,5-tetrahydo 2,4-dioxo 3H-1,5-benzodiazepine|1-phenyl 5-methyl 8-chloro 1,2,4,5-tetrahydro 2,4-dioxo 3H-1,5-benzodiazepine|1-Phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1, 5-benzodiazepine|1-Phenyl-5-methyl-8-chloro-1,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine",300.74,C16H13ClN2O2,40.6,423.0,2.1,21,0,2,1,"InChI=1S/C16H13ClN2O2/c1-18-13-8-7-11(17)9-14(13)19(16(21)10-15(18)20)12-5-3-2-4-6-12/h2-9H,10H2,1H3",CN1C(=O)CC(=O)N(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,CXOXHMZGEKVPMT-UHFFFAOYSA-N,"7-chloro-1-methyl-5-phenyl-1,5-benzodiazepine-2,4-dione",300.0665554,300.0665554,0,1,0,0,0,0,0,0,0,4069,16520,3830,Clobazam,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Associated Disorders and Diseases|Spectral Information,14,179|330|1471|1490|1688|1766|1768|2528|2546|2551|2662|27167|28681|29363|29811|113273|113677|114461|135326|227701|235587|235588|256135|256146|489300|489302|489304|492961|504327|504332|504749|504832|504834|504847|504865|588211|588212|588213|588579|588834|602332|624030|624031|624032|624044|624170|624172|624173|624296|624297|651631|651632|651633|651634|652048|652051|686978|686979|720516|720532|720533|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|727832|727834|727836|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743140|743244|1065309|1065310|1079931|1079932|1079933|1079934|1079935|1079936|1079937|1079938|1079939|1079940|1079941|1079942|1079943|1079944|1079945|1079946|1079947|1079948|1079949|1097336|1117301|1117302|1117303|1117311|1117315|1117318|1143184|1143187|1259251|1259344|1259355|1259356|1259407|1259416|1259421|1296008|1345199|1346983|1346984|1346985|1346986|1346987|1473738|1473739|1473740|1473741|1645882|1645883|1645886|1645887|1671498|1939348|1943395|1961681|1961683|1961684|1961689|1961691|1961692|1961694|1961695|1961697|1961699|1961701|1961705|1961707|1961708|1961710|1961712|1961714|1961720|1961721|1961722|1961724|1961727|1961730|1961734|1961738|1961748|1961755|1961758|1961760|1961762|1961766|1961767|1961770|1961771|1961773|1961774|1961776|1961778|1961780|1961781|1961785|1961788|1961789|1961790|1961791|1961803|1961807|1961809|1961810|1961815|1961817|1961818|1961825|1961827|1961837|1961846|1961847|1961848|1961849|1961851|1961852|1961855|1961856|1963987,20050325,"AbaChemScene|ABI Chem|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alsachim|AN PharmaTech|Aurora Fine Chemicals LLC|BenchChem|BindingDB|Biosynth|Broad Institute|CCSbase|ChEBI|Chembase.cn|ChEMBL|ChemDB|Chemical Carcinogenesis Research Information System (CCRIS)|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|Cheminformatics Friedrich-Schiller-University Jena|ChemMol|ChemoSapiens|ChemSpider|Clearsynth|Clinivex|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|CymitQuimica|Debye Scientific Co., Ltd|DiscoveryGate|DrugBank|DrugCentral|DTP/NCI|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|EPA DSSTox|EPA Substance Registry Services|FDA Global Substance Registration System (GSRS)|Google Patents|Human Metabolome Database (HMDB)|IBM|InvivoChem|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|LGC Standards|Macsen Labs|MassBank Europe|MassBank of North America (MoNA)|MedChemexpress MCE|Metabolomics Workbench|MLSMR|MolGenie|National Center for Advancing Translational Sciences (NCATS)|Nature Chemical Biology|NextBio|NextMove Software|NIAID ChemDB|NIST Chemistry WebBook|NIST Mass Spectrometry Data Center|NORMAN Suspect List Exchange|NovoSeek|PATENTSCOPE (WIPO)|Probes & Drugs portal|PubChem Reference Collection|Public Access to Neuroactive & Anticonvulsant Chemical Evaluations (PANAChE)|RR Scientific|Sigma-Aldrich|Springer Nature|SpringerMaterials|Starshine Chemical|SureChEMBL|THE BioTek|The Scripps Research Institute Molecular Screening Center|Therapeutic Target Database (TTD)|Thieme Chemistry|Thomson Pharma|Tox21|ToxPlanet|VWR, Part of Avantor|Wikidata|Wiley|xPharm: The Comprehensive Pharmacology Reference|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|ZeroPM - Zero Pollution of Persistent, Mobile Substances|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|D002491 - Central Nervous System Agents > D000927 - Anticonvulsants|D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants|D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents|D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents|D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018755 - GABA Agonists|N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives,"The exact mechanism of action for clobazam, a 1,5-benzodiazepine, is not fully understood but is thought to involve the potentiation of GABAergic neurotransmission resulting from binding at the benzodiazepine site of the GABA<sub>A</sub> receptor. Specifically, clobazam binds to the interface of the <sub>2</sub> and <sub>2</sub>-subunit of the GABA<sub>A</sub> receptor. It has a great affinity for the <sub>2</sub> subunit than the <sub>1</sub> subunit compared to other 1,4benzodiazepines.Binding of clobazam to the GABA<sub>A</sub> receptor causes chloride channels to open, resulting in an influx of chloride and thus hyperpolarization of neurons.",Clobazam is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older.,benzodiazepine
2809,Clorazepate,"clorazepate|Clorazepic acid|Cchlorazepic acid|23887-31-2|7-chloro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepine-3-carboxylic acid|7-chloro-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepine-3-carboxylic acid|4306-CB FREE ACID|D51WO0G0L4|ABBOTT-35616 FREE ACID|1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-|CHEBI:3761|DTXSID20863674|Tranxilene|Tencilan|Mendon|RefChem:57609|DTXCID40812260|245-926-8|Chlorazepate|149128-44-9|7-Chloro-2,3-dihydro-2,2-dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepic acid [BAN]|DEA No. 2768|HSDB 3041|EINECS 245-926-8|UNII-D51WO0G0L4|Tranxene&reg|1H-1,4-Benzodiazepine-3-carboxylicacid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, (-)-|(Chloromethyl)(dimethyl)(tridecyloxy)silane|CLORAZEPATE [VANDF]|CLORAZEPIC ACID [MI]|CLORAZEPIC ACID [HSDB]|GTPL7548|SCHEMBL1649064|CHEMBL1213252|CLORAZEPIC ACID [MART.]|SCHEMBL21244066|SCHEMBL29484725|CLORAZEPIC ACID [WHO-DD]|23887-31-2 (free acid)|DB00628|NS00004505|C06921|Q418850",314.72,C16H11ClN2O3,78.8,488.0,3.3,22,2,4,2,"InChI=1S/C16H11ClN2O3/c17-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)19-14(16(21)22)15(20)18-12/h1-8,14H,(H,18,20)(H,21,22)",C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)C(=O)O,XDDJGVMJFWAHJX-UHFFFAOYSA-N,"7-chloro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepine-3-carboxylic acid",314.0458199,314.0458199,0,1,0,1,0,1,0,0,0,409,10085,2673,Clorazepate Dipotassium,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Associated Disorders and Diseases|Spectral Information|Biological Test Results: Active,15,496817|496818|496819|496820|496821|496823|496824|496825|496826|496827|496828|496829|496830|496831|496832|497005|539464|540209|540210|540212|540213|588214|588215|588216|588217|588218|588219|1079931|1079932|1079933|1079934|1079935|1079936|1079937|1079938|1079939|1079940|1079941|1079942|1079943|1079944|1079945|1079946|1079947|1079948|1079949|1380730|1474166|1474167,20050325,"A2B Chem|AA BLOCKS|AAA Chemistry|ABI Chem|Ace Therapeutics|Achemica|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Ambinter|Angene Chemical|BenchChem|Biosynth|BOC Sciences|ChEBI|Chembase.cn|ChEMBL|ChemDB|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemoSapiens|ChemSpider|ChemTik|Clearsynth|Collaborative Drug Discovery, Inc.|CymitQuimica|DiscoveryGate|Drug Induced Liver Injury Rank (DILIrank) Dataset|DrugBank|DrugCentral|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|EPA DSSTox|EPA Substance Registry Services|EvitaChem|FDA Global Substance Registration System (GSRS)|Glixx Labs Inc|Google Patents|Human Metabolome Database (HMDB)|IBM|InvivoChem|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|LGC Standards|Metabolomics Workbench|MolGenie|MuseChem|Nature Chemical Biology|NextBio|NextMove Software|NIST Chemistry WebBook|NIST Mass Spectrometry Data Center|NORMAN Suspect List Exchange|NovoSeek|Parchem|PATENTSCOPE (WIPO)|Probes & Drugs portal|PubChem Reference Collection|RR Scientific|SCRIPDB|Sigma-Aldrich|Springer Nature|Starshine Chemical|SureChEMBL|THE BioTek|Therapeutic Target Database (TTD)|Thieme Chemistry|Thomson Pharma|ToxPlanet|Wikidata|xPharm: The Comprehensive Pharmacology Reference|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|ZeroPM - Zero Pollution of Persistent, Mobile Substances",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine|D002491 - Central Nervous System Agents > D000927 - Anticonvulsants|D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants|D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents|D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents|D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators,"Clorazepate is a benzodiazepine with depressant effects on the central nervous system. Benzodiazepines are able to enhance the binding of gamma-aminobutyric acid (GABA) to the GABA type A (GABA-A) receptor by binding to a region in the extracellular domain found at the interface between the alpha () and gamma () subunits of the GABA-A receptor. The interaction of GABA and the GABA-A receptor promotes channel opening, leading to an increased chloride influx. Consequently, the use of benzodiazepines, such as clorazepate, leads to neuronal hyperpolarization.",Clorazepate is indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety. It is also used as adjunctive therapy in the management of partial seizures and for the symptomatic relief of acute alcohol withdrawal.,benzodiazepine
4496,Nimetazepam,"nimetazepam|2011-67-8|1-Methylnitrazepam|Erimin|Methylnitrazepam|1,3-Dihydro-1-methyl-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Nimetazepamum|Ro 5-3453|S 1530|1-Methyl-5-phenyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|DTXSID6023369|S-1530|1-Methyl-7-nitro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one|1-methyl-7-nitro-5-phenyl-3H-1,4-benzodiazepin-2-one|DTXCID303369|4532264KW6|CHEBI:31912|1-methyl-7-nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|RefChem:854155|217-931-5|Elimin|2H-1,4-BENZODIAZEPIN-2-ONE, 1,3-DIHYDRO-1-METHYL-7-NITRO-5-PHENYL-|NCGC00164577-01|Nimetazepam (1mg/ml in Methanol)|Nimetazepam [INN:JAN]|Nimetazepamum [INN-Latin]|SMR000238177|CAS-2011-67-8|EINECS 217-931-5|BRN 0759813|Dormalon|DEA No. 2837|UNII-4532264KW6|Erimin (TN)|Nimetazepam (JAN/INN)|NIMETAZEPAM [MI]|NIMETAZEPAM [INN]|NIMETAZEPAM [JAN]|NIMETAZEPAM [MART.]|SCHEMBL79886|NIMETAZEPAM [WHO-DD]|MLS000759521|MLS001424150|CHEMBL13341|SCHEMBL29374297|Nimetazepam, 1mg/ml in Methanol|HMS2051L16|HMS3393L16|Tox21_112205|AKOS030239804|Tox21_112205_1|CCG-101044|FN26224|NC00294|NCGC00164577-02|NS00009644|D01593|011N678|A814257|Q6149812|7-nitro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",295.29,C16H13N3O3,78.5,480.0,2.2,22,0,4,1,"InChI=1S/C16H13N3O3/c1-18-14-8-7-12(19(21)22)9-13(14)16(17-10-15(18)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3",CN1C(=O)CN=C(C2=C1C=CC(=C2)[N+](=O)[O-])C3=CC=CC=C3,GWUSZQUVEVMBPI-UHFFFAOYSA-N,"1-methyl-7-nitro-5-phenyl-3H-1,4-benzodiazepin-2-one",295.09569129,295.09569129,0,1,0,0,0,0,0,0,0,107,7503,3229,nimetazepam,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Spectral Information|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,14,485|631|731|781|782|880|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1032|1040|1048|1049|1051|1066|1085|1135|1136|1195|1203|1209|1214|1216|1217|1220|1222|1229|1236|1251|1274|1304|1321|1325|1359|1362|1415|1416|1423|1424|1434|1439|1440|1441|1443|1445|1446|1448|1454|1456|1460|1461|1463|1466|1467|1468|1469|1471|1477|1479|1481|1486|1487|1490|1496|1509|1510|1515|1527|1529|1530|1531|1533|1556|1565|1566|1578|1619|1625|1626|1628|1631|1634|1654|1656|1665|1688|1700|1706|1721|1722|1766|1768|1775|1776|1777|1778|1779|1789|1800|1817|1822|1825|1845|1861|1863|1865|1868|1903|1961|1984|1986|2006|2012|2013|2014|2058|2071|2073|2100|2101|2107|2112|2147|2242|2288|2289|2314|2315|2451|2472|2517|2528|2546|2549|2551|2662|2675|2676|2685|2732|13304|13305|13306|13307|13308|139100|227697|227698|227701|228469|346025|463254|485281|485290|485294|485297|485298|485313|485314|485341|485344|485347|485353|485358|485364|485367|488837|492947|492961|493014|493056|493084|504327|504332|504333|504651|504652|504660|504749|504810|504812|504832|504834|504842|504847|504865|540275|540277|588220|588342|588579|588834|602332|624030|624031|624032|624044|624170|624172|624173|624296|624297|624349|625144|625145|625146|625147|625148|625149|625150|625151|625152|625153|625154|625155|625156|625157|625158|625159|625160|625161|625162|625163|625164|625165|625166|625167|625168|625169|625170|625171|625172|625173|625174|625175|625176|625177|625178|625179|625180|625181|625182|625183|625184|625185|625186|625187|625188|625189|625190|625191|625192|625193|625194|625195|625196|625197|625198|625199|625200|625201|625202|625203|625204|625205|625206|625207|625208|625209|625210|625211|625212|625213|625214|625215|625216|625217|625218|625219|625220|625221|625222|625223|625224|625225|625226|625227|625228|625229|625230|625231|625232|625233|625234|625235|625236|625237|625238|625239|625240|625241|625242|625243|625244|625245|625246|625247|625248|625249|625250|625251|625252|625253|625254|625255|625256|625257|625258|625259|625260|625261|625262|625263|625264|625265|625266|625267|625268|625269|625270|625271|625272|625273|625274|625275|651631|651632|651633|651634|651635|651828|652048|652051|686978|686979|720516|720532|720533|720552|720554|720634|720635|720637|720641|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720717|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743140|743191|743194|743199|743202|743203|743209|743210|743211|743212|743213|743215|743217|743218|743219|743220|743221|743222|743223|743224|743225|743226|743227|743228|743239|743240|743241|743242|743244|743268|743270|743271|743272|743281|1117298|1117304|1117305|1117310|1117312|1117314|1117319|1117326|1117329|1117336|1117340|1117341|1117342|1117343|1117346|1150161|1150162|1150163|1150164|1150165|1159509|1159515|1159516|1159517|1159518|1159519|1159520|1159521|1159523|1159525|1159526|1159527|1159528|1159529|1159531|1159551|1159552|1159553|1159555|1159607|1159614|1224834|1224835|1224836|1224837|1224838|1224839|1224840|1224841|1224842|1224843|1224844|1224845|1224846|1224847|1224848|1224849|1224857|1224859|1224867|1224868|1224869|1224870|1224871|1224872|1224873|1224874|1224875|1224876|1224877|1224878|1224879|1224880|1224881|1224882|1224883|1224884|1224885|1224886|1224887|1224888|1224889|1224890|1224892|1224893|1224894|1224895|1224896|1259241|1259242|1259243|1259244|1259247|1259248|1259251|1259310|1259325|1259344|1259355|1259356|1259364|1259365|1259366|1259367|1259368|1259369|1259374|1259377|1259378|1259379|1259380|1259381|1259382|1259383|1259384|1259385|1259386|1259387|1259388|1259389|1259390|1259391|1259392|1259393|1259394|1259395|1259396|1259397|1259398|1259400|1259401|1259402|1259403|1259404|1259406|1259413|1259422|1259423|1296008|1296009|1342825|1345084|1345199|1346378|1346428|1346784|1346795|1346798|1346799|1346824|1346829|1346859|1346877|1346891|1346924|1346977|1346978|1346979|1346980|1346981|1346982|1346983|1346984|1346985|1346986|1346987|1347030|1347031|1347032|1347033|1347034|1347035|1347036|1347037|1347038|1347053|1347055|1347080|1347082|1347083|1347085|1347086|1347089|1347090|1347091|1347092|1347093|1347094|1347095|1347096|1347097|1347098|1347099|1347100|1347101|1347102|1347103|1347104|1347105|1347106|1347107|1347108|1347154|1347395|1347397|1347398|1347399|1347407|1347424|1347425|1409565|1409566|1409567|1409568|1409569|1409570|1409571|1508602|1508616|1508620|1508623|1508624|1508630|1645839|1645840|1645841|1645842|1645843|1645851|1645870|1645876|1645877|1645882|1645883|1645886|1645887|1671188|1671190|1671193|1671194|1671196|1671197|1671198|1671199|1671200|1671201|1745845|1745856|1745857|1918969|1919968|1919969|1919970|1920063|1920064|1920065|1920067|1920068|1963577|1963578|1963579|1963580|1963581|1963582|1963583|1963584|1963585|1963586|1963587|1963588|1963589|1963590|1963591|1963592|1963593|1963594|1963595|1963596|1963823|1963824|2060913|2060914|2061098|2061099|2061100|2061101|2061102|2061103|2061104|2061105|2061106|2061107,20050325,"ABI Chem|AKos Consulting & Solutions|Alsachim|Amadis Chemical|Ambinter|AN PharmaTech|Angene Chemical|Aurora Fine Chemicals LLC|Biosynth|C. David Weaver Laboratory, Vanderbilt University|CCSbase|Center for Chemical Genomics, University of Michigan|ChEBI|Chembase.cn|ChEMBL|ChemDB|Chemhere|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|CymitQuimica|DiscoveryGate|DrugCentral|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|EPA DSSTox|FDA Global Substance Registration System (GSRS)|Fisher Drug Discovery Resource Center|Google Patents|Horrigan Lab, Baylor College of Medicine|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|InvivoChem|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|LGC Standards|MassBank Europe|MassBank of North America (MoNA)|Mcule|Milwaukee Institute for Drug Discovery|MLSMR|MolGenie|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NextBio|NextMove Software|NIH Clinical Collection|NIST Chemistry WebBook|NIST Mass Spectrometry Data Center|NORMAN Suspect List Exchange|NovoSeek|OChem|PATENTSCOPE (WIPO)|Probes & Drugs portal|PubChem Reference Collection|RR Scientific|Sigma-Aldrich|Small Molecule Screening Facility, UW Madison|Springer Nature|Starshine Chemical|SureChEMBL|THE BioTek|Thieme Chemistry|Thomson Pharma|Tox21|ToxPlanet|Wikidata|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|ZeroPM - Zero Pollution of Persistent, Mobile Substances|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine|D002491 - Central Nervous System Agents > D000927 - Anticonvulsants|D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives|D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents|D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents|D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators|N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives,,,benzodiazepine
33746,Ketazolam,"KETAZOLAM|Unakalm|Ansieten|Anxon|Loftran|Anseren|27223-35-4|Ketazolamum|U-28,774|NSC-338158|92A214MD7Y|U-28774|DTXSID20865350|11-Chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-4H-(1,3)oxazino(3,2-d)(1,4)benzodiazepine-4,7(6H)-dione|14-chloro-4,10-dimethyl-2-phenyl-3-oxa-7,10-diazatricyclo(9.4.0.0^(2,7))pentadeca-1(11),4,12,14-tetraene-6,9-dione|14-chloro-4,10-dimethyl-2-phenyl-3-oxa-7,10-diazatricyclo[9.4.0.0^{2,7}]pentadeca-1(11),4,12,14-tetraene-6,9-dione|(+-)-Ketazolam|RefChem:794268|DTXCID50813768|N05BA10|14-chloro-4,10-dimethyl-2-phenyl-3-oxa-7,10-diazatricyclo(9.4.0.02,7)pentadeca-1(11),4,12,14-tetraene-6,9-dione|248-346-3|Contamex|(+)-Ketazolam|Ketazolam, (+)-|(-)-Ketazolam|NSC 338158|424J5HGB8E|U 28774|Ketazolam, (-)-|UNII-424J5HGB8E|9ZBH5G9835|11-chloro-2,8-dimethyl-12b-phenyl-6H-[1,3]oxazino[3,2-d][1,4]benzodiazepine-4,7-dione|106938-99-2|4H-(1,3)Oxazino(3,2-d)(1,4)benzodiazepine-4,7(6H)-dione, 11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-|4H-(1,3)Oxazino(3,2-d)(1,4)benzodiazepine-4,7(6H)-dione, 11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-, (+)-|4H-(1,3)Oxazino(3,2-d)(1,4)benzodiazepine-4,7(6H)-dione, 8,12b-dihydro-11-chloro-2,8-dimethyl-12b-phenyl-|4H-[1,3]Oxazino[3,2-d][1,4]benzodiazepine-4,7(6H)-dione, 11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-|Ketazolamum [INN-Latin]|Ketazolam (1.0mg/ml in Acetonitrile)|106939-00-8|4H-(1,3)Oxazino(3,2-d)(1,4)benzodiazepine-4,7(6H)-dione, 11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-, (-)-|EINECS 248-346-3|Sedotime|Ketazolam [USAN:INN:BAN]|UNII-92A214MD7Y|KETAZOLAM [INN]|KETAZOLAM [MI]|Ketazolam (USAN/INN)|KETAZOLAM [USAN]|KETAZOLAM [MART.]|KETAZOLAM [WHO-DD]|(+/-)-KETAZOLAM|11-Chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-4H-(1,3)-oxazino(3,2-d)(1,4)benzodiazepine-4,7(6H)dione|SCHEMBL157329|UNII-9ZBH5G9835|CHEMBL2104356|SCHEMBL29369817|CHEBI:135556|HY-A0242|NSC338158|CS-6737|DB01587|4H-(1,3)-Oxazino(3,2-d)(1,4)benzodiazepine-4,7(6H)-dione, 11-chloro-8,12b-dihydro-2,8-dimethyl-|NS00006477|D04650|Q2397253|4H-[1,2-d]-[1,4]benzodiazepine-4,7(6H)-dione, 11-chloro-8,12b-dihydro-2,8-dimethyl-|11-Chloro-2,8-dimethyl-12b-phenyl-8,12b-dihydro-4H-[1,3]oxazino[3,2-d][1,4]benzodiazepine-4,7(6H)-dione|11-Chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-4H-(1,3)-oxazino(3,2-d)-(1,4)benzodiazepine-4,7(6H)dione|11-Chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-4H-(1,3)-oxazino(3,2-d)[1,4]benzodiazepine-4,7(6H)-dione|11-Chloro-8,8-dimethyl-12b-phenyl-4H-[1,3]-oxazino[3,2-d]-[1,4]benzodiazepine-4,7(6H)dione|4H-(1,3)-Oxazino(3,2-d)-(1,4)benzodiazepine-4,7(6H)-dione, 11-chloro-8,12b-dihydro-2,8-dimethyl-|4H-[1,2-d][1,4]benzodiazepine-4,7(6H)-dione, 11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-|Ketazolam; 11-Chloro-2,8-Dimethyl-12B-Phenyl-6H-[1,3]Oxazino[3,2-D][1,4]Benzodiazepine-4,7-Quinone; 11-Chloro-8,12B-Dihydro-2,8-Dimethyl-12B-Phenyl-4H-(1,3)-Oxazino(3,2-D)(1,4)Benzodiazepine-4,7(6H)Dione; 11-Chloro-8,12B-Dihydro-2,8-Dimethyl-12B-Phenyl-4H",368.8,C20H17ClN2O3,49.9,631.0,3.0,26,0,3,1,"InChI=1S/C20H17ClN2O3/c1-13-10-18(24)23-12-19(25)22(2)17-9-8-15(21)11-16(17)20(23,26-13)14-6-4-3-5-7-14/h3-11H,12H2,1-2H3",CC1=CC(=O)N2CC(=O)N(C3=C(C2(O1)C4=CC=CC=C4)C=C(C=C3)Cl)C,PWAJCNITSBZRBL-UHFFFAOYSA-N,"11-chloro-2,8-dimethyl-12b-phenyl-6H-[1,3]oxazino[3,2-d][1,4]benzodiazepine-4,7-dione",368.0927701,368.0927701,0,1,0,1,0,1,0,0,0,227,4257,977,ketazolam,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Associated Disorders and Diseases|Spectral Information,13,330,20050326,"AbaChemScene|ABI Chem|Alsachim|Ambinter|ChEBI|Chembase.cn|ChEMBL|ChemDB|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Clearsynth|Collaborative Drug Discovery, Inc.|CymitQuimica|DiscoveryGate|DrugBank|DrugCentral|DTP/NCI|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|EPA DSSTox|FDA Global Substance Registration System (GSRS)|Google Patents|Human Metabolome Database (HMDB)|IBM|InvivoChem|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|LGC Standards|MassBank of North America (MoNA)|MedChemexpress MCE|Metabolomics Workbench|MolGenie|MuseChem|NextBio|NIST Chemistry WebBook|NIST Mass Spectrometry Data Center|NORMAN Suspect List Exchange|NovoSeek|PATENTSCOPE (WIPO)|Probes & Drugs portal|Prous Science Drugs of the Future|PubChem Reference Collection|RR Scientific|SCRIPDB|Springer Nature|Starshine Chemical|SureChEMBL|THE BioTek|Thieme Chemistry|Thomson Pharma|ToxPlanet|Wikidata|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|ZeroPM - Zero Pollution of Persistent, Mobile Substances",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine|D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants|D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents|D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents|N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives,"Benzodiazepines share a similar chemical structure and their effects in humans are mainly produced by the allosteric modification of a specific kind of neurotransmitter receptor, the GABAA receptor, which increases the conductance of this inhibitory channel; this results in the various therapeutic effects as well as adverse effects of benzodiazepines. Binding of benzodiazepines to this receptor complex promotes binding of GABA, which in turn increases the conduction of chloride ions across the neuronal cell membrane. This increased conductance raises the membrane potential of the neuron resulting in inhibition of neuronal firing. In addition, different GABAA receptor subtypes have varying distributions within different regions of the brain and therefore control distinct neuronal circuits. Hence, activation of different GABAA receptor subtypes by benzodiazepines may result in distinct pharmacological actions.","Ketazolam could be used for the treatment of anxiety. In approved countries, it is indicated for the treatment of anxiety, tension, irritability and similar stress related symptoms.",benzodiazepine
31640,Halazepam,"Halazepam|Paxipam|Pacinone|Sch 12041|23092-17-3|Halazepamum|Sch-12041|Halazepam civ|7-Chloro-1,3-dihydro-5-phenyl-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepin-2-one|Alapryl|2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-5-phenyl-1-(2,2,2-trifluoroethyl)-|320YC168LF|DTXSID5023118|7-chloro-5-phenyl-1-(2,2,2-trifluoroethyl)-2,3-dihydro-1H-1,4-benzodiazepin-2-one|alazepam|RefChem:58717|DTXCID003118|N05BA13|245-425-4|Halazepamum [INN-Latin]|Schering 12041|7-chloro-5-phenyl-1-(2,2,2-trifluoroethyl)-3H-1,4-benzodiazepin-2-one|7-Chloro-5-phenyl-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one|2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-chloro-5-phenyl-1-(2,2,2-trifluoroethyl)-|Halazepam (1.0mg/ml in Acetonitrile)|Paxipam (TN)|Halazepam (USAN/INN)|EINECS 245-425-4|BRN 0898553|Halezepam|UNII-320YC168LF|DEA No. 2762|Halazepam [USAN:USP:INN:BAN]|HALAZEPAM [INN]|HALAZEPAM [MI]|HALAZEPAM [USAN]|HALAZEPAM [VANDF]|CHEMBL970|HALAZEPAM [MART.]|HALAZEPAM [WHO-DD]|SCHEMBL78995|5-24-04-00303 (Beilstein Handbook Reference)|CHEBI:5603|GTPL7195|HALAZEPAM [ORANGE BOOK]|SCHEMBL29375979|BDBM50408018|DB00801|NS00007779|D00338|Q5641126|7-Chloro-5-phenyl-1-(2,2,2-trifluorethyl)-1H-1,4-benzodiazepin-2(3H)-on",352.7,C17H12ClF3N2O,32.7,503.0,4.0,24,0,5,2,"InChI=1S/C17H12ClF3N2O/c18-12-6-7-14-13(8-12)16(11-4-2-1-3-5-11)22-9-15(24)23(14)10-17(19,20)21/h1-8H,9-10H2",C1C(=O)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3)CC(F)(F)F,WYCLKVQLVUQKNZ-UHFFFAOYSA-N,"7-chloro-5-phenyl-1-(2,2,2-trifluoroethyl)-3H-1,4-benzodiazepin-2-one",352.0590252,352.0590252,0,1,0,0,0,0,0,0,0,218,13492,2459,halazepam,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Associated Disorders and Diseases|Spectral Information|Biological Test Results: Active,14,1195|23479|40987|40995|194131|496817|496818|496819|496820|496821|496823|496824|496825|496826|496827|496828|496829|496830|496831|496832|497005|588214|588215|588216|588217|588218|588219|588220|1097336|1671498|1961681|1961683|1961684|1961686|1961691|1961692|1961694|1961695|1961697|1961698|1961701|1961703|1961707|1961708|1961710|1961714|1961715|1961720|1961721|1961722|1961724|1961727|1961728|1961729|1961734|1961738|1961742|1961748|1961753|1961754|1961758|1961760|1961762|1961764|1961765|1961766|1961767|1961770|1961771|1961773|1961774|1961776|1961778|1961781|1961785|1961788|1961790|1961791|1961801|1961802|1961803|1961807|1961809|1961810|1961811|1961815|1961817|1961818|1961823|1961824|1961825|1961827|1961837|1961847|1961848|1961849|1961852|1961855|1961856|1961858|1961878,20050327,"ABI Chem|AHH Chemical co.,ltd|Alsachim|AN PharmaTech|BenchChem|BindingDB|CCSbase|ChEBI|Chembase.cn|ChEMBL|ChemDB|ChemIDplus|ChemMol|ChemSpider|Clearsynth|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|CymitQuimica|DiscoveryGate|DrugBank|DrugCentral|ECI Group, LCSB, University of Luxembourg|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|EPA DSSTox|FDA Global Substance Registration System (GSRS)|Google Patents|Human Metabolome Database (HMDB)|IBM|InvivoChem|IUPHAR/BPS Guide to PHARMACOLOGY|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|LGC Standards|MassBank of North America (MoNA)|Metabolomics Workbench|MolGenie|Nature Chemical Biology|NextBio|NIST Chemistry WebBook|NIST Mass Spectrometry Data Center|NORMAN Suspect List Exchange|NovoSeek|PATENTSCOPE (WIPO)|Probes & Drugs portal|Prous Science Drugs of the Future|PubChem Reference Collection|RR Scientific|SCRIPDB|Springer Nature|SureChEMBL|THE BioTek|Therapeutic Target Database (TTD)|Thomson Pharma|ToxPlanet|Wikidata|xPharm: The Comprehensive Pharmacology Reference|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|ZeroPM - Zero Pollution of Persistent, Mobile Substances|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine|D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants|D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents|D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents|N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives,"Benzodiazepines bind nonspecifically to benzodiazepine receptors BNZ1, which mediates sleep, and BNZ2, which affects affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell.","Used to relieve anxiety, nervousness, and tension associated with anxiety disorders.",benzodiazepine
2441,Bromazepam,"bromazepam|Lexotanil|Lectopam|Lexotan|Lexomil|Creosedin|Lekotam|Lexaurin|Lexilium|1812-30-2|Calmepam|Normoc|Ultramidol|Ro 5-3350|Bromazepamum|Lexatin|Bromazepam civ|7-Bromo-1,3-dihydro-5-(2-pyridyl)-2H-1,4-benzodiazepin-2-one|7-Bromo-5-(2-pyridyl)-3H-1,4-benzodiazepin-2(1H)-one|2H-1,4-Benzodiazepin-2-one, 7-bromo-1,3-dihydro-5-(2-pyridinyl)-|Ro 53350|NSC-140669|DTXSID40171081|X015L14V0O|RO-5-3350|7-bromo-5-(pyridin-2-yl)-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Apo Bromazepam|Gen Bromazepam|Beta, Bromazepam|Von Ct, Bromazep|Bromazepam ratiopharm|Bromazepam Neuraxpharm|RefChem:388843|DTXCID8093572|N05BA08|7-Bromo-5-(pyridin-2-yl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one|217-322-4|Compedium|Durazanil|Compendium|LA Xvii|Bromazepamum [INN-Latin]|NSC 140669|7-bromo-5-pyridin-2-yl-1,3-dihydro-1,4-benzodiazepin-2-one|7-Bromo-1,3-dihydro-5-(2-pyridyl)-2H-1,4-benzdiazepin-2-one|1,3-Dihydro-7-bromo-5-(2-pyridyl)-2H-1,4-benzodiazepin-2-one|2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-bromo-5-(2-pyridyl)-|2H-1,4-BENZODIAZEPIN-2-ONE, 7-BROMO-1,3-DIHYDRO-5-(2-PYRIDYL)-|Bromazepamum [Latin]|Bromazepam (1mg/mL in Methanol)|7-bromo-5-(pyridin-2-yl)-1H-benzo[e][1,4]diazepin-2(3H)-one|Bromazepam (100?g/ml in Methanol)|Bromazepam [USAN:INN:BAN:JAN]|Lectopam (TN)|EINECS 217-322-4|Ro 4-9253|BRN 0618645|UNII-X015L14V0O|DEA No. 2748|7-Bromo-5-(2-pyridyl)-3H-1,4-benzodiaxepin-2(1H)-one|BROMAZEPAM [MI]|BROMAZEPAM [INN]|BROMAZEPAM [JAN]|BROMAZEPAM [USAN]|BROMAZEPAM [MART.]|BROMAZEPAM [WHO-DD]|SCHEMBL43933|5-26-05-00078 (Beilstein Handbook Reference)|MLS003899212|Bromazepam, analytical standard|CHEMBL277062|Bromazepam, 1mg/ml in Methanol|Bromazepam (JP18/USAN/INN)|BROMAZEPAM CIV [USP-RS]|SCHEMBL29366892|SCHEMBL29382152|SCHEMBL29521776|CHEBI:31302|BROMAZEPAM [EP MONOGRAPH]|7-bromo-5-(2-pyridyl)-1,3-dihydro-1,4-benzodiazepin-2-one|7-Bromo-1,4-benzodiazepin-2-one|Bromazepam 0.1 mg/ml in Methanol|Bromazepam 1.0 mg/ml in Methanol|NSC140669|DB01558|FB19015|SMR000058724|WLN: T67 GMV JN IHJ CE K- BT6NJ|NS00008673|D01245|2H-1, 7-bromo-1,3-dihydro-5-(2-pyridyl)-|2H-1, 7-bromo-1,3-dihydro-5-(2-pyridinyl)-|812B302|Bromazepam, drug standard, 1.0 mg/mL in methanol|Q422435|Bromazepam, European Pharmacopoeia (EP) Reference Standard|Bromazepam, United States Pharmacopeia (USP) Reference Standard|7-Bromo-5-(2-pyridinyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one #|7-Bromo-1,3-dihydro-5-(2-pyridinyl)-2H-1,4-benzodiazepin-2-one;Compendium;Creosedin",316.15,C14H10BrN3O,54.4,385.0,1.7,19,1,3,1,"InChI=1S/C14H10BrN3O/c15-9-4-5-11-10(7-9)14(17-8-13(19)18-11)12-3-1-2-6-16-12/h1-7H,8H2,(H,18,19)",C1C(=O)NC2=C(C=C(C=C2)Br)C(=N1)C3=CC=CC=N3,VMIYHDSEFNYJSL-UHFFFAOYSA-N,"7-bromo-5-pyridin-2-yl-1,3-dihydro-1,4-benzodiazepin-2-one",315.00072,315.00072,0,1,0,0,0,0,0,0,0,2057,12866,2391,Bromazepam,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Associated Disorders and Diseases|Spectral Information,13,248|256|7783|8002|19262|19424|26380|27575|27580|28233|28235|28236|29344|29421|29423|29925|227718|425652|425653|444050|444051|444052|444053|444054|444055|444056|444057|444058|476929|539464|540209|540210|540211|540212|540213|625279|625280|625281|625282|625283|625284|625285|625286|625287|625288|625289|625290|625291|625292|1097336|1147962|1147963|1147964|1147965|1147966|1259251|1261691|1660982|1671498|1961681|1961683|1961684|1961686|1961689|1961691|1961692|1961694|1961695|1961697|1961698|1961699|1961701|1961705|1961707|1961708|1961710|1961712|1961714|1961720|1961721|1961722|1961724|1961727|1961728|1961730|1961734|1961738|1961748|1961755|1961758|1961760|1961762|1961766|1961767|1961770|1961771|1961773|1961774|1961776|1961778|1961780|1961781|1961785|1961788|1961789|1961790|1961791|1961803|1961807|1961809|1961810|1961815|1961817|1961818|1961825|1961827|1961837|1961846|1961847|1961848|1961849|1961851|1961852|1961855|1961856,20050325,"A&J Pharmtech CO., LTD.|ABI Chem|Alsachim|Ambinter|AN PharmaTech|Aurora Fine Chemicals LLC|BenchChem|Biosynth|CCSbase|ChEBI|Chembase.cn|ChEMBL|ChemDB|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|Cheminformatics Friedrich-Schiller-University Jena|ChemMol|ChemoSapiens|ChemSpider|ChemTik|Clearsynth|Clinivex|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|CymitQuimica|DiscoveryGate|DrugBank|DrugCentral|DTP/NCI|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|EPA DSSTox|FDA Global Substance Registration System (GSRS)|Google Patents|Human Metabolome Database (HMDB)|IBM|InvivoChem|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|LGC Standards|MassBank Europe|MassBank of North America (MoNA)|Metabolomics Workbench|MLSMR|MolGenie|Nature Chemical Biology|NextBio|NextMove Software|NIAID ChemDB|NIST Chemistry WebBook|NIST Mass Spectrometry Data Center|NORMAN Suspect List Exchange|NovoSeek|OChem|PATENTSCOPE (WIPO)|Probes & Drugs portal|PubChem Reference Collection|RR Scientific|SCRIPDB|Sigma-Aldrich|Springer Nature|Starshine Chemical|SureChEMBL|THE BioTek|Therapeutic Target Database (TTD)|Thieme Chemistry|Thomson Pharma|ToxPlanet|VWR, Part of Avantor|Wikidata|Wiley|xPharm: The Comprehensive Pharmacology Reference|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|ZeroPM - Zero Pollution of Persistent, Mobile Substances|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine|D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants|D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents|D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents|D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators|N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives,Bromazepam binds to the GABA-A receptor producing a conformational change and potentiating its inhibitory effects. Other neurotransmitters are not influenced.,"For the short-term treatment of insomnia, short-term treatment of anxiety or panic attacks, if a benzodiazepine is required, and the alleviation of the symptoms of alcohol- and opiate-withdrawal.",benzodiazepine
4177,Mexazolam,"mexazolam|Melex|31868-18-5|CS-386|Mexazolamum|DTXSID9057715|DTXCID0031504|S5969B6237|CHEBI:31842|10-Chloro-11b-(2-chlorophenyl)-2,3,7,11b-tetrahydro-3-methyloxazolo(3,2-d)(1,4)benzodiazepin-6(5H)-one|10-chloro-2,3,7,11b-tetrahydro-3-methyl-11b-(2-chlorophenyl)oxazolo(3,2-d)(1,4)benzodiazepin-6(5H)-one|RefChem:818798|13-chloro-2-(2-chlorophenyl)-5-methyl-3-oxa-6,9-diazatricyclo(8.4.0.0^(2,6))tetradeca-1(10),8,11,13-tetraen-8-ol|13-chloro-2-(2-chlorophenyl)-5-methyl-3-oxa-6,9-diazatricyclo(8.4.0.02,6)tetradeca-1(10),8,11,13-tetraen-8-ol|10-chloro-11b-(2-chlorophenyl)-3-methyl-2,3,5,7-tetrahydro-[1,3]oxazolo[3,2-d][1,4]benzodiazepin-6-one|10-Chloro-11b-(o-chlorophenyl)-2,3,7,11b-tetrahydro-3-methyloxazolo(3,2-d)(1,4)benzodiazepin-6(5H)-one|Mexazolam [INN:JAN]|Mexazolamum [INN-Latin]|Mexazolam (1.0mg/ml in Acetonitrile)|CS 386|10-chloro-11b-(2-chlorophenyl)-3-methyl-2,3,7,11b-tetrahydrobenzo[f]oxazolo[3,2-d][1,4]diazepin-6(5H)-one|BRN 1091849|Sedoxil|UNII-S5969B6237|10-Chloro-11b-(2-chlorophenyl)-2,3,7,11b-tetrahydro-3-methyloxazolo[3,2-d][1,4]benzodiazepin-6(5H)-one; CS 386; Melex|Melex (TN)|Mexazolam (JAN/INN)|MEXAZOLAM [INN]|MEXAZOLAM [JAN]|MEXAZOLAM [MI]|MEXAZOLAM [MART.]|MEXAZOLAM [WHO-DD]|SCHEMBL218453|orb1696111|CHEMBL1743261|SCHEMBL28881105|SCHEMBL30565796|ANUCDXCTICZJRH-UHFFFAOYSA-N|GBA86818|Tox21_113740|Mexazolam (1 mg/mL in Acetonitrile)|AKOS040753046|DB15489|NCGC00253606-01|Oxazolo(3,2-d)(1,4)benzodiazepin-6(5H)-one, 10-chloro-11b-(2-chlorophenyl)-2,3,7,11b-tetrahydro-3-methyl-|CAS-31868-18-5|NS00120155|D01316|Q6148446",363.2,C18H16Cl2N2O2,41.6,505.0,3.7,24,1,3,1,"InChI=1S/C18H16Cl2N2O2/c1-11-10-24-18(13-4-2-3-5-15(13)20)14-8-12(19)6-7-16(14)21-17(23)9-22(11)18/h2-8,11H,9-10H2,1H3,(H,21,23)",CC1COC2(N1CC(=O)NC3=C2C=C(C=C3)Cl)C4=CC=CC=C4Cl,ANUCDXCTICZJRH-UHFFFAOYSA-N,"10-chloro-11b-(2-chlorophenyl)-3-methyl-2,3,5,7-tetrahydro-[1,3]oxazolo[3,2-d][1,4]benzodiazepin-6-one",362.0588831,362.0588831,0,1,0,2,0,2,0,0,0,65,1203,286,mexazolam,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing|Associated Disorders and Diseases|Spectral Information|Biological Test Results: Active|Biological Test Results: Micromolar,14,589039|651635|743191|743194|743199|743202|743203|743209|743210|743211|743212|743213|743215|743217|743218|743219|743220|743221|743222|743223|743224|743225|743226|743227|743228|743239|743240|743241|743242|1117298|1117304|1117305|1117310|1117312|1117314|1159509|1159515|1159516|1159517|1159518|1159519|1159520|1159521|1159523|1159525|1159526|1159527|1159528|1159529|1159531|1159551|1159552|1159553|1159555|1159614|1224834|1224835|1224836|1224837|1224838|1224839|1224840|1224841|1224842|1224843|1224844|1224845|1224846|1224847|1224848|1224849|1224857|1224859|1224867|1224868|1224869|1224870|1224871|1224872|1224873|1224874|1224875|1224876|1224877|1224878|1224879|1224880|1224881|1224882|1224883|1224884|1224885|1224886|1224887|1224888|1224889|1224890|1224892|1224893|1224894|1224895|1224896|1259241|1259242|1259243|1259244|1259247|1259248|1259364|1259365|1259366|1259367|1259368|1259369|1259377|1259378|1259379|1259380|1259381|1259382|1259383|1259384|1259385|1259386|1259387|1259388|1259390|1259391|1259392|1259393|1259394|1259395|1259396|1259400|1259401|1259402|1259403|1259404|1296008|1296009|1345084|1346378|1346428|1346784|1346795|1346798|1346799|1346824|1346829|1346859|1346877|1346891|1346924|1346977|1346978|1346979|1346980|1346981|1346982|1347030|1347031|1347032|1347033|1347034|1347035|1347036|1347037|1347038|1347053|1347055|1347082|1347083|1347085|1347086|1347089|1347090|1347091|1347092|1347093|1347094|1347095|1347096|1347097|1347098|1347099|1347100|1347101|1347102|1347103|1347104|1347105|1347106|1347107|1347108|1347154|1347395|1347397|1347398|1347399|1347407|1347424|1347425|1479145|1479147|1479149|1479150|1508616|1508620|1508623|1508624|1508630|1645839|1645840|1645841|1645842|1645845|1645846|1645851|1645870|1645876|1645877|1671188|1671190|1671193|1671194|1671196|1671197|1671198|1671199|1671200|1671201|1745845|1745856|1745857|1845191|1845192|1919968|1919969|1919970|1920063|1920064|1920065|1920067|1920068|1963577|1963578|1963579|1963580|1963581|1963582|1963583|1963584|1963585|1963586|1963587|1963588|1963589|1963590|1963591|1963592|1963593|1963594|1963595|1963596|1963597|1963823|1963824|1964107|2060913|2060914|2061098|2061099|2061100|2061101|2061102|2061103|2061104|2061105|2061106|2061107,20050325,"ABI Chem|Ace Therapeutics|AKos Consulting & Solutions|AN PharmaTech|BenchChem|Biorbyt|Biosynth|BOC Sciences|ChEBI|ChEMBL|ChemDB|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Collaborative Drug Discovery, Inc.|CymitQuimica|DiscoveryGate|DrugBank|DrugCentral|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|eMolecules|EPA DSSTox|EvitaChem|FDA Global Substance Registration System (GSRS)|Google Patents|IBM|InvivoChem|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|LGC Standards|MassBank Europe|Mcule|MolGenie|NextBio|NIST Mass Spectrometry Data Center|NORMAN Suspect List Exchange|NovoSeek|PATENTSCOPE (WIPO)|Probes & Drugs portal|Prous Science Drugs of the Future|PubChem Reference Collection|RR Scientific|SCRIPDB|Smolecule|Springer Nature|SureChEMBL|TargetMol|THE BioTek|Thieme Chemistry|Thomson Pharma|Tox21|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine|N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives,"Mexazolam is a benzodiazepine that binds to benzodiazepine-type receptors, inhibiting gamma-aminobutyric acid.",Mexazolam is indicated for the treatment of anxiety with or without psychoneurotic conditions.,benzodiazepine
40391,Pinazepam,"Pinazepam|Domar|52463-83-9|Pinazepamum|7-Chloro-1,3-dihydro-5-phenyl-1-(2-propynyl)-2H-1,4-benzodiazepin-2-one|7-Chloro-1-propargyl-5-phenyl-2H-1,4-benzodiazepin-2-one|5286RBZ882|DTXSID3023475|7-chloro-5-phenyl-1-(prop-2-yn-1-yl)-2,3-dihydro-1H-1,4-benzodiazepin-2-one|propazepam|RefChem:929293|DTXCID203475|N05BA14|7-chloro-5-phenyl-1-propargyl-1,4-benzodiazepin-2-one|257-934-9|Pinazepam [INN]|ZAMI 905|Duna|Z-905|2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-5-phenyl-1-(2-propynyl)-|Pinazepam (INN)|7-Chloro-2,3-dihydro-5-phenyl-1-propargyl-1H-1,4-benzodiazepin-2-one|2H-1,4-BENZODIAZEPIN-2-ONE, 1,3-DIHYDRO-7-CHLORO-5-PHENYL-1-(2-PROPYNYL)-|Pinazepamum [INN-Latin]|Pinazepam (1.0mg/ml in Acetonitrile)|EINECS 257-934-9|BRN 0758533|DEA No. 2883|UNII-5286RBZ882|Domar (TN)|PINAZEPAM [MI]|PINAZEPAM [MART.]|PINAZEPAM [WHO-DD]|SCHEMBL155928|CHEMBL1213352|SCHEMBL29407445|CHEBI:135315|7-chloro-5-phenyl-1-prop-2-ynyl-3H-1,4-benzodiazepin-2-one|DB13335|NS00032511|D07314|Q7194856|7-Chloro-5-phenyl-1-prop-2-ynyl-1,3-dihydro-benzo[e][1,4]diazepin-2-one|7-Chloro-5-phenyl-1-(2-propynyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one #|7-chloro-5-phenyl-1-prop-2-yn-1-yl-1,3-dihydro-2H-1,4-benzodiazepin-2-one",308.8,C18H13ClN2O,32.7,500.0,3.1,22,0,2,2,"InChI=1S/C18H13ClN2O/c1-2-10-21-16-9-8-14(19)11-15(16)18(20-12-17(21)22)13-6-4-3-5-7-13/h1,3-9,11H,10,12H2",C#CCN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,MFZOSKPPVCIFMT-UHFFFAOYSA-N,"7-chloro-5-phenyl-1-prop-2-ynyl-3H-1,4-benzodiazepin-2-one",308.0716407,308.0716407,0,1,0,0,0,0,0,0,0,124,3501,1029,pinazepam,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Associated Disorders and Diseases|Spectral Information|Biological Test Results: Active,13,1195|496817|496818|496819|496820|496821|496823|496824|496825|496826|496827|496828|496829|496830|496831|496832|497005,20050327,"ABI Chem|Alsachim|Ambinter|ChEBI|Chembase.cn|ChEMBL|ChemIDplus|ChemMol|ChemSpider|Clearsynth|Collaborative Drug Discovery, Inc.|CymitQuimica|DiscoveryGate|DrugBank|DrugCentral|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|EPA DSSTox|FDA Global Substance Registration System (GSRS)|Google Patents|Human Metabolome Database (HMDB)|IBM|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|LGC Standards|MassBank of North America (MoNA)|Metabolomics Workbench|MolGenie|NextBio|NextMove Software|NIST Chemistry WebBook|NIST Mass Spectrometry Data Center|NORMAN Suspect List Exchange|NovoSeek|PATENTSCOPE (WIPO)|Probes & Drugs portal|PubChem Reference Collection|RR Scientific|Springer Nature|SureChEMBL|THE BioTek|Therapeutic Target Database (TTD)|Thieme Chemistry|Thomson Pharma|ToxPlanet|Wikidata|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|ZeroPM - Zero Pollution of Persistent, Mobile Substances",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine|D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants|D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents|D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents|N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives,,,benzodiazepine
3033860,Loprazolam,"LOPRAZOLAM|Triazulenone|61197-73-7|Loprazolamum|RU-31158 FREE BASE|759N8462G8|DTXSID30894873|6-(2-Chlorophenyl)-2,4-dihydro-2-((4-methyl-1-piperazinyl)methylene)-8-nitro-1H-imidazo(1,2-a) (1,4)benzodiazepin-1-one|RefChem:154086|DTXCID50910064|N05CD11|8-nitro-6-(o-chlorophenyl)-1,2-dihydro-2-(N-methylpiperazin-1-yl)methylene-1H,4H-imidazo (1,2-a)(1,4)benzodiazepin-1-one methanesulfonate|(4Z)-9-(2-chlorophenyl)-4-((4-methylpiperazin-1-yl)methylidene)-12-nitro-2,5,8-triazatricyclo(8.4.0.02,?)tetradeca-1(10),5,8,11,13-pentaen-3-one|(4Z)-9-(2-chlorophenyl)-4-((4-methylpiperazin-1-yl)methylidene)-12-nitro-2,5,8-triazatricyclo(8.4.0.02,6)tetradeca-1(10),5,8,11,13-pentaen-3-one|RU 31158|triazulenone, (Z)-isomer|Triazulenone, (z)-|Loprazolam (INN)|(2Z)-6-(2-chlorophenyl)-2-[(4-methylpiperazin-1-yl)methylidene]-8-nitro-4H-imidazo[1,2-a][1,4]benzodiazepin-1-one|LOPRAZOLAM [INN]|(Z)-6-(o-Chlorophenyl)-2,4-dihydro-2-((4-methyl-1-piperazinyl)methylene)-8-nitro-1H-imidazo(1,2-a)(1,4)benzodiazepin-1-one|Loprazolam (1mg/mL in Acetonitrile)|Loprazolamum [INN-Latin]|(Z)-6-(2-chlorophenyl)-2-((4-methylpiperazin-1-yl)methylene)-8-nitro-2,4-dihydro-1H-benzo[f]imidazo[1,2-a][1,4]diazepin-1-one|Loprazolam (100 ?g/mL in Acetonitrile)|Loprazolam [INN:BAN]|DEA No. 2773|Dormonoct (TN)|UNII-759N8462G8|(Z)-6-(o-Chlorophenyl)-2,4-dihydro-2-[(4-methyl-1-piperazinyl)methylene]-8-nitro-1H-imidazo[1,2-a][1,4]benzodiazepin-1-one|LOPRAZOLAM [MI]|LOPRAZOLAM [WHO-DD]|SCHEMBL153761|Loprazolam, 1mg/ml in Methanol|CHEMBL2107448|SCHEMBL29357997|CHEBI:135754|UTEFBSAVJNEPTR-RGEXLXHISA-N|DB13643|1H-Imidazo(1,2-a)(1,4)benzodiazepin-1-one, 2,4-dihydro-6-(2-chlorophenyl)-2-((4-methyl-1-piperazinyl)methylene)-8-nitro-|NS00015441|D07326|Q411806|(2Z)-6-(2-CHLOROPHENYL)-2,4-DIHYDRO-2-((4-METHYL-1-PIPERAZINYL)METHYLENE)-8-NITRO-1H-IMIDAZO(1,2-A)(1,4)BENZODIAZEPIN-1-ONE|1H-IMIDAZO(1,2-A)(1,4)BENZODIAZEPIN-1-ONE, 6-(2-CHLOROPHENYL)-2,4-DIHYDRO-2-((4-METHYL-1-PIPERAZINYL)METHYLENE)-8-NITRO-, (2Z)-|1H-Imidazo[1,2-a][1,4]benzodiazepin-1-one, 6-(2-chlorophenyl)-2,4-dihydro-2-[(4-methyl-1-piperazinyl)methylene]-8-nitro-, (Z)-|6-(o-Chlorophenyl)-2,4-dihydro-2-[(4-methyl-1-piperazinyl)methylene]-8-nitro-1H-imidazo[1,2-a][1,4]benzodiazepin-1-one, (Z)-",464.9,C23H21ClN6O3,97.3,891.0,2.9,33,0,7,2,"InChI=1S/C23H21ClN6O3/c1-27-8-10-28(11-9-27)14-19-23(31)29-20-7-6-15(30(32)33)12-17(20)22(25-13-21(29)26-19)16-4-2-3-5-18(16)24/h2-7,12,14H,8-11,13H2,1H3/b19-14-",CN1CCN(CC1)/C=C\2/C(=O)N3C(=N2)CN=C(C4=C3C=CC(=C4)[N+](=O)[O-])C5=CC=CC=C5Cl,UTEFBSAVJNEPTR-RGEXLXHISA-N,"(2Z)-6-(2-chlorophenyl)-2-[(4-methylpiperazin-1-yl)methylidene]-8-nitro-4H-imidazo[1,2-a][1,4]benzodiazepin-1-one",464.1363662,464.1363662,0,1,0,0,0,0,1,1,0,298,8764,3769,triazulenone,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Associated Disorders and Diseases|Spectral Information,13,1135580|1135581|1135582|1135583|1135584|1135585|1135586|1135587|1671498,20050327,"ABI Chem|Alfa Chemistry|Alsachim|Ambinter|BenchChem|ChEBI|Chembase.cn|ChEMBL|ChemIDplus|ChemSpider|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|CymitQuimica|DiscoveryGate|DrugBank|DrugCentral|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|EPA DSSTox|FDA Global Substance Registration System (GSRS)|Google Patents|InvivoChem|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|LGC Standards|MolGenie|NextBio|NIST Mass Spectrometry Data Center|NORMAN Suspect List Exchange|NovoSeek|PATENTSCOPE (WIPO)|Probes & Drugs portal|Prous Science Drugs of the Future|PubChem Reference Collection|RR Scientific|Smolecule|Springer Nature|SureChEMBL|THE BioTek|Thieme Chemistry|Thomson Pharma|ToxPlanet|Wikidata|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine|D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants|D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents|D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents|N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives,,,benzodiazepine
37367,Camazepam,"Camazepam|Albego|Paxor|Limpidon|Camazepamum|Panevril|Nebolan|36104-80-0|SB 5833|HZ3XRH03C3|Carbamic acid, dimethyl-, 7-chloro-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl ester|3-N,N-Dimethylcarbamoyloxy-7-chloro-5-phenyl-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one|DTXSID50865803|(+-)-Camazepam|RefChem:573665|DTXCID10814170|N05BA15|7-chloro-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl N,N-dimethylcarbamate|B-5833|S-58-33|252-866-6|Camazepam [INN]|B 5333|Camazepam (INN)|7-Chloro-1,3-dihydro-3-(N,N-dimethylcarbamoyl)-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|7-Chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-1,4-benzodiazepin-2-one dimethylcarbamate|7-Chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one dimethylcarbamate (ester)|Camazepamum [INN-Latin]|Camazepam (1.0mg/ml in Acetonitrile)|EINECS 252-866-6|UNII-HZ3XRH03C3|BRN 0715180|DEA No. 2749|(7-chloro-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl) N,N-dimethylcarbamate|CAMAZEPAM [MI]|CAMAZEPAM [MART.]|CAMAZEPAM [WHO-DD]|Camazepam, (.+/-.)-|5-25-02-00244 (Beilstein Handbook Reference)|SCHEMBL156795|CHEMBL1095282|SCHEMBL29565155|CHEBI:135570|DB01489|NS00008965|D07315|Q3651150|7-Chloro-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl dimethylcarbamate #",371.8,C19H18ClN3O3,62.2,574.0,2.8,26,0,4,3,"InChI=1S/C19H18ClN3O3/c1-22(2)19(25)26-17-18(24)23(3)15-10-9-13(20)11-14(15)16(21-17)12-7-5-4-6-8-12/h4-11,17H,1-3H3",CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)OC(=O)N(C)C)C3=CC=CC=C3,PXBVEXGRHZFEOF-UHFFFAOYSA-N,"(7-chloro-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl) N,N-dimethylcarbamate",371.1036691,371.1036691,0,1,0,1,0,1,0,0,0,167,1893,312,camazepam,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Associated Disorders and Diseases|Spectral Information,13,476929|1079931|1079932|1079933|1079934|1079935|1079936|1079937|1079938|1079939|1079940|1079941|1079942|1079943|1079944|1079945|1079946|1079947|1079948|1079949|1961681|1961683|1961684|1961686|1961689|1961691|1961692|1961694|1961695|1961697|1961698|1961699|1961700|1961701|1961705|1961707|1961708|1961709|1961710|1961711|1961712|1961714|1961715|1961720|1961721|1961722|1961724|1961725|1961726|1961727|1961728|1961729|1961730|1961731|1961732|1961733|1961734|1961738|1961740|1961741|1961742|1961743|1961748|1961750|1961752|1961755|1961758|1961759|1961760|1961761|1961762|1961766|1961767|1961768|1961770|1961771|1961773|1961774|1961775|1961776|1961778|1961779|1961780|1961781|1961782|1961783|1961784|1961785|1961788|1961789|1961790|1961791|1961792|1961807|1961808|1961809|1961810|1961815|1961816|1961819|1961825|1961827|1961837|1961841|1961842|1961846|1961847|1961848|1961849|1961850|1961851|1961852|1961853|1961855|1961856|1961857|1961858|1961859|1961868|1961878,20050327,"ABI Chem|Alsachim|Ambinter|ChEBI|Chembase.cn|ChEMBL|ChemIDplus|ChemMol|ChemSpider|Clearsynth|Collaborative Drug Discovery, Inc.|CymitQuimica|DiscoveryGate|DrugBank|DrugCentral|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|EPA DSSTox|FDA Global Substance Registration System (GSRS)|Google Patents|IBM|InvivoChem|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|LGC Standards|MolGenie|MuseChem|NextBio|NIST Chemistry WebBook|NIST Mass Spectrometry Data Center|NORMAN Suspect List Exchange|NovoSeek|PATENTSCOPE (WIPO)|Probes & Drugs portal|Prous Science Drugs of the Future|PubChem Reference Collection|RR Scientific|Springer Nature|SureChEMBL|THE BioTek|Thieme Chemistry|Thomson Pharma|ToxPlanet|Wikidata|Wiley|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|ZeroPM - Zero Pollution of Persistent, Mobile Substances",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine|N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives,"Camazepam has been shown to bind competitively to benzodiazepine receptors in the brain with a relatively low affinity in animal models. This binding of benzodiazepine receptors by camazepam and its active metabolites is responsible for its anticonvulsant effects. Notably, only three metabolites were shown to exert anticonvulsant activity, temazepam, oxazepam, and hydroxy camazepam.   The anxiolytic properties of camazepam are also attributed to their ability to bind benzodiazepine receptors, also known as GABA receptors.  When benzodiazepines bind to GABA receptors they increase the efficiency with which the inhibitory neurotransmitter GABA binds.",Camazepam has been used in placebo controlled studies for the treatment of patients suffering from anxiety and depression.,benzodiazepine
9867812,Remimazolam,"Remimazolam|308242-62-8|CNS 7056|CNS-7056|ONO-2745|7V4A8U16MB|ONO2745|4H-Imidazo(1,2-a)(1,4)benzodiazepine-4-propanoic acid, 8-bromo-1-methyl-6-(2-pyridinyl)-, methyl ester, (4S)-|CNS7056|remimazolamum|RefChem:57866|N05CD14|methyl 3-((7S)-12-bromo-3-methyl-9-(pyridin-2-yl)-2,5,8-triazatricyclo(8.4.0.0^(2,6))tetradeca-1(14),3,5,8,10,12-hexaen-7-yl)propanoate|methyl 3-((4S)-8-bromo-2-methyl-6-pyridin-2-yl-4H-imidazo(1,2-a)(1,4)benzodiazepin-4-yl)propanoate|308242-62-8 (freee base)|Byfavo (TN)|methyl (S)-3-(8-bromo-1-methyl-6-(pyridin-2-yl)-4H-benzo[f]imidazo[1,2-a][1,4]diazepin-4-yl)propanoate|Methyl 3-[(4S)-8-bromo-1-methyl-6-(2-pyridyl)-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl]propanoate|Remimazolam [INN]|UNII-7V4A8U16MB|REMIMAZOLAM [MI]|Remimazolam (USAN/INN)|Remimazolam [USAN:INN]|REMIMAZOLAM [USAN]|REMIMAZOLAM [WHO-DD]|orb180886|SCHEMBL846435|CHEMBL4297526|SCHEMBL29379415|SCHEMBL29579211|DTXSID20953024|DEA NO. 2846|GLXC-21992|EX-A5536|ONO 2745|WHO 9232|MFCD18633229|AKOS025213215|DB12404|HY-14867|4523B|CS-0003605|NS00069587|D11788|EN300-18166931|BRD-K89413285-074-01-5|4H-IMIDAZOL(1,2-A)(1,4)BENZODIAZEPINE-4-PROPIONIC ACID, (S)-|(S)-methyl 3-(8-bromo-1-methyl-6-(pyridin-2-yl)-4H-benzo[f]imidazo[1,2-a][1,4]diazepin-4-yl)propanoate|methyl 3-[(7S)-12-bromo-3-methyl-9-(pyridin-2-yl)-2,5,8-triazatricyclo[8.4.0.0,2,6]tetradeca-1(10),3,5,8,11,13-hexaen-7-yl]propanoate|Methyl 3-[8-bromo-1-methyl-6-(pyridin-2-yl)-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl]propanoate|Methyl 3-{(4S)-8-bromo-1-methyl-6-(pyridin-2-yl)-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl}propanoate",439.3,C21H19BrN4O2,69.4,601.0,3.4,28,0,5,5,"InChI=1S/C21H19BrN4O2/c1-13-12-24-21-17(7-9-19(27)28-2)25-20(16-5-3-4-10-23-16)15-11-14(22)6-8-18(15)26(13)21/h3-6,8,10-12,17H,7,9H2,1-2H3/t17-/m0/s1",CC1=CN=C2N1C3=C(C=C(C=C3)Br)C(=N[C@H]2CCC(=O)OC)C4=CC=CC=N4,CYHWMBVXXDIZNZ-KRWDZBQOSA-N,"methyl 3-[(4S)-8-bromo-1-methyl-6-pyridin-2-yl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl]propanoate",438.06914,438.06914,0,1,0,1,1,0,0,0,0,832,394,91,remimazolam,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Associated Disorders and Diseases|Spectral Information,13,1409598|1640020|1645758|1749710|1749711|1964107,20061025,"10X CHEM|A2B Chem|AA BLOCKS|AbaChemScene|AbMole Bioscience|AbovChem LLC|Acorn PharmaTech Product List|Activate Scientific|AKos Consulting & Solutions|Amadis Chemical|Ambinter|Apexmol|Aurora Fine Chemicals LLC|AvaChem Scientific|BenchChem|Biorbyt|Boerchem|Broad Institute|Chem-Space.com Database|ChEMBL|ChemFish Tokyo Co., Ltd.|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|ChemSpider|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|Debye Scientific Co., Ltd|DiscoveryGate|DrugBank|DrugCentral|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|eMolecules|Enamine|EPA DSSTox|EvitaChem|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Fragmenta|Glixx Labs Inc|Google Patents|Human Metabolome Database (HMDB)|Hunan Chemfish Pharmaceutical Co., Ltd.|IBM|InvivoChem|Japan Chemical Substance Dictionary (Nikkaji)|KCS Online|KEGG|LabNetwork, a WuXi AppTec Company|LGC Standards|Mcule|MedChemexpress MCE|Molecule Market|MolGenie|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NextBio|NORMAN Suspect List Exchange|PATENTSCOPE (WIPO)|Probes & Drugs portal|PubChem Reference Collection|RR Scientific|SCRIPDB|SLING Consortium|Smolecule|Springer Nature|Starshine Chemical|SureChEMBL|THE BioTek|Thieme Chemistry|Thomson Pharma|ToxPlanet|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine|N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives|C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent,"Like other benzodiazepines, remimazolam exerts its therapeutic effects by potentiating the effect of gamma-aminobutyric acid (GABA) on GABA(A) receptors, the main inhibitory neurotransmitter receptors in the mammalian brain. GABA(A) receptors are a component of GABA-gated ionotropic chloride channels that produce inhibitory postsynaptic potentials - following activation by GABA, the channel undergoes a conformational change that allows the passage of chloride ions through the channel. The inhibitory potentials produced by GABA neurotransmission play an integral role in the suppression and control of epileptiform nerve firing such as that seen in epilepsy, which makes the GABA system a desirable target in the treatment of epilepsy.  Benzodiazepines are positive allosteric modulators of GABA(A) function. They bind to the interface between alpha () and gamma () subunits on the receptor, commonly referred to as the benzodiazepine binding site, and modulate the receptor such that its inhibitory response to GABA binding is dramatically increased.",Remimazolam is indicated for the induction and maintenance of procedural sedation in adults undergoing procedures lasting 30 minutes or less.,benzodiazepine
25215,Tetrazepam,"Tetrazepam|Myolastan|Musaril|Clinoxan|10379-14-3|CB 4261|CB-4261|FO92091VP8|DTXSID00146058|7-chloro-5-(cyclohex-1-en-1-yl)-1-methyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|7-chloro-5-(1-cyclohexen-1-yl)-1,3-dihydro-1-methyl-2h-1,4-benzodiazepin-2-one|RefChem:188914|DTXCID8068549|233-837-7|Ro 06-6657|4261 CB|7-Chloro-5-(cyclohexen-1-yl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one|2H-1,4-BENZODIAZEPIN-2-ONE, 7-CHLORO-5-(1-CYCLOHEXEN-1-YL)-1,3-DIHYDRO-1-METHYL-|Tetrazepam (INN)|7-Chloro-5-(1-cyclohexenyl)-1-methyl-2-oxo-2,3-dihydro-1H-(1,4)-benzo(f)diazepine|TETRAZEPAM [INN]|Tetrazepam (1mg/ml in Methanol)|Tetrazepamum|Tetrazepamum [INN-Latin]|EINECS 233-837-7|BRN 0890548|Tetrazepam [INN:BAN:DCF]|UNII-FO92091VP8|DEA No. 2886|Myolastan (TN)|TETRAZEPAM [MI]|TETRAZEPAM [MART.]|TETRAZEPAM [WHO-DD]|5-24-04-00064 (Beilstein Handbook Reference)|SCHEMBL157998|CHEMBL2105527|SCHEMBL29500955|TETRAZEPAM [EP MONOGRAPH]|CHEBI:135198|Tetrazepam 0.1 mg/ml in Methanol|Tetrazepam, 1mg/ml in Acetonitrile|CS-6656|DB13324|7-Chloro-5-(1-cyclohexen-1- yl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one|HY-101615|NS00000617|D07277|Q421104|7-Chloro-5-(1-cyclohexen-1-yl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one #|7-chloro-5-(cyclohex-1-en-1-yl)-1-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one",288.77,C16H17ClN2O,32.7,457.0,3.2,20,0,2,1,"InChI=1S/C16H17ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h5,7-9H,2-4,6,10H2,1H3",CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CCCCC3,IQWYAQCHYZHJOS-UHFFFAOYSA-N,"7-chloro-5-(cyclohexen-1-yl)-1-methyl-3H-1,4-benzodiazepin-2-one",288.1029409,288.1029409,0,1,0,0,0,0,0,0,0,698,3042,552,tetrazepam,Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Spectral Information,11,,20050327,"AbaChemScene|ABI Chem|Alsachim|Ambinter|ChEBI|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|Cheminformatics Friedrich-Schiller-University Jena|ChemSpider|Collaborative Drug Discovery, Inc.|CymitQuimica|DiscoveryGate|DrugBank|DrugCentral|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|EPA DSSTox|FDA Global Substance Registration System (GSRS)|Google Patents|Human Metabolome Database (HMDB)|IBM|InvivoChem|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|LGC Standards|MassBank Europe|MassBank of North America (MoNA)|MedChemexpress MCE|Metabolomics Workbench|MolGenie|MuseChem|NextBio|NIST Chemistry WebBook|NIST Mass Spectrometry Data Center|NORMAN Suspect List Exchange|NovoSeek|Parchem|PATENTSCOPE (WIPO)|Probes & Drugs portal|PubChem Reference Collection|RR Scientific|SCRIPDB|Springer Nature|SureChEMBL|THE BioTek|Thieme Chemistry|Thomson Pharma|ToxPlanet|Wikidata|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|ZeroPM - Zero Pollution of Persistent, Mobile Substances|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine|D002491 - Central Nervous System Agents|D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents|M - Musculo-skeletal system > M03 - Muscle relaxants > M03B - Muscle relaxants, centrally acting agents",,,benzodiazepine
3398,Flutazolam,"flutazolam|27060-91-9|Coreminal|Flutazolamum|5G2K7O5D8S|DTXSID6023072|10-Chloro-11b-(2-fluorophenyl)-2,3,7,11b-tetrahydro-7-(2-hydroxyethyl)oxazolo(3,2-d)(1,4)benzodiazepin-6(5H)-one|RefChem:921729|DTXCID203072|10-chloro-11b-(2'-fluorophenyl)-2,3,5,6,7,11b-hexahydro-7-(2''-hydroxyethyl)benzo(6,7)-1,4-diazepino(5,4-b)oxazol-6-one|10-chloro-11b-(2-fluorophenyl)-7-(2-hydroxyethyl)-3,5-dihydro-2H-[1,3]oxazolo[3,2-d][1,4]benzodiazepin-6-one|10-Chloro-11b-(o-fluorophenyl)-2,3,7,11b-tetrahydro-7-(2-hydroxyethyl)oxazolo(3,2-d)(1,4)benzodiazepin-6(5H)-one|Flutazolam [INN:JAN]|Flutazolamum [INN-Latin]|C19H18ClFN2O3|MS-4101|BRN 1092501|UNII-5G2K7O5D8S|Coreminal (TN)|10-Chloro-11b-(2-fluorophenyl)-2,3,7,11b-tetrahydro-7-(2-hydroxyethyl)oxazolo[3,2-d][1,4]benzodiazepin-6(5H)-one; Coreminal; Flutazolam; MS 4101; Ro 7-6102; 10-Chloro-11b-(o-fluorophenyl)-2,3,7,11b-tetrahydro-7-(2-hydroxyethyl)-oxazolo[3,2-d][1,4]benzodiazepin-6(5H)-one|10-chloro-11b-(2-fluorophenyl)-7-(2-hydroxyethyl)-2,3,5,11b-tetrahydrooxazolo(3,2-d) [1,4]benzodiazepin-6(7H)-one|10-chloro-11b-(2-fluorophenyl)-7-(2-hydroxyethyl)-2,3,5,11b-tetrahydrooxazolo(3,2-d)[1,4]benzodiazepin-6(7H)-one|10-chloro-11b-(2-fluorophenyl)-7-(2-hydroxyethyl)-2,3,5,11b-tetrahydrooxazolo[3,2-d] [1,4]benzodiazepin-6(7H)-one|10-Chloro-11b-(2-fluorophenyl)-7-(2-hydroxyethyl)-2,3,5,11b-tetrahydrooxazolo[3,2-d][1,4]benzodiazepin-6(7H)-one|FLUTAZOLAM [MI]|Flutazolam (JAN/INN)|FLUTAZOLAM [INN]|FLUTAZOLAM [JAN]|FLUTAZOLAM [MART.]|FLUTAZOLAM [WHO-DD]|SCHEMBL546958|CHEMBL1697836|SCHEMBL29366182|CHEBI:31628|WMFSSTNVXWNLKI-UHFFFAOYSA-N|GLXC-10548|CBA06091|AKOS040748369|Flutazolam (1.0mg/ml in Acetonitrile)|10-chloro-11b-(2-fluorophenyl)-7-(2-hydroxyethyl)-3,5-dihydro-2H-oxazolo[3,2-d][1,4]benzodiazepin-6-one|DA-73413|Oxazolo(3,2-d)(1,4)benzodiazepin-6(5H)-one, 10-chloro-11b-(o-fluorophenyl)-2,3,7,11b-tetrahydro-7-(2-hydroxyethyl)-|HY-111481|CS-0042166|D01286|Q5462935|10-chloro-11b-(2-fluorophenyl)-7-(2-hydroxyethyl)-2,3,5,11b-tetrahydrooxazolo(3,2-d)[ 1,4]benzodiazepin-6(7H)-one|10-chloro-11b-(2-fluorophenyl)-7-(2-hydroxyethyl)-2,3,7,11b-tetrahydro[1,3]oxazolo[3,2-d][1,4]benzodiazepin-6(5H)-one",376.8,C19H18ClFN2O3,53.0,539.0,2.2,26,1,5,3,"InChI=1S/C19H18ClFN2O3/c20-13-5-6-17-15(11-13)19(14-3-1-2-4-16(14)21)22(8-10-26-19)12-18(25)23(17)7-9-24/h1-6,11,24H,7-10,12H2",C1COC2(N1CC(=O)N(C3=C2C=C(C=C3)Cl)CCO)C4=CC=CC=C4F,WMFSSTNVXWNLKI-UHFFFAOYSA-N,"10-chloro-11b-(2-fluorophenyl)-7-(2-hydroxyethyl)-3,5-dihydro-2H-[1,3]oxazolo[3,2-d][1,4]benzodiazepin-6-one",376.0989983,376.0989983,0,1,0,1,0,1,0,0,0,32,1647,323,flutazolam,Biological Test Results|Chemical and Physical Properties|Classification|Literature|Patents|Toxicity|Spectral Information|Biological Test Results: Active,8,1195|588220,20050325,"3WAY PHARM INC|AbaChemScene|ABI Chem|AKos Consulting & Solutions|Alfa Chemistry|AN PharmaTech|BenchChem|Biosynth|ChEBI|ChEMBL|ChemDB|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemoSapiens|ChemSpider|Clearsynth|Collaborative Drug Discovery, Inc.|CymitQuimica|Debye Scientific Co., Ltd|DiscoveryGate|DrugCentral|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|eInhibitors|EPA DSSTox|FDA Global Substance Registration System (GSRS)|Glixx Labs Inc|Google Patents|IBM|iChemical Technology USA Inc|InvivoChem|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|LGC Standards|Mcule|MedChemexpress MCE|MolGenie|MuseChem|NextBio|NextMove Software|NovoSeek|PATENTSCOPE (WIPO)|Probes & Drugs portal|Prous Science Drugs of the Future|PubChem Reference Collection|RR Scientific|Smolecule|Springer Nature|SureChEMBL|THE BioTek|Thieme Chemistry|Thomson Pharma|ToxPlanet|Wikidata|Wubei-Biochem",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine,,,benzodiazepine
71272,Metaclazepam,"Metaclazepam|Brometazepam|84031-17-4|Metuclazepam|Metaclazepamum|KC-2547|7-Bromo-5-(o-chlorophenyl)-2,3-dihydro-2-(methoxymethyl)-1-methyl-1H-1,4-benzodiazepine|C2N2B1303L|DTXSID40905121|1H-1,4-Benzodiazepine, 7-bromo-5-(2-chlorophenyl)-2,3-dihydro-2-(methoxymethyl)-1-methyl-|Ka-2527|RefChem:156760|DTXCID301334227|1H-1,4-Benzodiazepine, 7-bromo-5-(2-chlorophenyl)-2,3-dihydro-2-methoxy-1-methyl-|Metaclazepam [INN]|Metaclazepam free base|Talis|KA-2547|7-Bromo-5-(2-chlorophenyl)-2,3-dihydro-2-(methoxymethyl)-1-methyl-1H-1,4-benzodiazepine|84031-17-4 (free base)|7-bromo-5-(2-chlorophenyl)-2-(methoxymethyl)-1-methyl-2,3-dihydro-1,4-benzodiazepine|65517-27-3|KC 2547; Ka 2547; Metaclazepam; Metuclazepam; Talis; Talis (pharmaceutical)|Metaclazepamum [INN-Latin]|UNII-C2N2B1303L|METACLAZEPAM [MI]|METACLAZEPAM [WHO-DD]|SCHEMBL433172|CHEMBL1290783|EX-A890|CHEBI:135621|WABYCCJHARSRBH-UHFFFAOYSA-N|AKOS040753008|NS00007823|Q6822419|7-bromo-5-(2-chlorophenyl)-2-(methoxymethyl)-1-methyl-2,3-dihydro-1H-benzo[e][1,4]diazepine",393.7,C18H18BrClN2O,24.8,433.0,4.4,23,0,3,3,"InChI=1S/C18H18BrClN2O/c1-22-13(11-23-2)10-21-18(14-5-3-4-6-16(14)20)15-9-12(19)7-8-17(15)22/h3-9,13H,10-11H2,1-2H3",CN1C(CN=C(C2=C1C=CC(=C2)Br)C3=CC=CC=C3Cl)COC,WABYCCJHARSRBH-UHFFFAOYSA-N,"7-bromo-5-(2-chlorophenyl)-2-(methoxymethyl)-1-methyl-2,3-dihydro-1,4-benzodiazepine",392.0291,392.0291,0,1,0,1,0,1,0,0,0,94,1613,753,metaclazepam,Biological Test Results|Chemical and Physical Properties|Classification|Literature|Patents|Toxicity|Use and Manufacturing|Spectral Information|Biological Test Results: Active,9,539464|1671498,20050808,"001Chemical|A2B Chem|AA BLOCKS|ABI Chem|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Ambinter|AstaTech, Inc.|BenchChem|BioChemPartner|BLD Pharm|BOC Sciences|ChEBI|Chembase.cn|ChEMBL|ChemIDplus|ChemShuttle|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|Cooke Chemical Co., Ltd|CymitQuimica|Debye Scientific Co., Ltd|DiscoveryGate|DrugCentral|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|Elsa Biotechnology|EPA DSSTox|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Google Patents|IBM|InvivoChem|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|LabNetwork, a WuXi AppTec Company|LeadScope|LGC Standards|Mcule|MolCore|MolGenie|Molport|NextBio|NIST Mass Spectrometry Data Center|NORMAN Suspect List Exchange|NovoSeek|PATENTSCOPE (WIPO)|Probes & Drugs portal|Prous Science Drugs of the Future|PubChem Reference Collection|RR Scientific|Smolecule|Springer Nature|Starshine Chemical|SureChEMBL|THE BioTek|Thieme Chemistry|Thomson Pharma|ToxPlanet|Wikidata|ZeroPM - Zero Pollution of Persistent, Mobile Substances",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine,,,benzodiazepine
3033985,Meclonazepam,"Meclonazepam|58662-84-3|Meclonazepamum|RN43209SMA|Ro 11-3128|DTXSID10207366|Ro 11-3128/002|(+)-(S)-5-(o-Chlorophenyl)-1,3-dihydro-3-methyl-7-nitro-2H-1,4-benzodiazepin-2-one|3-Methylclonazepam|2H-1,4-Benzodiazepin-2-one, 5-(2-chlorophenyl)-1,3-dihydro-3-methyl-7-nitro-, (S)-|Meclonazepam, (S)-|Ro-11-3128|RefChem:156207|DTXCID10129857|5-(2-Chlorophenyl)-1,3-dihydro-3-methyl-7-nitro-2H-1,4-benzodiazepin-2-one|Ro11-3128|RO 11-3128 002|RO 11-3128-002|2H-1,4-Benzodiazepin-2-one, 5-(2-chlorophenyl)-1,3-dihydro-3-methyl-7-nitro-|Meclonazepam [INN]|(3S)-5-(2-chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one|Meclonazepam (1.0mg/ml in Methanol)|(S)-5-(2-chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one|2H-1,4-Benzodiazepin-2-one, 5-(2-chlorophenyl)-1,3-dihydro-3-methyl-7-nitro-, (3S)-|Meclonazepam, (S)-isomer|Meclonazepamum [INN-Latin]|UNII-RN43209SMA|Ro 113128|3(S)-Methylclonazepam|Ro 11-3128;Ro 11-3128/002|Meclonazepam [NFLIS-DRUG]|SCHEMBL2109365|CHEMBL1908326|SCHEMBL29365672|LMUVYJCAFWGNSY-VIFPVBQESA-N|Ro-113128|CS-0021828|NS00098699|662M843|Q6804826|(S)-5-(o-chlorophenyl)-1,3-dihydro-3-methyl-7-nitro-2H-1,4-benzodiazepin-2-one|5-(2-chlorophenyl)-3-methyl-7-nitro-2,3-dihydro-1H-1,4-benzodiazepin-2-one",329.74,C16H12ClN3O3,87.3,519.0,2.7,23,1,4,1,"InChI=1S/C16H12ClN3O3/c1-9-16(21)19-14-7-6-10(20(22)23)8-12(14)15(18-9)11-4-2-3-5-13(11)17/h2-9H,1H3,(H,19,21)/t9-/m0/s1",C[C@H]1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3Cl,LMUVYJCAFWGNSY-VIFPVBQESA-N,"(3S)-5-(2-chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one",329.0567189,329.0567189,0,1,0,1,1,0,0,0,0,70,189,45,meclonazepam,Biological Test Results|Chemical and Physical Properties|Classification|Literature|Patents|Pharmacology and Biochemistry|Spectral Information,7,40995|322433,20050808,"001Chemical|A2B Chem|AA BLOCKS|AbaChemScene|ABI Chem|AN PharmaTech|AstaTech, Inc.|BenchChem|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|CymitQuimica|DiscoveryGate|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|eNovation Chemicals|EPA DSSTox|EPA Substance Registry Services|FDA Global Substance Registration System (GSRS)|Google Patents|IBM|iChemical Technology USA Inc|InvivoChem|Japan Chemical Substance Dictionary (Nikkaji)|LGC Standards|MolGenie|NextBio|NextMove Software|NORMAN Suspect List Exchange|NovoSeek|OChem|PATENTSCOPE (WIPO)|Probes & Drugs portal|Prous Science Drugs of the Future|PubChem Reference Collection|RR Scientific|Smolecule|Springer Nature|SureChEMBL|THE BioTek|Thomson Pharma|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine|D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics,,,benzodiazepine
3400,Flutoprazepam,"flutoprazepam|Restas|25967-29-7|Flutoprazepamum|KB-509|2GHY1101MM|DTXSID20180631|7-Chloro-1-cyclopropylmethyl-1,3-dihydro-5-(2-fluorophenyl)-2H-1,4-benzodiazepin-2-one|RefChem:921732|DTXCID60103122|7-Chloro-1-cyclopropylmethyl-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one|2H-1,4-Benzodiazepin-2-one, 7-chloro-1-(cyclopropylmethyl)-5-(2-fluorophenyl)-1,3-dihydro-|7-chloro-1-(cyclopropylmethyl)-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one|2H-1,4-Benzodiazepin-2-one, 7-chloro-1-(cyclopropylmethyl)-5-(o-fluorophenyl)-1,3-dihydro-|Restar|7-chloro-1-(cyclopropylmethyl)-5-(2-fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepin-2-one|7-Chloro-1-(cyclopropylmethyl)-5-(o-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Flutoprazepam [INN:JAN]|C19H16ClFN2O|Flutoprazepamum [INN-Latin]|7-chloro-1-(cyclopropylmethyl)-5-(2-fluorophenyl)-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one|Flutoprazepam (1.0mg/ml in Acetonitrile)|ID-1937|BRN 0898682|UNII-2GHY1101MM|7-Chloro-1-(cyclopropylmethyl)-5-(2-fluorophenyl)-1H-benzo[e][1,4]diazepin-2(3H)-one|Restas (TN)|FLUTOPRAZEPAM [MI]|FLUTOPRAZEPAM [INN]|FLUTOPRAZEPAM [JAN]|Flutoprazepam (JP18/INN)|FLUTOPRAZEPAM [MART.]|SCHEMBL124578|FLUTOPRAZEPAM [WHO-DD]|CHEMBL2106743|SCHEMBL29440278|CHEBI:31629|ABA96729|AKOS016013927|HY-W681659|D01279|Q5462983",342.8,C19H16ClFN2O,32.7,521.0,3.0,24,0,3,3,"InChI=1S/C19H16ClFN2O/c20-13-7-8-17-15(9-13)19(14-3-1-2-4-16(14)21)22-10-18(24)23(17)11-12-5-6-12/h1-4,7-9,12H,5-6,10-11H2",C1CC1CN2C(=O)CN=C(C3=C2C=CC(=C3)Cl)C4=CC=CC=C4F,OFVXPDXXVSGEPX-UHFFFAOYSA-N,"7-chloro-1-(cyclopropylmethyl)-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one",342.093519,342.093519,0,1,0,0,0,0,0,0,0,26,2077,692,flutoprazepam,Chemical and Physical Properties|Classification|Literature|Patents|Toxicity|Spectral Information,6,,20050325,"001Chemical|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|ABI Chem|AHH Chemical co.,ltd|AKos Consulting & Solutions|Ambinter|AN PharmaTech|Aurora Fine Chemicals LLC|BenchChem|BePharm Ltd.|Bic Biotech|Biosynth|ChEBI|Chem-Space.com Database|ChEMBL|ChemDB|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|CymitQuimica|DC Chemicals|DiscoveryGate|DrugCentral|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|eInhibitors|EPA DSSTox|FDA Global Substance Registration System (GSRS)|Google Patents|IBM|InvivoChem|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|LGC Standards|MassBank Europe|Mcule|MedChemexpress MCE|MolCore|MolGenie|Molport|NextBio|NovoSeek|OXCHEM CORPORATION|PATENTSCOPE (WIPO)|Probes & Drugs portal|Prous Science Drugs of the Future|PubChem Reference Collection|RR Scientific|Smolecule|Springer Nature|Starshine Chemical|SureChEMBL|THE BioTek|Thieme Chemistry|Thomson Pharma|Thoreauchem|ToxPlanet|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent|C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine,,,benzodiazepine
37114,Fosazepam,"Fosazepam|35322-07-7|Fosazepamum|HR 930|HR-930|13AK3H33SG|DTXSID10188828|2H-1,4-Benzodiazepin-2-one, 7-chloro-1-((dimethylphosphinyl)methyl)-1,3-dihydro-5-phenyl-|7-Chloro-1-((dimethylphosphinyl)methyl)-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|7-Chloro-1-(dimethylphosphinmethyl)-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one|7-Chloro-1-[(dimethylphosphinyl)methyl]-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|RefChem:921786|DTXCID70111319|7-chloro-1-(dimethylphosphorylmethyl)-5-phenyl-3H-1,4-benzodiazepin-2-one|Fosazepamum [INN-Latin]|BRN 0896155|UNII-13AK3H33SG|Fosazepam [USAN:INN:BAN]|FOSAZEPAM [INN]|Fosazepam (USAN/INN)|FOSAZEPAM [USAN]|5-24-04-00298 (Beilstein Handbook Reference)|SCHEMBL114556|CHEMBL2106762|JMYCGCXYZZHWMO-UHFFFAOYSA-N|2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-chloro-1-((dimethylphosphinyl)methyl)-5-phenyl-|NS00122577|D04248|Q5473321",360.8,C18H18ClN2O2P,49.7,553.0,2.1,24,0,3,3,"InChI=1S/C18H18ClN2O2P/c1-24(2,23)12-21-16-9-8-14(19)10-15(16)18(20-11-17(21)22)13-6-4-3-5-7-13/h3-10H,11-12H2,1-2H3",CP(=O)(C)CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,JMYCGCXYZZHWMO-UHFFFAOYSA-N,"7-chloro-1-(dimethylphosphorylmethyl)-5-phenyl-3H-1,4-benzodiazepin-2-one",360.0794425,360.0794425,0,1,0,0,0,0,0,0,0,35,3331,606,fosazepam,Chemical and Physical Properties|Classification|Literature|Patents|Toxicity|Spectral Information,6,,20050808,"3WAY PHARM INC|ABI Chem|Alfa Chemistry|BOC Sciences|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Collaborative Drug Discovery, Inc.|DiscoveryGate|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|EPA DSSTox|FDA Global Substance Registration System (GSRS)|Google Patents|IBM|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|MolGenie|NextBio|NIST Mass Spectrometry Data Center|NORMAN Suspect List Exchange|NovoSeek|PATENTSCOPE (WIPO)|Probes & Drugs portal|Prous Science Drugs of the Future|PubChem Reference Collection|RR Scientific|Smolecule|Springer Nature|SureChEMBL|THE BioTek|Thomson Pharma|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine,,,benzodiazepine
36834,Fletazepam,"FLETAZEPAM|34482-99-0|Fletazepamum|Sch 15698|3AH8OSQ79O|SCH-15698|DTXSID10188040|RefChem:921658|DTXCID40110531|7-chloro-2,3-dihydro-1-(2,2,2-trifluoroethyl)-5-(o-fluorophenyl)-1H-1,4-benzodia zepine|252-056-2|7-chloro-5-(2-fluorophenyl)-1-(2,2,2-trifluoroethyl)-2,3-dihydro-1,4-benzodiazepine|7-Chloro-5-(o-fluorophenyl)-2,3-dihydro-1-(2,2,2-trifluoroethyl)-1H-1,4-benzodiazepine|1H-1,4-Benzodiazepine, 7-chloro-5-(2-fluorophenyl)-2,3-dihydro-1-(2,2,2-trifluoroethyl)-|Fletazepamum [INN-Latin]|UNII-3AH8OSQ79O|Fletazepam [USAN:INN:BAN]|EINECS 252-056-2|FLETAZEPAM [INN]|Fletazepam (USAN/INN)|FLETAZEPAM [USAN]|SCHEMBL119540|orb2695400|orb2695404|CHEMBL2107281|7-Chloro-2,3-dihydro-1-(2,2,2-trifluoroethyl)-5-(o-fluorophenyl)-1H-1,4-benzodiazepine|NS00054569|D04191|Q5458733",356.7,C17H13ClF4N2,15.6,468.0,5.6,24,0,6,2,"InChI=1S/C17H13ClF4N2/c18-11-5-6-15-13(9-11)16(12-3-1-2-4-14(12)19)23-7-8-24(15)10-17(20,21)22/h1-6,9H,7-8,10H2",C1CN(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F,CIZCSUNUBQXVFP-UHFFFAOYSA-N,"7-chloro-5-(2-fluorophenyl)-1-(2,2,2-trifluoroethyl)-2,3-dihydro-1,4-benzodiazepine",356.0703388,356.0703388,0,1,0,0,0,0,0,0,0,4,362,84,fletazepam,Classification|Literature|Patents,3,,20050808,"3WAY PHARM INC|ABI Chem|Alfa Chemistry|BenchChem|Biorbyt|ChEMBL|ChemIDplus|ChemSpider|Collaborative Drug Discovery, Inc.|DiscoveryGate|ECI Group, LCSB, University of Luxembourg|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|EPA DSSTox|FDA Global Substance Registration System (GSRS)|Google Patents|IBM|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|MolGenie|NextBio|NORMAN Suspect List Exchange|NovoSeek|PATENTSCOPE (WIPO)|Probes & Drugs portal|PubChem Reference Collection|RR Scientific|Smolecule|Springer Nature|SureChEMBL|TargetMol|THE BioTek|Thieme Chemistry|Thomson Pharma|ToxPlanet|Wikidata|ZeroPM - Zero Pollution of Persistent, Mobile Substances",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine,,,benzodiazepine
4540,Desalkylflurazepam,"2886-65-9|Norfludiazepam|Descarbethoxyloflazepate|DTXSID30183057|RefChem:1083168|DTXCID40105548|Norflutoprazepam|norflurazepam|7-Chloro-5-(2-fluorophenyl)-1H-benzo[e][1,4]diazepin-2(3H)-one|7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one|2H-1,4-Benzodiazepin-2-one, 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-|Ro 5-3367|CM 7116|7-Chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Sch 17514|nor-Flurazepam|7-Chloro-5-(2-fluoro-phenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one|MFCD00083443|CHEMBL974|Norfludiazepam; Norflurazepam|X9U41NXR6M|MLS000028851|2H-1,4-Benzodiazepin-2-one, 7-chloro-5-(o-fluorophenyl)-1,3-dihydro-|2H-1,4-BENZODIAZEPIN-2-ONE, 1,3-DIHYDRO-7-CHLORO-5-(2-FLUOROPHENYL)-|SMR000058397|nor-Flurazepam (1.0 mg/mL in Methanol)|EINECS 220-748-3|UNII-X9U41NXR6M|CM-7116|BRN 0754061|SCH-17514|Ro-05-3367|J13.722G|Opera_ID_747|Midazolam EP Impurity F|5-24-04-00319 (Beilstein Handbook Reference)|MLS001146946|SCHEMBL5177297|SCHEMBL30529978|SCHEMBL30730010|CHEBI:135197|HMS2236J07|HMS3371H16|Norfludiazepam, analytical standard|LBC43001|7-chloro-1,3-dihydro-5-(2-fluorophenyl)-2H-1,4-benzodiazepin-2-one|7-chloro-5-(2-fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepin-2-one|BDBM50408014|AKOS015854231|Desalkylflurazepam, 1mg/ml in Methanol|FC26451|Ro-053367|NCGC00247051-01|NCGC00247051-02|AC-11173|DS-18402|MIDAZOLAM IMPURITY F [EP IMPURITY]|DB-047480|CS-0025852|NS00010456|F21326|886F659|Q27293739|FLURAZEPAM MONOHYDROCHLORIDE IMPURITY B [EP IMPURITY]|7-Chloro-5-(2-fluorophenyl)-1H-benzo-[e][1,4]diazepin-2(3H)-one|7-Chloro-5-(o-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one|(E)-7-Chloro-5-(2-fluorophenyl)-1H-benzo[e][1,4]diazepin-2(3H)-one|7-chloro-1,3-dihydro-5 -(2-fluorophenyl)-2H-1,4-benzodiazepin-2-one|7-chloro-1,3-dihydro-5-(2-fluorophenyl)-2H-1,4-benzodiazepine-2-one|5-(2-Fluorophenyl)-1,3-dihydro-7-chloro-2H-1,4-benzodiazepin-2-one;Norfludiazepam;Desalkylflurazepam",288.7,C15H10ClFN2O,41.5,415.0,2.7,20,1,3,1,"InChI=1S/C15H10ClFN2O/c16-9-5-6-13-11(7-9)15(18-8-14(20)19-13)10-3-1-2-4-12(10)17/h1-7H,8H2,(H,19,20)",C1C(=O)NC2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F,UVCOILFBWYKHHB-UHFFFAOYSA-N,"7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one",288.0465688,288.0465688,0,1,0,0,0,0,0,0,0,44,287,127,,Biological Test Results|Chemical and Physical Properties|Classification|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Associated Disorders and Diseases|Spectral Information|Biological Test Results: Active|Biological Test Results: Micromolar,12,485|631|731|757|758|759|760|761|764|775|781|782|793|797|798|799|800|803|804|817|818|827|828|841|861|862|868|871|873|878|880|894|898|920|932|940|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1040|1046|1048|1049|1051|1063|1066|1085|1135|1136|1203|1209|1214|1216|1217|1220|1222|1229|1236|1239|1242|1251|1273|1274|1276|1285|1296|1304|1321|1325|1326|1359|1362|1376|1377|1379|1381|1385|1415|1416|1422|1423|1424|1430|1434|1439|1440|1441|1443|1445|1446|1448|1452|1454|1456|1457|1458|1460|1461|1463|1465|1466|1468|1469|1476|1477|1478|1479|1481|1486|1487|1490|1496|1509|1510|1511|1515|1527|1529|1530|1531|1532|1554|1556|1565|1566|1578|1619|1621|1626|1631|1634|1654|1656|1662|1663|1672|1688|1700|1706|1721|1722|1766|1768|1775|1776|1777|1778|1779|1789|1800|1813|1814|1817|1822|1825|1832|1845|1850|1861|1862|1863|1865|1867|1868|1870|1873|1875|1885|1887|1899|1903|1906|1910|1947|1950|1956|1961|1962|1974|1984|1986|1987|2006|2012|2013|2014|2016|2023|2025|2029|2052|2057|2058|2066|2071|2073|2094|2097|2098|2099|2100|2101|2107|2112|2129|2130|2147|2156|2174|2177|2205|2216|2221|2227|2234|2235|2237|2239|2242|2247|2270|2271|2272|2273|2274|2280|2288|2289|2300|2314|2315|2326|2380|2391|2417|2435|2445|2451|2462|2472|2517|2520|2521|2523|2524|2528|2540|2544|2546|2549|2550|2551|2553|2557|2563|2599|2606|2629|2642|2648|2650|2661|2662|2674|2675|2676|2685|2690|2706|2716|2717|2718|2732|2751|2796|2797|2805|2806|2825|13304|13305|13306|13307|13308|23479|40987|40995|194131|194132|194134|227697|227698|228469|407138|407139|407140|407141|407142|434955|434962|434973|434989|435003|435005|435022|435030|449728|449739|449762|449763|449768|463073|463075|463079|463082|463104|463111|463115|463141|463165|463187|463190|463193|463195|463210|463212|463254|485270|485272|485273|485275|485281|485290|485294|485297|485298|485313|485314|485341|485344|485346|485347|485349|485353|485358|485360|485364|485367|488806|488837|488839|488847|488862|488890|488895|488896|488899|488922|488965|488966|488975|488977|489030|489031|492947|492953|492956|492972|493005|493008|493011|493012|493014|493027|493035|493036|493056|493084|493087|493091|493098|493131|493160|493187|493244|504326|504327|504329|504332|504333|504339|504357|504406|504408|504411|504414|504423|504441|504444|504454|504459|504462|504466|504467|504490|504523|504541|504558|504577|504582|504594|504600|504621|504634|504648|504651|504652|504660|504690|504692|504700|504706|504707|504720|504734|504766|504775|504803|504810|504812|504832|504834|504842|504845|504847|504884|504891|504894|504937|540253|540256|540263|540267|540275|540276|540277|540295|540303|540308|540317|540336|540364|588334|588335|588342|588352|588354|588358|588368|588391|588405|588413|588436|588453|588456|588458|588459|588460|588461|588473|588475|588478|588489|588492|588493|588497|588499|588501|588506|588511|588549|588550|588579|588590|588591|588621|588627|588664|588674|588675|588676|588685|588689|588692|588726|588727|588795|588814|588819|588850|588852|588855|588856|602123|602141|602162|602163|602179|602229|602233|602244|602247|602248|602250|602252|602261|602274|602281|602310|602313|602329|602332|602340|602342|602346|602363|602393|602396|602399|602405|602410|602429|602438|602440|602449|602481|623870|623877|623901|624037|624038|624040|624125|624126|624127|624168|624169|624170|624171|624172|624173|624178|624202|624204|624246|624256|624263|624267|624268|624288|624296|624297|624304|624330|624352|624354|624377|624414|624415|624416|624417|624418|624463|624464|624465|624466|624467|624483|651550|651560|651572|651582|651602|651635|651636|651640|651644|651654|651658|651660|651661|651687|651699|651702|651704|651710|651711|651718|651723|651724|651725|651768|651800|651819|651820|651821|651957|651958|651965|651999|652010|652017|652025|652039|652048|652051|652054|652067|652104|652105|652106|652115|652126|652154|652162|652163|652197|652257|686940|686964|686970|686971|686978|686979|686992|686996|687014|687016|720504|720508|720509|720511|720542|720543|720551|720553|720579|720580|720582|720596|720647|720648|720700|720702|720704|720706|720707|720708|720709|720711|743126|743238|743247|743255|743266|743269|743279|743280|743282|743397|743398|1053175|1053188|1053197|1117319|1150161|1150162|1150163|1150164|1150165|1159524|1159583|1159606|1224864|1224865|1224903|1259251|1259309|1259311|1259313|1259318|1259415|1259416|1272365|1346378|1347041|1347056|1347071|1347075|1347076|1347120|1347131|1645853|1645854|1645855|1645856|1645857|1645858|1645859|1645860|1671190|1671463|1745845|1920062|2161948|2161949,20050325,"001Chemical|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Achemo Scientific Limited|Acmec Biochemical|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Ambinter|Angene Chemical|Anward|Apexmol|Aribo Reagent|Ark Pharma Scientific Limited|AstaTech, Inc.|Aurora Fine Chemicals LLC|BenchChem|BePharm Ltd.|BindingDB|Biocore|Biosynth|BOC Sciences|Boerchem|Bradner/Qi Labs at DFCI|Buhrlage Lab, Dana-Farber Cancer Institute and Novartis Institutes for BioMedical Research (Cambridge, Mass)|Carbott PharmTech Inc.|CATO Research Chemicals Inc.|ChangChem|ChEBI|Chembase.cn|ChEMBL|ChemDB|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|Cheminformatics Friedrich-Schiller-University Jena|ChemMol|ChemoSapiens|ChemSpider|ChemTik|Chung Lab, Department of Pediatrics, Emory University|Clearsynth|Clinivex|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|Cooke Chemical Co., Ltd|CymitQuimica|Debye Scientific Co., Ltd|DiscoveryGate|DrugCentral|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|EPA DSSTox|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Founder Pharma|Google Patents|Hairui Chemical|Hangzhou APIChem Technology|Hangzhou Trylead Chemical Technology|Human Metabolome Database (HMDB)|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|iChemical Technology USA Inc|InvivoChem|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|Key Organics/BIONET|King Scientific|LabNetwork, a WuXi AppTec Company|labseeker|LeadScope|LGC Standards|MassBank Europe|MassBank of North America (MoNA)|Matrix Scientific|Mcule|MLSMR|MolCore|Molepedia|MolGenie|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NextBio|NextMove Software|NIST Chemistry WebBook|NIST Mass Spectrometry Data Center|NORMAN Suspect List Exchange|NovoSeek|Oakwood Products|OChem|OXCHEM CORPORATION|PATENTSCOPE (WIPO)|Pi Chemicals|Probes & Drugs portal|PubChem Reference Collection|RR Scientific|SCRIPDB|Shandong Benrite New Chemical Materials Co.,Ltd|Sigma-Aldrich|Sinfoo Biotech|Small Molecule Screening Facility, UW Madison|Smolecule|Springer Nature|SureChEMBL|Syntree|THE BioTek|Thieme Chemistry|Thomson Pharma|Thoreauchem|ToxPlanet|Tractus|Veeprho|Wikidata|Wubei-Biochem|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|Yuhao Chemical|ZeroPM - Zero Pollution of Persistent, Mobile Substances|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,,,,benzodiazepine
443375,Devazepide,"DEVAZEPIDE|103420-77-5|MK-329|Devazepida|Devazepidum|MK 329|L-364,718|(S)-N-(2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)indole-2-carboxamide|JE6P7QY7NH|L 364718|L-364718|DTXSID2046092|BRN 5156082|L 364,718|3(S)-(-)-1,3-Dihydro-3-(2-indolecarbonylamino)-1-methyl-5-phenyl-2H-(1,4)benzodiazepin-2-one|CHEBI:4460|DTXCID0026092|1H-Indole-2-carboxamide, N-(2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-, (S)-|N-[(3S)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]-1H-indole-2-carboxamide|MK329|N-((3S)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl)-1H-indole-2-carboxamide|RefChem:388921|L364,718|N-(1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl)-1H-indole-2-carboxamide|683-026-0|CHEMBL9506|MFCD00864500|N-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-1H-indole-2-carboxamide|NCGC00159551-01|CAS-103420-77-5|Devazepide [USAN:INN]|Devazepidum [INN-Latin]|UNII-JE6P7QY7NH|Devazepida [INN-Spanish]|Devacade|Devazepide (Standard)|DEVAZEPIDE [INN]|Devazepide (USAN/INN)|DEVAZEPIDE [USAN]|CCK antagonist synthetic 17|CCK antagonist synthetic 18|SCHEMBL148766|orb1707386|SCHEMBL29406251|SCHEMBL31616311|NFHRQQKPEBFUJK-HSZRJFAPSA-N|GLXC-22907|HMS3268J20|1H-Indole-2-carboxamide, N-[(3S)-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-;1H-Indole-2-carboxamide, N-[(3S)-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-|1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide|DEA42077|Tox21_111744|BDBM50005463|NSC778303|PDSP1_000936|PDSP2_000922|AKOS024457038|Devazepide, >=98% (HPLC), powder|Tox21_111744_1|HY-106301R|NSC-778303|NCGC00159551-02|(S)-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-1H-indole-2-carboxamide|MS-27018|HY-106301|CS-0025544|NS00123725|D02693|G12673|Q5266620|BRD-K31238592-001-01-6|(R)-1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide: 0.1C4H10O|(S)-1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide|(Z)-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-1H-indole-2-carboxamide|1H-Indole-2-carboxylic acid ((S)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide|1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide (L-364,718 ((S)-devazepide)|1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide (MK-329, L-364,718)|1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide(Devazepide or (R) L364718)|1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide(devazepide)|1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide(L-364718)|1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide: 0.1C4H10O. 0.15CH2Cl2",408.5,C25H20N4O2,77.6,716.0,4.2,31,2,3,3,"InChI=1S/C25H20N4O2/c1-29-21-14-8-6-12-18(21)22(16-9-3-2-4-10-16)27-23(25(29)31)28-24(30)20-15-17-11-5-7-13-19(17)26-20/h2-15,23,26H,1H3,(H,28,30)/t23-/m1/s1",CN1C2=CC=CC=C2C(=N[C@@H](C1=O)NC(=O)C3=CC4=CC=CC=C4N3)C5=CC=CC=C5,NFHRQQKPEBFUJK-HSZRJFAPSA-N,"N-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-1H-indole-2-carboxamide",408.15862589,408.15862589,0,1,0,1,1,0,0,0,0,982,737,198,Devazepide,Biological Test Results|Interactions and Pathways|Classification|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Associated Disorders and Diseases|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,12,880|881|894|1030|1379|1452|1457|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1490|1688|1766|1768|1865|1948|2101|2107|2112|2314|2315|2451|2472|2517|2528|2546|2549|2551|2662|19010|19011|50505|50512|50518|50523|50680|50692|50815|50819|50829|50830|50954|50961|50965|50966|51102|51113|51114|51118|51120|51440|51441|51447|51613|52279|52413|52420|52568|52889|52890|52898|52901|52907|52916|52917|52919|53029|53031|53038|53042|53044|53054|53057|74344|74349|78288|113301|128001|131536|131538|135326|150391|181989|181990|182130|182131|182135|182136|182138|182139|224779|229930|234374|234648|234942|235048|262758|262760|262761|310316|340240|342381|402081|485281|485290|492961|504327|504332|504749|504832|504834|504847|504865|588211|588212|588213|588579|588834|602332|624030|624031|624032|624044|624101|624136|624137|624138|624139|624141|624151|624170|624172|624173|624260|624296|624297|651548|651631|651632|651633|651634|651635|652048|652051|686978|686979|720516|720532|720533|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743140|743191|743194|743199|743202|743203|743209|743210|743211|743212|743213|743215|743217|743218|743219|743220|743221|743222|743223|743224|743225|743226|743227|743228|743239|743240|743241|743242|743244|1053188|1117298|1117304|1117305|1117310|1117312|1117314|1159509|1159515|1159516|1159517|1159518|1159519|1159520|1159521|1159523|1159524|1159525|1159526|1159527|1159528|1159529|1159531|1159551|1159552|1159553|1159555|1159614|1224834|1224835|1224836|1224837|1224838|1224839|1224840|1224841|1224842|1224843|1224844|1224845|1224846|1224847|1224848|1224849|1224857|1224859|1224867|1224868|1224869|1224870|1224871|1224872|1224873|1224874|1224875|1224876|1224877|1224878|1224879|1224880|1224881|1224882|1224883|1224884|1224885|1224886|1224887|1224888|1224889|1224890|1224892|1224893|1224894|1224895|1224896|1259241|1259242|1259243|1259244|1259247|1259248|1259344|1259355|1259356|1259364|1259365|1259366|1259367|1259368|1259369|1259377|1259378|1259379|1259380|1259381|1259382|1259383|1259384|1259385|1259386|1259387|1259388|1259390|1259391|1259392|1259393|1259394|1259395|1259396|1259400|1259401|1259402|1259403|1259404|1259416|1259421|1296008|1296009|1345084|1345199|1346378|1346428|1346784|1346795|1346798|1346799|1346824|1346829|1346859|1346877|1346891|1346924|1346977|1346978|1346979|1346980|1346981|1346982|1346983|1346984|1346985|1346986|1346987|1347030|1347031|1347032|1347033|1347034|1347035|1347036|1347037|1347038|1347053|1347055|1347082|1347083|1347085|1347086|1347089|1347090|1347091|1347092|1347093|1347094|1347095|1347096|1347097|1347098|1347099|1347100|1347101|1347102|1347103|1347104|1347105|1347106|1347107|1347108|1347131|1347154|1347395|1347397|1347398|1347399|1347407|1347424|1347425|1449628|1508616|1508620|1508623|1508624|1508630|1645839|1645840|1645841|1645842|1645851|1645870|1645876|1645877|1645882|1645883|1645886|1645887|1671188|1671190|1671193|1671194|1671196|1671197|1671198|1671199|1671200|1671201|1671498|1694830|1694831|1694832|1694833|1694834|1694835|1694840|1694842|1694843|1694844|1745845|1745856|1745857|1794731|1794732|1794733|1794735|1794736|1794738|1794739|1794740|1794742|1794745|1794746|1794748|1794750|1794751|1794752|1794753|1794754|1794755|1794756|1794757|1794758|1794759|1794760|1794761|1794763|1794764|1794766|1794767|1794768|1794769|1794771|1794772|1794773|1794774|1794775|1794776|1794777|1794778|1794779|1794780|1794782|1794783|1794785|1794786|1794787|1794788|1794789|1794790|1794792|1794793|1794794|1794795|1794796|1794798|1794799|1794800|1835836|1835874|1836765|1836803|1837694|1837732|1838623|1838661|1839552|1839590|1840481|1840519|1841410|1841448|1842339|1842377|1843268|1843306|1844197|1844235|1912612|1912613|1912614|1912615|1912616|1912617|1912618|1912619|1912620|1912621|1912622|1912623|1912624|1912625|1912626|1912627|1912628|1912629|1912630|1912631|1912632|1912633|1912634|1912635|1912636|1912637|1912638|1912639|1912640|1912641|1912642|1912643|1912644|1912645|1912646|1912647|1912648|1919968|1919969|1919970|1920063|1920064|1920065|1920067|1920068|1963577|1963578|1963579|1963580|1963581|1963582|1963583|1963584|1963585|1963586|1963587|1963588|1963589|1963590|1963591|1963592|1963593|1963594|1963595|1963596|1963823|1963824|2039371|2039383|2039384|2039385|2039386|2039387|2039388|2039389|2039390|2039391|2039392|2039393|2039394|2039395|2039396|2039397|2039398|2039399|2039400|2039401|2039402|2039403|2039404|2039405|2039406|2039407|2039408|2039409|2039410|2039411|2039412|2039413|2039414|2039415|2039416|2039417|2039418|2039419|2039420|2039421|2039422|2039423|2039482|2039485|2039487|2039489|2039490|2039492|2039494|2039495|2060913|2060914|2061098|2061099|2061100|2061101|2061102|2061103|2061104|2061105|2061106|2061107|2162134|2162135|2162136|2162137|2162138|2162139|2162140|2162141|2162142|2162143,20050624,"001Chemical|10X CHEM|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AbaChemScene|ABI Chem|Accel Scientific|Ace Therapeutics|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Chemistry|Amadis Chemical|ApexBio Technology|AstaTech, Inc.|Aurora Fine Chemicals LLC|BenchChem|BindingDB|BioCrick|Biorbyt|Biosynce Pharmatech|Biosynth|BOC Sciences|Broad Institute|CATO Research Chemicals Inc.|ChEBI|ChemBank|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemoSapiens|ChemSpider|ChemTik|Combi-Blocks|Comparative Toxicogenomics Database (CTD)|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DiscoveryGate|DTP/NCI|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|eNovation Chemicals|EPA DSSTox|FDA Global Substance Registration System (GSRS)|Glentham Life Sciences Ltd.|Glixx Labs Inc|Google Patents|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|InvivoChem|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|Key Organics/BIONET|Lan Pharmatech|LGC Standards|Mcule|MedChemexpress MCE|Metabolomics Workbench|MolGenie|Molport|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NextBio|NextMove Software|NORMAN Suspect List Exchange|Novartis Institutes for BioMedical Research|NovoSeek|PATENTSCOPE (WIPO)|Probes & Drugs portal|Protein Data Bank in Europe (PDBe)|Prous Science Drugs of the Future|PubChem Reference Collection|RR Scientific|Santa Cruz Biotechnology, Inc.|SCRIPDB|Shanghai Titan Scientific|Sigma-Aldrich|Smolecule|Springer Nature|Starshine Chemical|SureChEMBL|SynHet - Synthetic Heterocycles|TargetMol|THE BioTek|Thomson Pharma|Tocris Bioscience|Tox21|ToxPlanet|Tractus|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist|D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists",,,benzodiazepine
3307,Etizolam,"etizolam|40054-69-1|Depas|Sedekopan|Etizolamum|Y-7131|4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine|DTXSID0023030|A76XI0HL37|DEA NO. 2780|4-(o-Chlorophenyl)-2-ethyl-9-methyl-6H-thieno(3,2-f)-s-triazolo(4,3-a)(1,4)diazepine|DTXCID203030|7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.0^{2,6}]trideca-2(6),4,7,10,12-pentaene|7-(2-Chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene|4-(2-Chlorophenyl)-2-ethyl-9-methyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine|7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8,11,12-tetraazatricyclo(8.3.0.0^(2,6))trideca-2(6),4,7,10,12-pentaene|7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8,11,12-tetraazatricyclo(8.3.0.02,6)trideca-2(6),4,7,10,12-pentaene|RefChem:596842|N05BA19|662-368-4|NCGC00182031-01|Etizolam [INN:JAN]|Etizolam (1.0 mg/mL in Methanol)|Etizolamum [INN-Latin]|AHR 3219|BRN 0572740|UNII-A76XI0HL37|Sedekopan (TN)|6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine, 4-(2-chlorophenyl)-2-ethyl-9-methyl-; AHR 3219; Depas; Etizolam; Y 7131|AHR3219;Y7131|ETIZOLAM [INN]|ETIZOLAM [JAN]|ETIZOLAM [MI]|Etizolam (JP18/INN)|ETIZOLAM [MART.]|ETIZOLAM [WHO-DD]|6-(o-Chlorophenyl)-8-ethyl-1-methyl-4H-s-triazolo(3,4-c)thieno(2,3-e)(1,4)-diazepine|6-(o-Chlorphenyl)-8-aethyl-1-methyl-4H-s-triazolo(3,4-c)thieno(2,3-e)(1,4)diazepin [German]|6H-Thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine, 4-(2-chlorophenyl)-2-ethyl-9-methyl-|8-Ethyl-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo(3,4c)thieno(2,3e)-1,4-diazepine|SCHEMBL42920|Etizolam, 1mg/ml in Methanol|CHEMBL1289779|SCHEMBL30665015|CHEBI:31583|Etizolam 0.1 mg/ml in Methanol|Etizolam 1.0 mg/ml in Methanol|4c66|HMS3652N06|HY-B0677|Tox21_112931|s4276|AKOS022185397|DB09166|DS-3112|4H-s-Triazolo(3,4-c)thieno(2,3-e)(1,4)-diazepine, 6-(o-chlorophenyl)-8-ethyl-1-methyl-|6-(o-Chlorphenyl)-8-aethyl-1-methyl-4H-s-triazolo(3,4-c)thieno(2,3-e)(1,4)diazepin|NCGC00182031-05|CAS-40054-69-1|NS00098696|SW219903-1|D01514|Q409966|SR-01000883960|SR-01000883960-1|BRD-K68232413-001-01-2|4-(2-Chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f] [1,2,4]triazolo[4,3-a] [1,4]diazepine|4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]-triazolo[4,3-a][1,4]diazepine|H4C",342.8,C17H15ClN4S,71.3,474.0,2.6,23,0,4,2,"InChI=1S/C17H15ClN4S/c1-3-11-8-13-16(12-6-4-5-7-14(12)18)19-9-15-21-20-10(2)22(15)17(13)23-11/h4-8H,3,9H2,1-2H3",CCC1=CC2=C(S1)N3C(=NN=C3CN=C2C4=CC=CC=C4Cl)C,VMZUTJCNQWMAGF-UHFFFAOYSA-N,"7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene",342.0705954,342.0705954,0,1,0,0,0,0,0,0,0,525,4469,971,etizolam,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Associated Disorders and Diseases|Spectral Information|Biological Test Results: Active|Biological Test Results: Micromolar,15,1195|539464|588220|602332|624030|624170|624172|624173|651631|651632|651633|651634|651635|652048|652051|686978|686979|720516|720532|720533|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743140|743191|743194|743199|743202|743203|743209|743210|743211|743212|743213|743215|743217|743218|743219|743220|743221|743222|743223|743224|743225|743226|743227|743228|743239|743240|743241|743242|743244|977608|1117298|1117304|1117305|1117310|1117312|1117314|1159387|1159509|1159515|1159516|1159517|1159518|1159519|1159520|1159521|1159523|1159525|1159526|1159527|1159528|1159529|1159531|1159551|1159552|1159553|1159555|1159614|1224834|1224835|1224836|1224837|1224838|1224839|1224840|1224841|1224842|1224843|1224844|1224845|1224846|1224847|1224848|1224849|1224857|1224859|1224867|1224868|1224869|1224870|1224871|1224872|1224873|1224874|1224875|1224876|1224877|1224878|1224879|1224880|1224881|1224882|1224883|1224884|1224885|1224886|1224887|1224888|1224889|1224890|1224892|1224893|1224894|1224895|1224896|1259241|1259242|1259243|1259244|1259247|1259248|1259251|1259310|1259344|1259364|1259365|1259366|1259367|1259368|1259369|1259374|1259377|1259378|1259379|1259380|1259381|1259382|1259383|1259384|1259385|1259386|1259387|1259388|1259390|1259391|1259392|1259393|1259394|1259395|1259396|1259400|1259401|1259402|1259403|1259404|1259416|1259421|1259422|1296008|1296009|1345084|1345199|1346378|1346428|1346784|1346795|1346798|1346799|1346824|1346829|1346859|1346877|1346891|1346924|1346977|1346978|1346979|1346980|1346981|1346982|1346986|1346987|1347030|1347031|1347032|1347033|1347034|1347035|1347036|1347037|1347038|1347053|1347055|1347080|1347082|1347083|1347085|1347086|1347089|1347090|1347091|1347092|1347093|1347094|1347095|1347096|1347097|1347098|1347099|1347100|1347101|1347102|1347103|1347104|1347105|1347106|1347107|1347108|1347154|1347395|1347397|1347398|1347399|1347407|1347424|1347425|1409598|1409605|1479145|1479147|1479149|1479150|1508586|1508601|1508602|1508616|1508620|1508623|1508624|1508630|1640020|1645758|1645839|1645840|1645841|1645842|1645845|1645846|1645851|1645870|1645876|1645877|1645882|1645883|1645886|1645887|1671188|1671190|1671193|1671194|1671196|1671197|1671198|1671199|1671200|1671201|1745845|1745856|1745857|1749710|1749711|1845191|1845192|1918969|1919968|1919969|1919970|1920063|1920064|1920065|1920067|1920068|1961681|1961683|1961684|1961686|1961691|1961692|1961694|1961695|1961697|1961699|1961701|1961703|1961704|1961707|1961708|1961710|1961712|1961714|1961715|1961720|1961721|1961722|1961724|1961727|1961728|1961729|1961734|1961738|1961742|1961748|1961758|1961760|1961762|1961766|1961767|1961770|1961773|1961774|1961776|1961778|1961780|1961781|1961785|1961788|1961790|1961791|1961801|1961802|1961803|1961807|1961809|1961810|1961811|1961815|1961817|1961818|1961825|1961827|1961837|1961846|1961847|1961848|1961849|1961852|1961855|1961856|1961858|1961878|1963577|1963578|1963579|1963580|1963581|1963582|1963583|1963584|1963585|1963586|1963587|1963588|1963589|1963590|1963591|1963592|1963593|1963594|1963595|1963596|1963823|1963824|1964107|2060913|2060914|2061098|2061099|2061100|2061101|2061102|2061103|2061104|2061105|2061106|2061107,20050325,"3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABI Chem|AbMole Bioscience|AbovChem LLC|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Ambinter|Angene Chemical|AstaTech, Inc.|Aurora Fine Chemicals LLC|BioChemPartner|Boerchem|Broad Institute|ChEBI|Chembase.cn|ChEMBL|ChemDB|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|Cheminformatics Friedrich-Schiller-University Jena|ChemMol|ChemSpider|Clearsynth|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DiscoveryGate|DrugBank|DrugCentral|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|EPA DSSTox|FDA Global Substance Registration System (GSRS)|Google Patents|Human Metabolome Database (HMDB)|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|iChemical Technology USA Inc|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|Key Organics/BIONET|King Scientific|LabNetwork, a WuXi AppTec Company|LeadScope|LGC Standards|MassBank Europe|Mcule|MedChemexpress MCE|Metabolomics Workbench|Molecule Market|MolGenie|National Center for Advancing Translational Sciences (NCATS)|NCBI Structure|NextBio|NextMove Software|NIST Mass Spectrometry Data Center|NORMAN Suspect List Exchange|Novartis Institutes for BioMedical Research|NovoSeek|PATENTSCOPE (WIPO)|Probes & Drugs portal|Prous Science Drugs of the Future|PubChem Reference Collection|Race Chemical|RR Scientific|Selleck Chemicals|Shanghai Institute of Organic Chemistry|Sigma-Aldrich|Springer Nature|Starshine Chemical|SureChEMBL|Syntharise Chemical|Syntree|THE BioTek|The Scripps Research Institute Molecular Screening Center|Thieme Chemistry|Thomson Pharma|Tox21|ToxPlanet|UCSC Chemical Screening Center|Wikidata|Wiley|Wolves R&D chemical|Wubei-Biochem|Yuhao Chemical|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine|D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants|D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents|N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives,"Etizolam is selectively a full agonist at GABA-A receptors to increase GABAergic transmission and enhance GABA-induced Cl- currents. It is reported to bind to the benzodiazepine binding site which is located across the interface between the alpha and gamma subunits. Benzodiazapines are reported to only bind to receptors that contain gamma 2 and alpha 1/2/3/5 subunits. Alpha-1-containing receptors mediate the sedative effects of etizolam whereas alpha-2 and alpha-3 subunit-containing receptors mediate the anxiolytic effect. Etizolam shows high potency and affinity towards GABA-A receptor with alpha 1 beta 2 gamma 2S subunit combination. By binding to the regulatory site of the receptor, etizolam potentiates GABA transmission by facilitating the opening of GABA-induced chloride channels. Etizolam is a specific antagonist at PAFR. It inhibits PAF-induced platelet aggregation by inhibiting PAF binding to the receptors located on the surface of platelets with an IC50 of 22nM.","Indicated for the treatment of generalized anxiety disorder with depression, panic disorder and insomnia.",benzodiazepine
2451,Brotizolam,"brotizolam|Lendormin|Lendorm|57801-81-7|Mederantil|Sintonal|WE 941|Brotizolamum|WE-941|Nimbisan|WE-941-BS|5XZM1R3DKF|2-bromo-4-(2-chlorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine|DTXSID0022692|2-Bromo-4-(2-chlorophenyl)-9-methyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine|DTXCID902692|2-Bromo-4-(o-chlorophenyl)-9-methyl-6H-thieno(3,2-f)-s-triazolo(4,3-a)(1,4)diazepine|6H-Thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine, 2-bromo-4-(2-chlorophenyl)-9-methyl-|2-Bromo-4-(o-chlorophenyl)-9-methyl-6H-thieno[3,2-f]-s-triazolo[4,3-a][1,4]diazepine|6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine, 2-bromo-4-(2-chlorophenyl)-9-methyl-|RefChem:570418|N05CD09|260-964-5|4-bromo-7-(2-chlorophenyl)-13-methyl-3-thia-1,8,11,12-tetraazatricyclo(8.3.0.02,?)trideca-2(6),4,7,10,12-pentaene|4-bromo-7-(2-chlorophenyl)-13-methyl-3-thia-1,8,11,12-tetraazatricyclo(8.3.0.02,6)trideca-2(6),4,7,10,12-pentaene|6H-Thieno(3,2-F)(1,2,4)Triazolo(4,3-A)(1,4)Diazepine,2-Bromo-4-(2-Chlorophenyl)-9-Methyl-|CHEMBL32479|WE 941-BS|NCGC00183872-01|C15H10BrClN4S|Brotizolamum [INN-Latin]|Brotizolam (1.0mg/ml in Acetonitrile)|EINECS 260-964-5|UNII-5XZM1R3DKF|BRN 0839277|Lendormine|Indormyl|Ladormin|WE 941BS|Brotizolam [USAN:INN:BAN:JAN]|Lendormin (TN)|Brotizolam; 2-Bromo-4-(2-chlorophenyl)-9-methyl-6H-thieno-[3,2-f][1,2,4]-triazolo[4,3-a][1,4]diazepine|BROTIZOLAM [MI]|BROTIZOLAM [INN]|BROTIZOLAM [JAN]|BROTIZOLAM [USAN]|BROTIZOLAM [MART.]|8-Bromo-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo(3,4c)thieno(2,3e)-1,4-diazepine|BROTIZOLAM [WHO-DD]|SCHEMBL44067|Brotizolam (JP18/USAN/INN)|SCHEMBL29396298|CHEBI:31308|BROTIZOLAM [EP MONOGRAPH]|WE941|Brotizolam 0.1 mg/ml in Methanol|Brotizolam 1.0 mg/ml in Methanol|Tox21_113601|BDBM50011875|AKOS016014338|DB09017|4-bromo-7-(2-chlorophenyl)-13-methyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene|CAS-57801-81-7|DB-053108|NS00006212|D01744|L000775|Q850074|2-Bromo-4-(2-chloro-phenyl)-9-methyl-6H-1-thia-5,7,8,9a-tetraaza-cyclopenta[e]azulene|2-Bromo-4-(o-chlorophenyl)-9-methyl-6H-thieno[3,2-f]-s-triazolo[4,3-a]-[1,4]diazepine|2-BROMO-4-(2-CHLOROPHENYL)-9-METHYL-6H-THIENO(3,2-F)-S-TRIAZOLO(4,3-A)(1,4)DIAZEPINE|8-BROMO-6-(O-CHLOROPHENYL)-1-METHYL-4H-S-TRIAZOLO(3,4-C)THIENO(2,3-E)-1,4-DIAZEPINE",393.7,C15H10BrClN4S,71.3,465.0,2.8,22,0,4,1,"InChI=1S/C15H10BrClN4S/c1-8-19-20-13-7-18-14(9-4-2-3-5-11(9)17)10-6-12(16)22-15(10)21(8)13/h2-6H,7H2,1H3",CC1=NN=C2N1C3=C(C=C(S3)Br)C(=NC2)C4=CC=CC=C4Cl,UMSGKTJDUHERQW-UHFFFAOYSA-N,"4-bromo-7-(2-chlorophenyl)-13-methyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene",391.94981,391.94981,0,1,0,0,0,0,0,0,0,768,10530,1801,brotizolam,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Associated Disorders and Diseases|Spectral Information|Biological Test Results: Active|Biological Test Results: Micromolar,15,1195|27167|28681|29359|29813|76841|78323|157741|540209|540210|540211|540212|540213|588211|588212|588213|589039|602332|624030|624170|624172|624173|651631|651632|651633|651634|651635|652048|652051|686978|686979|720516|720532|720533|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743140|743244|1097336|1259344|1296008|1345199|1346986|1346987|1479145|1479147|1479149|1479150|1645845|1645846|1645882|1645883|1645886|1645887|1671498|1692392|1845191|1845192|1964107,20050325,"3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|ABI Chem|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Ambinter|AN PharmaTech|BenchChem|Bic Biotech|BindingDB|CCSbase|ChEBI|Chembase.cn|ChEMBL|ChemDB|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Clinivex|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|CymitQuimica|Debye Scientific Co., Ltd|DiscoveryGate|DrugBank|DrugCentral|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|EPA DSSTox|FDA Global Substance Registration System (GSRS)|Glentham Life Sciences Ltd.|GLIDA, GPCR-Ligand Database|Google Patents|IBM|InvivoChem|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|LGC Standards|MassBank Europe|Mcule|MolGenie|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NextBio|NextMove Software|NIST Chemistry WebBook|NIST Mass Spectrometry Data Center|NORMAN Suspect List Exchange|NovoSeek|Parchem|PATENTSCOPE (WIPO)|Probes & Drugs portal|Prous Science Drugs of the Future|PubChem Reference Collection|RR Scientific|Springer Nature|SureChEMBL|THE BioTek|Thieme Chemistry|Thomson Pharma|Thoreauchem|Tox21|ToxPlanet|Wikidata|Wiley|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|ZeroPM - Zero Pollution of Persistent, Mobile Substances|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine|D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives|N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives,,Brotizolam is indicated for 2-4 weeks in the treatment of severe or debilitating insomnia.,benzodiazepine
2811,Clotiazepam,"clotiazepam|Rize|Rizen|Tienor|33671-46-4|Clotiazepamum|Clozan|Y-6047|5-(o-Chlorophenyl)-7-ethyl-1,3-dihydro-1-methyl-2H-thieno(2,3-e)-1,4-diazepin-2-one|DTXSID0022852|ZCN055599V|5-(2-Chlorophenyl)-7-ethyl-1-methyl-1,3-dihydro-2H-thieno(2,3-e)(1,4)diazepin-2-one|2H-Thieno(2,3-e)-1,4-diazepin-2-one, 5-(2-chlorophenyl)-7-ethyl-1,3-dihydro-1-methyl-|2H-Thieno[2,3-e]-1,4-diazepin-2-one, 5-(2-chlorophenyl)-7-ethyl-1,3-dihydro-1-methyl-|5-(2-chlorophenyl)-7-ethyl-1-methyl-1,3-dihydro-2H-thieno[2,3-e][1,4]diazepin-2-one|5-(2-chlorophenyl)-7-ethyl-1-methyl-1H,2H,3H-thieno[2,3-e][1,4]diazepin-2-one|5-(2-chlorophenyl)-7-ethyl-1-methyl-1H,2H,3H-thieno(2,3-e)(1,4)diazepin-2-one|RefChem:577767|Y6047|DTXCID102852|N05BA21|251-627-3|Trecalmo|Rise|Clotiazepamum [INN-Latin]|Y 6047|5-(2-chlorophenyl)-7-ethyl-1-methyl-3H-thieno[2,3-e][1,4]diazepin-2-one|2H-Thieno(2,3e)(1,4)-diazepin-2-one, 5-(o-chlorophenyl)-7-ethyl-1,3-dihydro-1-methyl-|Distensan|Veratran|Clotiazepam [INN:JAN]|2H-Thieno(2,3-e)(1,4)diazepin-2-one, 1,3-dihydro-5-(o-chlorophenyl)-7-ethyl-1-methyl-|Clotiazepam (1 mg/mL in Methanol)|Clotiazepam (1.0mg/ml in Acetonitrile)|Rize (TN)|EINECS 251-627-3|BRN 0623332|UNII-ZCN055599V|DEA No. 2752|CLOTIAZEPAM [MI]|CLOTIAZEPAM [INN]|CLOTIAZEPAM [JAN]|Clotiazepam (JP17/INN)|CLOTIAZEPAM [MART.]|SCHEMBL44592|CLOTIAZEPAM [WHO-DD]|CHEMBL1697737|SCHEMBL29368955|CHEBI:31425|Clotiazepam, 1mg/ml in Methanol|HY-U00317|AKOS005065735|CS-7319|DB01559|NS00009354|D01328|Q2263999|2H-Thieno[2,3-E]-1,4-diazepine-2-one, 5-(2-chlorophenyl)-7-ethyl-1,3-dihydro-1-methyl-",318.8,C16H15ClN2OS,60.9,442.0,3.5,21,0,3,2,"InChI=1S/C16H15ClN2OS/c1-3-10-8-12-15(11-6-4-5-7-13(11)17)18-9-14(20)19(2)16(12)21-10/h4-8H,3,9H2,1-2H3",CCC1=CC2=C(S1)N(C(=O)CN=C2C3=CC=CC=C3Cl)C,CHBRHODLKOZEPZ-UHFFFAOYSA-N,"5-(2-chlorophenyl)-7-ethyl-1-methyl-3H-thieno[2,3-e][1,4]diazepin-2-one",318.059362,318.059362,0,1,0,0,0,0,0,0,0,308,6639,2157,clotiazepam,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Associated Disorders and Diseases|Spectral Information|Biological Test Results: Active|Biological Test Results: Micromolar,15,1195|588211|588212|588213|603955|611614|688286|688292|1079931|1079932|1079933|1079934|1079935|1079936|1079937|1079938|1079939|1079940|1079941|1079942|1079943|1079944|1079945|1079946|1079947|1079948|1079949,20050325,"AbaChemScene|ABI Chem|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alsachim|AN PharmaTech|BenchChem|ChEBI|Chembase.cn|ChEMBL|ChemDB|ChemIDplus|ChemMol|ChemSpider|Clearsynth|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|CymitQuimica|DiscoveryGate|DrugBank|DrugCentral|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|EPA DSSTox|FDA Global Substance Registration System (GSRS)|Google Patents|Human Metabolome Database (HMDB)|IBM|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|LGC Standards|MassBank Europe|MassBank of North America (MoNA)|MedChemexpress MCE|Metabolomics Workbench|MolGenie|MuseChem|NextBio|NextMove Software|NIST Chemistry WebBook|NIST Mass Spectrometry Data Center|NORMAN Suspect List Exchange|NovoSeek|PATENTSCOPE (WIPO)|Probes & Drugs portal|Prous Science Drugs of the Future|PubChem Reference Collection|RR Scientific|Springer Nature|SureChEMBL|THE BioTek|Therapeutic Target Database (TTD)|Thieme Chemistry|Thomson Pharma|ToxPlanet|Wikidata|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|ZeroPM - Zero Pollution of Persistent, Mobile Substances|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine|N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives,"Clotiazepam acts at the benzodiazepine receptors (BZD). This agonizes the action of GABA, increasing the frequency of opening of the channel chlorinates and penetration of the ions chlorinates through the ionophore. Increase in membrane polarization decreases the probability of discharge of neurons.",For the treatment of anxiety disorders.,benzodiazepine
135412795,Bentazepam,"Bentazepam|Thiadipone|29462-18-8|Tiadipone|Bentazepamum|CI-718|QM-6008|66JKK43S1Z|1,3,6,7,8,9-Hexahydro-5-phenyl-2H-(1)benzothieno(2,3-e)-1,4-diazepin-2-one|DTXSID40897431|6,7-Tetramethylene-5-phenyl-1,2-dihydro-3H-thieno(2,3-e)(1,4)diazepin-2-one|2H-(1)BENZOTHIENO(2,3-e)-1,4-DIAZEPIN-2-ONE, 1,3,6,7,8,9-HEXAHYDRO-5-PHENYL-|1,3,6,7,8,9-Hexahydro-5-phenyl-2H-[1]benzothieno[2,3-E]-1,4-diazepin-2-one|RefChem:561261|N05BA24|DTXCID801326772|14-phenyl-8-thia-10,13-diazatricyclo(7.5.0.0^(2,7))tetradeca-1(9),2(7),13-trien-11-one|MLS001240209|SMR000674576|Bentazepam (1mg/mL in acetonitrile)|Bentazepam [USAN:INN]|5-Phenyl-1,2,3,4,7,9-hexahydro-10-thia-6,9-diaza-benzo[a]azulen-8-one|5-phenyl-1,3,6,7,8,9-hexahydro-[1]benzothiolo[2,3-e][1,4]diazepin-2-one|Bentazepamum [INN-Latin]|CI 718|BRN 1083088|UNII-66JKK43S1Z|Tiadipona|BENTAZEPAM [INN]|Bentazepam (USAN/INN)|BENTAZEPAM [USAN]|BENTAZEPAM [MART.]|BENTAZEPAM [WHO-DD]|Oprea1_231952|SCHEMBL44343|cid_34592|SCHEMBL1648551|CHEMBL1521495|SCHEMBL27655733|BDBM70137|CHEBI:135252|HMS2233H05|HMS3370L02|EBA46218|MFCD00868003|5-phenyl-3,4,6,7,8,9-hexahydro-[1]benzothiolo[2,3-e][1,4]diazepin-2-one|5-phenyl-3,4,6,7,8,9-hexahydrobenzothiopheno[2,3-e][1,4]diazepin-2-one|AKOS000707556|MSK38023-100A|DB14719|5-Phenyl-6,7,8,9-tetrahydro-1H-benzo[4,5]thieno[2,3-e][1,4]diazepin-2(3H)-one|NCGC00244971-01|DA-71375|SY270603|CS-0028142|NS00114140|Bentazepam Solution in Acetonitrile, 100ug/mL|D03083|AB00876242-04|Q1421936|BRD-K89490285-001-08-1",296.4,C17H16N2OS,69.7,444.0,3.7,21,1,3,1,"InChI=1S/C17H16N2OS/c20-14-10-18-16(11-6-2-1-3-7-11)15-12-8-4-5-9-13(12)21-17(15)19-14/h1-3,6-7H,4-5,8-10H2,(H,19,20)",C1CCC2=C(C1)C3=C(S2)NC(=O)CN=C3C4=CC=CC=C4,AIZFEOPQVZBNGH-UHFFFAOYSA-N,"5-phenyl-1,3,6,7,8,9-hexahydro-[1]benzothiolo[2,3-e][1,4]diazepin-2-one",296.09833431,296.09833431,0,1,0,0,0,0,0,0,0,36,4854,852,bentazepam,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Associated Disorders and Diseases|Spectral Information|Biological Test Results: Active|Biological Test Results: Micromolar,14,1490|1511|1527|1529|1530|1531|1554|1556|1565|1566|1578|1621|1631|1634|1654|1656|1662|1663|1672|1700|1706|1721|1722|1766|1768|1777|1778|1779|1789|1800|1813|1814|1817|1822|1825|1832|1845|1850|1861|1863|1875|1885|1899|1903|1906|1910|1947|1950|1961|1962|1974|1984|1986|1987|1996|2006|2012|2013|2014|2016|2023|2025|2029|2052|2057|2058|2066|2071|2073|2094|2097|2098|2099|2100|2101|2129|2130|2156|2174|2177|2216|2221|2227|2234|2235|2237|2239|2247|2280|2288|2289|2300|2314|2315|2326|2380|2391|2435|2445|2451|2462|2472|2517|2520|2521|2524|2528|2540|2544|2546|2550|2551|2553|2557|2563|2599|2606|2629|2642|2648|2650|2661|2662|2675|2676|2685|2690|2716|2717|2718|2751|2796|2797|2805|2806|2825|434947|434954|434955|434962|434973|434989|435003|435005|435022|435030|449728|449762|449763|463079|463082|463104|463111|463141|463165|463190|463195|463210|463212|463254|485270|485272|485273|485275|485281|485294|485297|485298|485313|485314|485317|485341|485344|485346|485347|485349|485353|485358|485364|485367|488837|488839|488847|488862|488890|488895|488896|488899|488922|488965|488966|488975|488977|489030|489031|492947|492953|492956|492972|493005|493008|493011|493012|493014|493036|493056|493084|493087|493091|493098|493131|493160|493187|493244|504326|504327|504329|504333|504339|504357|504406|504408|504411|504414|504423|504441|504444|504454|504462|504466|504467|504490|504523|504558|504577|504582|504621|504634|504648|504651|504652|504660|504690|504692|504700|504706|504707|504720|504734|504766|504775|504803|504810|504812|504832|504834|504842|504845|504847|504884|504891|504894|504937|540253|540263|540267|540275|540277|540295|540303|540308|540317|540336|540364|588334|588335|588342|588352|588354|588358|588391|588405|588413|588436|588453|588456|588458|588473|588475|588478|588489|588492|588493|588497|588499|588501|588511|588549|588579|588590|588591|588621|588627|588664|588674|588675|588676|588689|588692|588726|588727|588795|588814|588819|588850|588852|588855|588856|602123|602141|602162|602163|602179|602229|602233|602244|602247|602248|602250|602252|602261|602274|602281|602310|602313|602329|602332|602340|602342|602346|602363|602393|602396|602399|602405|602410|602429|602438|602440|602449|602481|623870|623877|623901|624037|624038|624040|624125|624126|624127|624168|624169|624170|624171|624172|624173|624178|624202|624204|624246|624256|624263|624267|624268|624288|624296|624297|624304|624330|624352|624354|624377|624414|624415|624416|624417|624418|624463|624464|624465|624466|624467|624483|651550|651560|651572|651582|651602|651610|651635|651636|651640|651644|651647|651654|651658|651661|651687|651699|651702|651704|651710|651711|651718|651719|651723|651724|651725|651768|651800|651819|651820|651821|651957|651958|651965|651999|652010|652017|652025|652039|652048|652051|652054|652067|652104|652105|652106|652115|652126|652154|652162|652163|652197|652257|686940|686964|686970|686971|686978|686979|686992|687014|687016|720504|720508|720509|720511|720542|720543|720551|720553|720579|720580|720582|720596|720648|720700|720702|720704|720707|720708|720709|720711|743126|743238|743247|743255|743258|743261|743266|743269|743279|743397|743398|1053175|1053197|1079931|1079932|1079933|1079934|1079935|1079936|1079937|1079938|1079939|1079940|1079941|1079942|1079943|1079944|1079945|1079946|1079947|1079948|1079949|1159524|1159583|1159606|1224865|1259251|1259309|1259311|1259313|1259318|1259415|1272365|1346378|1347041|1347056|1347071|1347075|1347076|1347120|1347131|1671190|1671463|1671498|1745845|1920062|1961680|1961685|1961687|1961688|1961693|1961706|1961716|1961718|1961723|1961736|1961739|1961749|1961751|1961756|1961769|1961772|1961777|1961785|1961786|1961787|1961812|1961813|1961814|1961820|1961826|1961828|1961838|1961839|1961840|1961844|1961845,20190115,"3WAY PHARM INC|AbaChemScene|ABI Chem|Accela ChemBio Inc.|Achemtek|AKos Consulting & Solutions|AN PharmaTech|BenchChem|BindingDB|Biosynth|Broad Institute|ChEBI|ChemBank|ChEMBL|ChemDB|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|Cheminformatics Friedrich-Schiller-University Jena|ChemMol|ChemSpider|Collaborative Drug Discovery, Inc.|Cooke Chemical Co., Ltd|CymitQuimica|DC Chemicals|Debye Scientific Co., Ltd|DiscoveryGate|DrugBank|DrugCentral|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|eNovation Chemicals|EPA DSSTox|FDA Global Substance Registration System (GSRS)|Google Patents|Human Metabolome Database (HMDB)|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|InvivoChem|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|LGC Standards|Mcule|MLSMR|MolGenie|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NextBio|NORMAN Suspect List Exchange|NovoSeek|PATENTSCOPE (WIPO)|Probes & Drugs portal|Prous Science Drugs of the Future|PubChem Reference Collection|RR Scientific|Small Molecule Screening Facility, UW Madison|Smolecule|Southern Research Institute|Springer Nature|Starshine Chemical|SureChEMBL|THE BioTek|Therapeutic Target Database (TTD)|Thomson Pharma|ToxPlanet|Wikidata|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent|C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine|D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives|N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives,,,benzodiazepine